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INTRODUCTION 
 
It was well known to ancient world that plants are a rich source of a 
variety of chemicals with nutritive and therapeutic properties.  In modern era 
herbals are seen as potential medicine for a variety of diseases often 
viewed to supercede the pharmacological efficacy of allopathic drugs.  
There has been a striking increase in use of herbals in both developing and 
the developed countries due to their natural origin and minimal or no side 
effects.  World over the pharmaceutical companies and research 
organization are focusing on the vast untapped potential of herbal as potent 
drugs have been sourced and decades, several drugs have been sourced 
and isolated from herbal medicine (eg) reserpine, vincristine and 
vinblastine. Neem and turmeric have attracted much attention and have 
patented recently. 
 
Apart from usage of herbals in Siddha, metals and minerals are also 
used to combat notorious disease like cancer and AIDS. In our country 
nearly 60% of people are below the poverty line.  The simplicity and efficacy 
of herbal drugs made it popular in rural area.  It is proudful to everybody 
that this ancient system of medicine belongs to our and its everyone’s 
responsibility to elucidase the hidden secrets of this system with the help of 
modern science. Remaining this the author selected “Senkodiveliver 
Chooranam (Plumbago rosea)” for “Azhal Keel Vayu ( Osteo arthritis)”. 
 
It is not a  never discovery and it is a simple endevour of unveiling the 
secrets of Siddha medicine with the assistance of modern technology. 
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AIM AND OBJECTS 
 
The origin of modern medicine started from the evolution of herbal 
system.  The antibiotic era started from the invention of antibiotics from 
moulds, which are one part of plant kingdom. 
 
Highly populated countries like India will have to face the difficulties 
to provide a full pledged medical facilities to everyone.  As most of the 
people are being poor, they need a simple cheaper and effective remedy for 
various diseases. 
 
Considering this the author selected root of Senkodiveli for treationg 
the dreadful disease ““Azhal Keel Vayu ”.  Now Azhal Keel Vayu  is the 
commonest problem among the geriatric population and people above the 
age of 45 suffer from this disorder. 
 
 The main aim of this dissertation is to establish that the drug 
Senkodiveliver Chooranam is an effective remedy for the disease “Azhal 
keel vayu”.  It has been suggested as an effective drug for Azhal keel vayu 
in Gunapadam mooligai (page No.383).   
 
The drug Senkodiveliver is easily available and has not been 
evaluated for Azhal keel vayu.Keeping this in mind, the author has selected 
Senkodiveliver chooranam.The study is done in the following aspects, 
1. Botanical aspects 
2. Gunapadam aspects 
3. Collection of update works on senkodiveliver 
4. Biochemical analysis 
5. Pharmacological analysis 
6. Microbiological analysis 
7. Toxicological analysis 
8. Clinical assessment 
9. Bio statistical analysis 
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BOTANICAL ASPECT 
SENKODIVELIVER 
 
Botanical name  : Plumbago rosea, Linn. 
Synonym  : Plumbago indica, Linn. 
 
Classification: 
According to Bentham and Hooker’s classification (1862-83), 
Plumbago rosea, Linn is classified as follows 
Kingdom   :  Plantae 
Division : Flowering plant 
Class  : Dicotyledanae 
Sub class : Gamopetallae 
Order  : Primulales 
Family : Plumbaginaceae 
Genus :  Plumbago 
Species : rosea 
 
Distribution (Habitat): 
Throughout India often as a cultivated plant or as a garden escape, 
especially in Sikkim and Khasia.  
- Flora of British India page No.481 by Sir J.D. Hooker. 
 
Morphological description: 
A shrubby perennial with semiwoody striate stems and flexible, erect, 
ternate simple and upwards branching. Roots are cylindrical sometimes 
irregularly bent or curved. 
 
60-90 cm long and 1.3-2 cm thick, light yellowish brown, smooth, 
often with short transverse shallow fissures at the region of bends.  Dried 
roots are darker or nearly black. 
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Leaves: 
Leaves are simple, oblong, altemate, oblong, short-cuneate at the 
base passing into a very short amplexicaul, exauriculate reddish petiole.  
Leaves are dark green above and pale below. 
 
Flowers: 
Flowers are 3-5 cm long forming very long terminal & axillary lax 
spikes, which after flowering reach 30-60 cm, rachis quite glabrous. 
Bracteoles ovate, cuspidate, subequal, four times shorter than the calyx, 
almost pellucid. 
 
Calyx: 
Red, short, cylindric, shortly and acutely 5-dentate along the ribs 
covered with stipitate bifarios and subsessile glands. 
 
Corolla : 
Corolla tube slender, four times as long as the calyx, limb wide, 
segments ovate, rotund cuspidate. 
 
Androecium : 
5 stamens, adnate to the base of corolla tube, filaments to 1.2 cm 
long, stamens as many as and opposite to the lobes of a regular corolla . 
 
Gynoecium : 
Ovary 1mm to 3 mm long, ellipsoidal, unilocular, 1-ovuled, styles 5 to 
1.3cm long, filiform. Ovary superior, ovules solitary, pendulous from an 
ascending funicle.  Free central placentation. 
 
Fruit : 
Capsule 2-5 mm long ellipsoid enclosed in persistent calyx. 
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Floral formula : 
Br, Brl, ,  , K(5), C(5), A5, G(5) 
 
- Flora of coorg, page No.443 
- Ayurvedic Pharmacopoeia of  India, Part – II Page No.29. 
 
In the earlier days, Plumbago rosea and the two other species (P. 
Zeylenica and P. Capensis) were used for lead (Plumbum)  poisoning. 
Hence the genus got its name ‘Plumbago’.  
 
Macroscopic Description of dried root: 
Roots 30 cm or more in length, 6 mm or more in diameter as also as 
short stout pieces, including root stocks reddish to deep brown, scars of 
rootlets present, bark thin and brown, internal structure striated, odour 
disaggreable, taste acrid. 
 
Microscopic Description of dried root: 
Transverse section of root shows outermost tissue of cork consisting 
of 5-7 rows of cubical to rectangular dark brown cells, secondary cortex 
consist of 2-3 rows of thin walled rectangular, light brown cells, most of the 
cortex cells contain starch grains, secondary cortex followed by a wide zone 
of cortex, composed of large polygonal to tangenitially elongated 
parenchymatous cells, varying in size and shape, containing starch grains 
and some cells with yellow contents, fibres scattered singly or in groups of 
2-6; phloem, a narrow  zone of usual elements and phloem fibres usually in 
groups of 2-5 or more but occasionally occurring singly, lignified with 
pointed ends and narrow lumen, similar in shape and size to those of 
secondary cortex, cambium indistinct, xylem light yellow to whitish vessels 
radially arranged with pitted thickenings, medullary rays straight 1-6 seriate, 
cells radially elongated and filled with starch grains, stone cells absent. 
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Identity, purity and strength : 
 Foreign matter 
Total ash 
Acid insoluble ash 
Alcohol soluble extractive 
Water soluble 
Not more than 3% 
Not more than 3% 
Not more than 1% 
Not less than 1% 
Not less than 12% 
 
Constituents: 
 Plumbagin 
- Ayurvedic pharmacopoeia of India, Part I, Vol. I, Page – 29. 
 
ROOT CULTURE OF PLUMBAGO ROSEA 
 
Plumbagin production by the root cultures: 
After a few subcultures, the culture roots were examined for their 
ability to produce plumbagin. TLC-densitometric method was used because 
this method is simple, rapid and without prior purification steps (Tewtrakul 
et al. 1992). It was found that the 4-week-old root cultures accumulated 
plumbagin at 0.016 ± 0.0030% DW, The root cultures of Plumbago rosea 
produced higher plumbagin concentration than those of Drosera capensis 
and D. natalensis in vitro cultivations [0.0004% Fresh weight (FW)] (Crouch 
etal. 1990) and the calluses of Plumbago zeylanica (0.0001 - 0.003% FW) 
(Heble et al. 1974). The concentration of plumbagin was, however, less 
than that of Drosophyllum lusitanicum suspension cultures (3.5% FW) 
(Nahalka et al. 1996). In addition, the present study found that the intact 
roots of the 3-year-old Plumbago rosea contain 0.32 - 1.16% DW of 
plumbagin. An attempt to increase the plumbagin production was 
undertaken using medium manipulation and high yielding plant selection. It 
was found that B5 medium supplemented with 1% sucrose was able to 
increase plumbagin production in the root cultures. The growth of the 
culture root, however, decreased (Table 1). Taking into account production 
per litre, the root cultures treated with 3% sucrose yielded higher plumbagin 
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production. In contrast, the influence of (NH4)2S04 exhibited that 2-fold of 
(NH4)2S04 slightly increased plumbagin production but not affected the 
growth of cultured roots (Table 1). The effect of sucrose on increasing 
plumbagin production might be related to the retardation of the growth, 
while increasing (NH4)2S04 concentration or NH4+/N03" ratio should be 
affected on the improvement of plumbagin production by the root cultures. 
 
To select high plumbagin producing Plumbago rosea plants, the 
variation of plumbagin content was assessed in fifty-seven plant samples. 
The average yield of plumbagin in the root samples was 0.86 + 0.186% 
DW. The highest and lowest yields were 1.16 ± 0.020 and 0.32 ± 0.026% 
DW, respectively. The high-yielding plant was selected and its leaves were 
used as an initial explant for the establishment of P. rosea root cultures in 
the conditions described above. It was found that the root culture initiated 
from high plumbagin producing plant produced 0.129 ± 0.0139% plumbagin 
DW. Although the roots under these conditions produced less plumbagin 
than the intact roots of Plumbago rosea, the growing time is shorter when 
compared to field growing plants. This study also indicated that the use of 
high producing plants for the initiation of tissue culture is the way to 
succeed in an increasing of secondary metabolite production by plant tissue 
cultures. 
 
During the 48-day period of the culture growth, it was found that 
plumbagin was initially accumulated in the exponential phase (after day 7) 
and actively biosynthesized until reaching the late linear phase. The highest 
content of plumbagin was observed at day 34; after that the production rate 
began to slow down. This fact suggests that the biosynthesis of plumbagin 
took place at the same time that other primary metabolites used for growth 
promotion. This phenomenon is different from most secondary metabolite 
production, which usually takes place when the growth rate is declined 
 
- Electronic Journal of Biotechnology ISSN: 0717-3458 
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PHYTO CHEMICAL ASPECT  
 
Root of Plumbago (indica) rosea contains,  
 
¾ Orange yellow pigment called plumbagin (5-hydroxy -2-methyl – 1, 4 
naphtho quinone C11, H8, O3), m.p. 77-780 ) 
¾ A sitosterol glycoside (C33 H36 06, m.p. 259-600) 
¾ A sitosterol 
¾ A fatty alcohol 
¾ Tannis 
¾ An amorphous brown pigment 
 
CH3
OH
O
O  
PLUMBAGIN 
Plumbagin is the active principle of the drug and is present in 
Plumbago rosea upto the extent of about 0.91%. Plumbagin (5-hydroxy–2 
methyl–1,4 naphthoquinone) has been widely used as phytomedicine.  The 
concentration of plumbagin varies according to the locality, growth and age 
of the plant according of the soil and the season of the year.  The older the 
plant and drive the soil, the greater is the quantity of the active principle 
found in the root. The fresh roots give much higher yields of plumbagin than 
the roots stored for a long period. 
 
Plumbagin is a pharamacologically important natural product derived 
from acetate malonate pathway, which is formed from L-tyrosine most likely 
by homogentisate ring cleavage pathway. The key enzyme of this ring 
cleavage reaction is homogentisate oxidase. 
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These compounds represent a chemical defense for plants and have 
many known biological properties.  It occurs in various parts of the plant in 
different species, in a colourless combined form that can be processed to 
plumbagin by acid treatment. 
 
Uses of plumbagin: 
Plumbagin is used as gastric stimulant and appetizer.  Locally it is 
vesicant. It has specific action on the uterus.  Root is said to increase the 
digestive power and promotes appetite. Plumbagin stimulates the central 
nervous system in small dose. The blood pressure shows a slight fall. 
Plumbagin is a powerful irritant and has well marked antiseptic properties.  
In small doses, the drug is a sudorific.  It is suggested that the action is 
probably due to the direct effect of the drug on the muscles.  A liniment 
made form bruised root mixed with a little bland oil is used as a rubefacient 
in rheumatism, paralytic affections, in enlarged glands, buboes etc.. 
 
Plumbagin in small doses has a stimulant action on central nervous 
system on plain muscles, and on secretion of sweat, urine and bile.  Blood 
pressure shows a slight fall and the peripheral vessels are found to dilate.  
Stimulation is not properly observed in the isolated heart of the frog.  
Plumbagain in a dilution of 1ppm stimulates the isolated rabbit  uterus  and 
10 times the concentration inhibits it. Studies on oxytoxic effect of the 
aqueous extract of the roots on isolated rat uterus, isolated uterine strips 
indicate that the drug has a powerful action on uterus. 
 
Plumbagin acts as a powerful irritant and has well marked antiseptic 
properties.  In 20ppm dilution, it inhibits pathogenic fungi such as 
Coccidioides, immitis, Histoplasma capsulatum, Ctesnomyces radians, and 
Trichophyton ferrugineum. It acts as an antimetabolite towards 
Mycobacterium tuberculosis preliminary studies have shown that Plumbagin 
may be useful in the treatment of early cases of leucoderma and baldness 
of head. 
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Therapeutic properties of Plumbagin : 
Plumbagin has been identified and commercially exploited from many  
species like Plumbago rosea are in red listed category and are protected 
hence an alternative source for plumbagin extraction in mass propogation 
of these source plants. This can be achieved with using tissue culture 
technique and by the aid of biochemical, and molecular techniques, 
plumbagin production can be enhanced.  There is much evidence to 
suggest that plumbagin may have potential as a chemotherapeutic agent 
and exhibits a variety of pharmacological activities. It is useful in treating 
bronchial infection, whooping cough, incipient phthisis and is used against 
old age arteriosclerosis, hyperglycemic, hypolipidemic, immunomodulator, 
cosmetic, aphrodisiac, chitin synthetase inhibitor, insecticidal and enhance 
in vitro phagocytosis of human granulocytes.  The extract used in certain 
sweets as a leishmanicide, in dyspepsia, piles, anasarca, diarrhoea and 
skin disease. It inhibits the development of insect and parastic nematodes.  
It is useful for removal of corns, warts, keratoses, freckles and sunbums. 
The antimicrobial, antiasthma, antituberculosis, anti-spasmodic, anticancer, 
antileprosy, antifertility, abortifacient, antimalarial properties are also well 
known. 
 
Plumbagin showed in vitro immunosuppressive cytotoxicity at 
concentrations 1.0-0.01 mg/ml and a reversed effect (immunostimulating) at 
very low concentrations.  The dual effect of plumbagin was observed on 
human granulocytes in vitro studies, where the compound exerted cytotoxic 
effects at high concentrations (100 ug – 10 fg/ml) and no effect of 2.5 ng – 
25 pg/ml.  Similar dose dependent activity was observed in a parallel study 
for several well known cytotoxic or cytostatic agents. 
 
Plumbagin has also been evaluated by Developmental Therapautics 
program, National Cancer Institute (NCI) in its screening panel HIV-1. 
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Biological activity of Plumbagin: 
Plumbagin administrated to hyper-lipidaemic rabbits reduced serum 
cholesterol by 53-86% and LDL cholesterol by 61-91%. It lowers 
cholesterol/ phospholipids ratio by 45.8% and elevates decreased HDL 
cholesterol significantly. It prevents accumulation of cholesterol and 
triglycerides in liver and aorta and regressed atheramatous plaques of 
thoracic and abdominal aorta. Plumbagin treated hyperlipidaemic subjects 
excreted more faecal cholesterol and phospholipids. 
 
- Wealth of India, Page 162-163 
- Materia Medica of India and their therapeutics, Page 381. 
- Flowering plants of Travancore, Page – 232. 
- Indian medicinal  plants, page -172. 
- Herbal drugs, page – 140. 
- Compendum of Indian medicinal  plants, page -22. 
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TOXICOLOGICAL ASPECT 
 
The root and probably other portions of these plants contain an active 
principle plumbagin  a highly acid crystalline glycoside. When the bruised 
root or twigs are applied externally the skin becomes red and vesicates . 
Taken internally in small doses the plant acts as a sudorific and stimulates 
the contraction of the muscular tissues of the heart,intestine and uterus. 
Taken internally in large doses the plant acts as an irritant or norcotic irritant 
poison and produces the same symptoms as Calotropis. The treatment and 
post mortum appearances are also similar . 
 
Medicolegal aspects: 
 Plumbago is chiefly use as an  abortifacient and for this pupose it has 
been used either by ingestion or by local application directly of the root or 
twig or the paste by means of an abortion stick to the ‘os uteri. Malingerers 
have used plumbago to produce artrificial acts as an irritant or norcotic 
irritant poison and produces the same effect of madar juice. Plumbago has 
rarely been used as a homicidal poison. 
 
Symptoms: 
           Applied externally,roots produce irritation and blisters.Taken 
internally there is burning pain from mouth to stomach, vomiting ,thirst 
,diarrhoea, collapse and death . 
 
Post mortum appearances : 
         Signs of gastric enterictis and congestion of internal organs are found.  
         -The essential of forensic medicine  and toxicology , page 406. 
- Prikh’s textbook of medical jurisprudence and toxicology, Page 800 & 980. 
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eQ;R KwpT: 
1. gRnea;iaf; Fbf;f Ntz;Lk; 
2. ey;nyz;iza;apy; cSe;J til Rl;L cz;zyhk; 
3. Nga;ggPh;f;F>Nfhiuf;fpoq;F Mfpa ,uz;ilAk; Nrh;j;Jf;  
fpahokpl;L nfhLj;jhYk; rpj;jpu%yNth; eQ;R ePq;Fk;. 
- eQ;R KwpT Ehy;> gf;fk; 57. 
 
Uterotrophic, Fetotoxic and Abortifacient Effect of a Malaysian 
variety of Plumbago rosea L. on Isolated Rat uterus and Pregnant 
Mice. 
 
Acute toxicity study:  
Acute toxicity study in mice (n=12)revealed that the LD50 of the 
root extract of Plumbago rosea L, is ≥1000 mg kg-1. 
 
Result:  
  Date obtained on both in vitro and in vivo study suggested 
that this local Malayasian variety of Plumbago rosea L. might 
have uterotrophic activity but not oxytocic activity. The plant 
also exhibited pronounced fetotoxicity and mild abortifacient 
activity. Hence the presnt study provides some supports for its 
accredited traditional use as abortifacient that has been in 
practice in the region. However,further indepth studies are 
required to substantiate these results and isolation of 
compounds with possible antiferti l ity potentials should be 
pursued to develop this plant based contraceptive measures.  
- Pakistan Journal of Biological Sciences 10(5). 763-7(57, 2007 
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GUNAPADAM ASPECT 
nrq;nfhbNtypNth; 
 
NtWngah;fs; (%d;W nfhbNtypf;Fk; nghJthdJ) : 
 mzpQ;rpy;> mjpfehhp> mjpgJq;fp> moy>; cjhrdd>; vhp> vOjh> xyp> 
fUehfk;> fdyp> fhhpif> nfhLNtyp> fhdpype;jpud;> fhzpyk;> nfhbr;rp> 
rpj;jpu%yp> rpj;jpu%yk;> rpj;jpuk;> ngUfpop> joy;> jpf;F> jpireh> tQ;rjhuk;> 
td;dp> mf;dp> mjprdfp> cjftd;> rjhNtjh> rpj;jpufk;> jgdd;> jpfdh> 
trfk;. tdkh> td;dpghpak;> rpj;ufk;> nfhbtd;dp> typtd;dp> jptpgpehkk;. 
 
nrq;nfhbNtypf;Fhpa NtWngah;fs; : 
 rptg;Gr;rpj;jpu%yk;> nfhb%yp> nrq;nfhb%yp. 
- Fzghlk; - %ypif tFg;G> gf;fk; 381-382. 
 
“fyf;fkpy;yh tjpdhjp G+nld;Wk; NgU 
 fUthd tf;fpdpNfh %r;rputy;yp 
Ayf;fky;yh Tgtuspjnkd;Wk; NgU 
 xfpfhth ohdUj;jp te;juf;fndd;Wk; NgU 
kyf;fkpy;yhkyNfhb twhsnkd;Wk; NgU 
 trdpj;NjhQ;rpj; jUf;fhia tl;nll;Lg;NgU 
ayf;f nkd;wq;f lf;ifawpth ndd;Wk; NgU 
 mUspNdhq; nfhbNtyp ajw;Fg; NgNu” 
 
nghUs;: 
 mjpdhjpG+L> mf;fpdp> NfhKr;rputy;yp> cgtuspjk;> mUj;jp> muf;fd;> 
mlf;ifawpthd;. 
- mfj;jpah; gQ;rfhtpa epfz;L> gf;fk; 93. 
 
“rpj;jpu%yg; Ngh;jidNa nrg;gf; NfS 
 rpj;jpukhq; nfhbNrhjp fhe;j KNkahFk; 
gj;jpukhk; gfg;ghjp ghtpghsp 
 ghr NfhjUzhf;fpdp AkhFq; 
#j;jpukhk; Rthypdp thshr;rpifAkhFq; 
nfhbajf tpNdhjj;jhy; gl;rkhk; 
gj;jpukhk; gbghlf; Fr;Rg Kf;fhFk; 
 gz;ghdr; rpj;jpu%yg; NgUkhNk” 
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nghUs;: 
 nfhbNrhjp> fhe;jk;> gfg;ghjp> ghtpghsp> jUzhf;fpdp> Rthypdp> 
thshr;rpif> RgKf;F. 
   - Nghfh epfz;L 1200> gf;fk; 196. 
 “td;dpf;nfhbNtyp td;rpj; jpu%yk; 
 cd;Dkow; flTs; xg;ghFk;” 
 
nghUs;: 
 td;dp> rpj;jpu%yk;> mf;fpdp 
  -mfj;jpah; itj;jpa rpe;jhkzp 4000 2k;ghfk;> gf;fk; 322. 
 
Vernacular Names: 
Eng :  Red Leadwort, Fire plant, Officinal leadwort, Rose 
  flowered leadwort 
Hindi  : Rakka – Chitra 
Sans  : Chitraka, Druna 
Beng  : Lal Chitra 
Mar  : Lal chitra 
Tel  : Errachitramulam 
Guj  : Lal Chitrak, ratochatro 
Tam  : Senkodiveli 
Kan  : Kampacitramulam 
Mal  : Chivappukodiveli 
Ori  : Rongachitramulo, lat chitra 
Kashmir : Shitray, Shitranj 
Assam : Agechhit 
Pers  : Shitareh 
Arab  : Shitaraj, Chitramul, Shitturridge, Shitarajeshmar  
Punj  : Chitra 
Urdu  : Sheetraj 
 
rq;f ,yf;fpa ngah; : nrq;nfhLNthp 
gpw;fhy ,yf;fpa ngah; : nrq;nfhLNtyp 
cyftof;Fngah;  : nrq;nfhbNtyp 
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“nrq;nfhLNthp Njkh kzpr;rpif” fgpyh; (FwpQ;rpg;ghl;L-64) 
 fgpyh; $wpa nrq;nfhLNthp vd;gjw;F nrq;nfhLNthpg;G+ vd;W ciu 
$wpdhh; er;rpdhh;f;fpdpah;. ,J ,f;fhyj;jpy; nfhbNtyp vd;W toq;Fk; 
rpWnrbNa MFk;. 
 
 “nrq;nfhL Nthpr; nrOk; G+k;gpizay;” - (rpyg;gjpfhhuk; 14>91) 
 vd;W fhh;g;gUt xg;gidg; G+f;fisg; gw;wp $Wfpwhh; ,sq;Nfhtbfs; 
 
tiffs;: 
 1. ntz;nfhbNtyp - Plumbago zeylanica 
 2. nrq;nfhbNtyp - Plumbago rosea 
 3. fUq;nfhbNtyp - Plumbago Capensis 
 
 ,k;%d;wpd; FzKk; ngUk;ghYk; xd;NwahFk;. 
 
 nrq;nfhbNtyp ,e;jpah KOtJk; fpilf;FnkdpDk; Nkw;Fj; njhlh;r;rp 
kiyr;rhh;ig mLj;j ,lq;fspNy fpilf;Fk;. rpw;rpy Njhl;lq;fspy; ,ij 
moFf;fhf itj;J gapuhf;FtJz;L. 
 
gad;gLk; cWg;G :   
Nth;  
Organaleptic Characters: 
Rit (Taste)   : fhh;g;G 
jd;ik (Potence)   : ntg;gk; 
gphpT (Post digestive effect) : fhh;g;G 
 
nra;if : 
 ntg;gKz;lhfp - Stimulant  
 jbg;Gz;lhf;fp - Rubefacient 
 
Gwr;nra;if  :  
 Gz;zhf;fp  - Caustic 
 nfhg;GsnkOg;gp - Vesicant  
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nghJf;Fzk; : 
 “#iyAk; tha;TQ; Rfrd;dp khe;jRuQ; 
 rPyrpu Neha;thje; jPUq;fhz; - Nfhykape; 
 Nglida khNj gpwq;FnrQ;rpj; u%yk; 
 NrL nrk;igj; Ja;agw;gQ; nra;.” 
 
 ,J fgk;> tPf;fk;> fpuhzp> thjNeha;fs;> tapw;Wg;GO> ghz;L> #iy> 
thA> Rfrd;dp> ke;jRuk;> jiyNeha; Mfpatw;iw fz;bf;Fk;. NkYk; ,J 
nrk;igg; gw;gkhf;Fk;. ,jd;Fzk; fUq;nfhbNtypf;FhpaJ. Mdhy; rpWePh; 
nfhjpg;Gz;lhfhJ. 
 
msT: 
 “fhy;Kjy; miu tuhfndil 
  msTf;F kpQ;rpdhy; tplkpf;Fk;” 
 
nghUs; : 
 1– 2 fpuhk; tiu toq;fyhk; 
 
Properties and Action : 
 Rasa  - Katu 
 Guna  - Laghu, Ruksa, Tiksha 
 Vinja  - Usna 
 Vipaka - Katu 
 Kama  - Dipana, Pacana, Grahi, Kaphavatachara 
    Arsohara, Sulabara, Suthahara 
- Ayurvedic Pharmacopeia, Page – 29 
gad;fs;; : 
1. “tif tifahk; thjq;fs; khshtprh;g;gp rpNyl;Lkk; 
gifgifahk; vd;Nwgfh;.” 
nghUs;:  
thjk;> rpye;jp> fgk;. Nghd;witfSf;Ff; nfhbNtyp gifahFk;. 
2. “fl;b tpuzq; fpue;jp fhy;fsiuahg;Gf; 
fl;b# iytPf;fq; fhy;;%y – Kl;buj;jf; 
fl;LeP Nuw;wq; fdj;j. ngUtapW 
kl;Lq; nfhLNtyp ahk;.” 
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nghUs; :  
nfhbNtypahdJ tpj;jpujp> Gz;> nrhwp> rpuq;F> thjNuhfk;> Fj];jhd 
tpj;jpujp> Fj;jy;> Nrhig> %yNuhfk;. cjpuf;fl;L> [y];uhtk;> kNfhjuk; 
Mfpaitfisf; Fzkhf;Fk;. 
 
nra;if :  
 cw;rhffhhp. KiwtpahjpahNuhfp> RNtjfhhp> Jt];Nghlfhhp> 
UJth;j;jdjhhp> N~hzfhhp> jputfhhp> jhJÑPzNuhjp. 
 
 ,jd; Nth;g;gl;ilia miuj;J Ntisf;F ¼ my;yJ ½ Rz;ilf;fha; 
gpukhzk;> gRk;ghypyhtJ my;yJ nts;shl;Lg; ghypyhtJ fyf;fp 10 
my;yJ 15 ehs; nfhLj;Jtug; goQ;Ruk;> #iyf;fl;b> GiuNahLk; 
miuahg;Gf;fl;b #iyg;gpbg;G> ntb#iy> Njfj;jpy; fuL Kulhff; 
fl;LQ;#iy> cs;%yk;> fpue;jp> fh;g;gthA Kjypa gygpzpfs; jPUk;. 
ngz;fSf;F tPl;Ltpyf;fk; rhpahff; fhzhj rkak; ,jd; Nth;g;gl;il 
miuj;J Rkhh; ½ Rz;ilf;fha; gpukhznkLj;J NfhopKl;ilapd; 
ntz;fUtpy; fyf;fpf; nfhLf;fTk;. ,t;thW fhiy khiy 3 ehs; nfhLf;f 
khjtpyf;F rhpahff; fhZk;. #jfthAitAk; fz;bf;Fk;. 
 
 ,ijf; nfhz;L jahhpf;fg;gLk; japiu czTld; cz;Ltu %yKis 
mw;W NghFk;. 
- gjhh;j;j Fztpsf;fk; - %yth;f;fk;> gf;fk; - 79. 
 
tof;F : 
1. rpj;jpu%yNth;g;gl;il> kpsfuizNth;gl;il> nehr;rpNth;g;gl;il> 
,it xt;nthd;iwAk; tiff;F 180 fpuhk; vLj;Jg; nghbj;J 
ntUfb msT Fsph;e;j ePhpy; nfhs;s rfy thjKk; Nghk;. 
 
2. nfhbNtyp Nth;gl;il> vUf;fz; Nth;gl;il> rq;fd;Nth;g;gl;il 
Fq;Fkg;G+ ,tw;iw xnuilahf vLj;Jg; nghbj;J ntUfbasT 
%d;W ehs; fhiy> khiy> ,UNtisAk; rhg;gpl;L ehd;fhk; 
ehs; jiyKOfp> japUQ;rhjKk; rhg;gpl typg;Gj; jPUk; 
gj;jpak; : cg;G MfhJ. 
 
3. nfhbNtypg;nghb: 
nfhbNtypNth;> Gq;fd;Nth;> Mapy;gl;il ,itfspd;  nghb 
tiff;Fg; gyk; xd;W> fLf;fha;> jpg;gpyp> fLF> fUQ;rPufk;> 
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,itfis rpWtWg;ghf tWj;Jg; nghbj;J jdpj;jdp tiff;F 
6 fpuhk; ,it ahtw;iwAk; xd;whff; fye;J Ntis xd;Wf;F 
%d;W tpuy; msT ehw;gJ ehl;fs; nfhs;s> fpuhzp> cjuthA> 
%ythA> thjthA> gl;rthjk;> Kjypad jPUk;. 
 
4. nfhbNtyp> 36 fpuhk;> Rf;F> kpsF. jpg;gpyp> Xkk;;> rpWNjf;F> 
ahidj;jpg;gpyp> Nfh~;lk;> fLFg;nghb ,it tiff;F 1fpuhk>; 
ngUq;fhak;> trk;G ,it ,uz;Lk; tiff;F 18fpuhk; 
,itfis ,stWg;gha; tWj;Jg; nghbj;J rPdp rkd; $l;bf; 
nfhs;sTk;. ,jdhy; thjNeha;fs; Nghd;wit jPUk;. 
 
5. nfhbNtyp vz;nza;: 
,j;ijyj;ij ,uz;L my;yJ %d;W ehs; jiyapy; itj;Jj; 
jiy KOfptu ePh;g;gpdprk;. Jk;ky;. jPuhj;jiytyp ,itfs; 
jPUk;. thjNeha;fSk; Nghk;. 
 
,Nj ijyj;Jld; fUg;Gf;fl;b Nrh;j;J tbj;Jf; fLk;gj;jpakhf 
%d;Wehs;  6 Ntis rhg;gpl;L ehd;fhk; ehs; tpl;L Ie;jhk; 
ehs; jiyf;F ePh; thh;j;J cg;ig tWj;Jf; $l;l miuahg;G 
ePq;Fk;. 
 
6. nfhbNtypj; ijyk; : 
jhsprhjp> jhd;wpf;fha;. gRtpd;ntz;nza; Nghd;w nghUl;fs; 
Nrh;j;J nra;ag;gLk; ,j;ijyj;ijj; Nja;j;J %o;fptu nrhwp> 
miuahg;G> Gz;Giufs;> gpsit jPUk;. 
 
7. rpj;jpu%yf;Fspif: 
  msT   : kpsfsT cUz;il> ,UNtis gj;Jehs;  
     gj;jpakhf ,Uf;fTk;. 
 
    jPUk; Neha;fs; : tpuzk;> ,uzf;fpue;jp> Nahdpg;Gw;W.  
       ypq;fg;Gw;W> fs;spg;G+f;fpue;jp> ngsj;jpuk;.  
       vz;tpjf;Fd;kk; Nghk;. 
 
8. nfhbNtypf;FbePh;: 
    msT   : 30 kp.yp> ehs; xd;Wf;F> %d;Wjuk;  
 
    jPUk; Neha;  : thAtpdhYz;lhFk; clk;Gf;Fj;jy; 
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9. nfhbNtypg;gw;W: 
  nfhbNtypNtiu ey;nyz;nza; tp;l;liuj;Jg; gw;WNghl fUiz%yk;> 
miuahg;G> fz;lkhiy ,it fiuAk;. 
 
10. fUg;igthia mfykhf;FQ; nra;if cz;lhf;f ,jd;Ntiu mt;tplk; 
nrYj;jf; fUit ntspg;gLj;Jk;. Nth;g;gl;ilia miuj;J xU 
tuhfndil msthf cl;nfhs;tJk; cz;L. 
 
11. ,jd;Nth; cyh;e;jhy; td;ik FiwAk;. mij miuj;J Nkfg;gil> 
Fl;lk;. ,itfSf;F Nkw;g;G+r;rhf toq;fyhk;. 
 
12. nfhbNtyp Ntiug; ghf;fsT miuj;J gRtpd; ghypy; (fwe;j Mtp 
khWKd;) Fbf;f> gh~hzj;jpd; tPW jzpAk;. 
- Fzghlk; - %ypif tFg;G> gf;fk;-383-385. 
 
Rj;jp: 
nfhbNtyp Ntiu Rz;zhk;G ePhpy; fhy;kzp Neuk; Cwitj;j gpd; 
Rj;jePhpy; fOtp> cyh;j;jpnaLj;Jf; nfhs;tNj Rj;jpahFk;. 
- %ypif ,ay;> gf;fk; 203 
Uses: 
 The root is used as a powerful  sialogogue. In south India, the dried 
root is highly valued as a remedy for secondary syphilis and leprosy.  
 
 The milky juice is useful in ophthalmic and external application for 
scabies. It’s vesicating  properties have been successfully utilized in curing 
certain cases of leucoderma. 
 
 The root in combination with other drugs is prescribed for snake bite 
and scorpion sting but the drug in not an antidote to either snake venom to 
scorpion venom. Bruised root in its natural state, acrid and stimulating, but 
when tempered with a little bland oil, it is used as an external application in 
rheumatic and paralytic affections. It is also prescribed internally in small 
doses for the same complaints in combination with some other as simple 
powder. 
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 Vesicant properties of the root were known to old writers, but it was 
O’ Shagginessy, who first tried this drug in between three hundred and four 
hundred cases and found that the root bark being rubbed with water into a 
paste and 12-18 hours and that it can be used as a cheap substitute for 
cantharides, with the additional advantage of causing no irritation of the 
genito urinary organs. When administrated internally it acts as a stimulant  
 
 The Javanese apply the root topically for curing toothache. Tubers 
ground with jaggery or molasses and boiled in coconut oil and given 
internally in tumours in any part of the body. Root with curd, bruised and 
applied to cure formation of flesh and ulcers. Root boiled in oil and applied 
to the head cured formation of flesh in the eyes or nose. Root is used as an 
alterative. A paste of it is used as a stimulant application to abscesses to 
promote suppuration and the root is said to increase the digestive power 
and promote appetite. A tincture   of the root is used in dyspepsia, piles, 
flatulance, loss of appetite and other digestive complaints. In Java, the root 
is used as a veterinary medicine for expelling worms in horses. 
 
- Wealth of India, Page 162 - 163. 
- Materia Medica of India and their therapeutics,page- 381.  
- Flowering plants of Travancore, page - 232. 
- Flora of British India - Vol.III, page - 240. 
- Indian Medicine Plants, Page - 172. 
- Holistic Online.Com  
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nfhbNtyp NrUk; thjNeha;f;fhd kUe;Jfs; 
1. nfhbNtypr; #uzk;: 
msT : xU fpuhk;> ,UNtis> xU kz;;lyk; cl;nfhs;sTk;. 
- capH fhf;Fk; rpj;j kUj;Jtk;> gf;fk; 435. 
2. rpj;jpu %y ,sfk;: 
msT : 5fpuhk; ,UNtis 
- capH fhf;Fk; rpj;j kUj;Jtk;> gf;fk; 458. 
3. khy;fpq;fpdpf; ijyk; : 
gpuNahfk; ,j;ijyj;ijf; if>fhy; Filr;ry; Neha;> ghhprthjk; 
Nghd;witfSf;F Nja;j;J neUg;gdypy; fhl;l FzkhFk;. 
- rpfpr;rhuj;djPgk;; gf;fk; 196. 
4. re;jpf thjf; f~hak; : 
 ruf;Ffs;: 
nfhbNtyp NtH  -  1 gyk; 
jpg;gpyp   -  1 gyk; 
fz;lj;jpg;gpyp  -  1 gyk; 
nrt;tpak;   -  1 gyk; 
Rf;F   -  1 gyk; 
 
nra;Kiw> gad;: 
,itfis xd;whf ,bj;J 1 NrH ePH tpl;L vl;bnyhd;whf tw;w 
itj;J urnre;J}uk;> fhe;j nre;J}uk; $l;b mUe;jp te;jhy; %l;Lfspy; 
Vw;gLk; thjq;fs; jPUk;. 
- jd;te;jphp itj;jpak;> gf;fk; 350. 
5. gQ;rhHf;fj; ijyk;: 
Nky; g+r thjtif ahTk; jPUk;. 
- mfj;jpaH itj;jpa rpe;jhkzp> 2Mk; ghfk; gf;fk; 68. 
 
6. kfhG+jpfhj; ijyk;: 
 clypy; G+rp jiy %o;fTk; erpakhfTk; gad;gLj;jyhk;. ,jdhy; 
ghhprthA> fuj;jk;gk;> NkfthA kw;Wk; vz;gJ tifahd thjNeha;fSk; 
jPUk;. 
- mfj;jpaH itj;jpa rpe;jhkzp 4000> 2Mk; ghfk;> gf;fk; 99. 
 
7. tyuhf;fpr tlfk;: 
cgNahfk; : Ntz;Lk; NghJ ,ij ey;nyz;iza;apy; nghhpj;J cl;nfhs;sTk;. 
- mfj;jpaH itj;jpa fhtpak; 1500 ghfk; 2> gf;fk; 196. 
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8. thjuhl;r urk;: 
msT : 
Fd;wpasT(130 kp.fp.)> ,UNtis 
 
mDghdk; : 
Njd; nte;ePH 
- Nfhrhap ghfk; 2 gf;fk; 413. 
 
9. rJHtifr; rhw;wpd; ijyk; 
jPUk; Neha;fs;: 
xU thuk; clk;gpy; g+rptu ehl;gl;l thjNeha;fs; jPUk;. 
- ruNge;jpuH thj Nuhf rpfpr;ir> gf;fk; 15. 
 
10. fe;jf urhadk;: 
jpdk; ,UNtis fow;rpf; nfhl;ilasT rhg;gpl 80 tif 
thjNeha;fs; jPUk;. 
- fz;Zrhkp guk;giu itj;jpak>; gf;fk; 460. 
 
11. ee;jp nkOF: 
msT : 150 kp.fp. gidnty;yj;Jld; jpdk; 2 Ntis 7 ehl;fl;F nfhLj;J 
7 ehs; ,ilntsptpl;L jpUk;g nfhLf;fTk;. ,t;thwhf 5 Kiw 
nfhLf;fTk;. 
 
gj;jpak; : ey;nyz;iza;> kPd;> fLF> ,iwr;rp> fUthL> Gsp> Gif 
ePf;fTk; 
- jkpof rpj;j itj;jpa FUFyk;> gf;fk; 425. 
 
12. ,bty;yhjp:  
msT :200 kp.fp Kjy; 1 fpuhk; tiu> ,UNtis 
mDghdk;: gidnty;yk; 
- jkpof rpj;j itj;jpa FUFyk; gf;fk - 503 
 
13. ,ypq;fg; gjq;fk;: 
msT : 130kp.fp.> ,UNtis 
 
mDghdk;: gid nty;yk;> Njd>; ntz;nza;. 
- mDNghf itj;jpa etePjk; Vohk; ghfk;> gffk; 124. 
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14. fe;jf nea;: 
msT: 5 fpuhk;> ,UNtisahf xU kz;lyk; cl;nfhs;sTk;. 
- capH fhf;Fk; rpj;j kUj;Jtk;> gf;fk; 437. 
 
15. rPd ty;yhjp nkOF: 
msT : 5 fpuhk;> ,UNtis xUkz;lyk; cl;nfhs;sTk; 
- mfj;jpaH ty;yhjp 600> gf;fk; 8. 
16. mkpHjnfe;jp Ff;fpy; ty;yhjp : 
msT : 5 fpuhk;> ,UNtis> xUkz;lyk; cl;nfhs;sTk.; 
- mfj;jpaH ty;yhjp 600> gf;fk; 12. 
17. kfhrhHj;J}yhjpf; Fspif: 
msT: 1-2 fpuhk;> tpbaw;fhiyapy; 
- mfj;jpaH ty;yhjp 600> gf;fk; 41. 
18. kfh mdYUtr; #uzk;: 
msT> JizkUe;J: 1 fpuhk; Njdpy; nfhs;sNtz;Lk;  
- mfj;jpaH ty;yhjp 600> gf;fk; 113. 
-  
 25
nfhbNtyp NrUk; gpwNeha;fSf;fhd kUe;Jfs; 
 
1. nfhbNtyp khj;jpiu: 
msT : 1 khj;jpiu> ,UNtis> 7 ehl;fs; kl;Lk; 
JizkUe;J : nts;shl;Lg;ghy>; gRk;ghy; 
jPUk; Neha;fs; : fpue;jp> Gz;> #iy> if>fhy;fspy; Filr;ry;> ngz;fs; 
njhlHghy; cz;lhd NkfNeha;fs;. 
- jkpof rpj;j itj;jpa FUFyk>; gf;fk; 386 
 
2. rpj;jpu%yhjpj; J}s:; 
msT  : xU fpuhk;> ,UNtis 
mDghdk;> jPUk; Neha;fs; : Njd>; rHf;fiuapy; cl;nfhs;s 
mf;fpdpke;jk;> mjprhuk;> Fd;kk; jPUk;. 
- capH fhf;Fk; rpj;j kUj;Jtk;> gf;fk; 433. 
 
3. nfhbNtyp vz;nza; : 
ruf;Ffs;: 
nfhbNtyp NtHg;gl;il -  vYkpr;rq;fhasT 
rHf;fiu   - vYkpr;rq;fhasT 
ey;nyz;nza;  - Mohf;F 
nra;Kiw: ,tw;iwf; fye;J gjj;jpy; ,wf;fp itj;Jf; nfhs;sNtz;Lk;. 
msT: 8kp.yp. fLFld; 3 ehs;> fhiyapy; kl;Lk; 
jPUk; Neha;: miuahg;G 
-mfj;jpaH kzp 4000> 2Mk; ghfk;> gf;fk; 49. 
4. rpj;jputy;yhjp ,sfk;: 
msT: 5fpuhk;> jpdk; ,UNtis tPjk; xU kz;lyk; rhg;gplTk.; 
jPUk; Neha;fs;: R+iy> fpue;jp> Klf;FNkfthjk;> ntSg;G> fz;lkhiy> 
Gw;W. 
- jkpof rpj;j itj;jpa FUFyk;> gf;fk; 250. 
5.  jrjPghf;fpdpr; #uzk;: 
msT: Ntisf;F 3 fpuhk; tPjk; jpdk; ,UNtis 
jPUk;Neha;fs;: mrPuzk;> ,Uky;> Ruk;> Ngjp ghz;L mNuhrfk; 
Kjypaitfs; ePq;Fk;. 
gj;jpak; : ,r;rhgj;jpak; 
- rpfpr;rhuj;d jPgk; - gf;fk; 117. 
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6. nfhbf;fs;sp vz;nza;: 
msT : jpde;NjhWk; fhiyapy; Njftd;ikf; Nfw;wthW 5kp.yp. tPjk; 5 
my;yJ 7 ehs; rhg;gplTk;. 
jPUk; Neha;fs; : Nkftpuzq;fs>; gpbg;G> #iy> miuahg;G> nfhWf;F> 
fz;lkhiy> khHghzp Kjypa gpzpfs; jPUk;. 
gj;jpak; : cg;ig tWj;Jk;> Gspiar; Rl;Lk; $l;bf; nfhs;sTk;. 
- rpfpr;rhuj;djPgk;> gf;fk; 186. 
 
7. thjRuf; fpahok;: 
cgNahfk; : ,e;jf; fpahoj;ij %d;W ghfkhfg; gq;fpl;L ehd;F kzp 
Neuj;jpw;F xU Kiw nfhLf;fTk;. ,g;gb Kd;W ehs; xd;gJ Ntis 
nfhLf;f thjRuk; FzkhFk;. 
- fz;Zrhkp guk;giu itj;jpak;> gf;fk; 51. 
 
8. tpy;thjp Nyfpak;: 
msT  : 5 fpuhk;> ,UNtis 
jPUk; Neha;fs; :  ghz;L> fhkhiy> Nrhif> tpf;fy;> gpj;jk;. gytpjNgjp> 
- fz;Zrhkp guk;giu itj;jpak>; gf;fk; 173. 
 
9. ahidf;fhYf;F Nkfrpe;jhkzp nkOF : 
cgNahfk; : 250kp.fp.> ,UNtis gidnty;yj;Jld; 20ehs; nfhLf;fTk; 
- fz;Zrhkp guk;giu itj;jpak>; gf;fk; 200. 
 
10. gQ;rhf;fpdpr; #uzk; : 
ruf;Ffs;: 
nfhbNtyp NtH 
gpuz;ilf; fpoq;F 
kUs; fpoq;F 
fhl;Lf; fUizf; fpoq;F 
Gspeuisf; fpoq;F 
- ,itfs; tiff;F 1 gyk; 
 
nra;Kiw: ,itfisr; rpWrpW Jz;Lfshf eWf;fpf; fhaitj;J ,bj;J  
   t];jpufhak; nra;J gj;jpug;gLj;jTk;. 
cgNahfk;: ,r;R+uzk; 8fpuhk; vLj;J Nkhhpy; fye;J fhiy Ntisapy; gUfTk;. 
jPUk; Neha;fs; : R+iyfs; jPUk; 
- ruNge;jpuH itj;jpa Kiwfs;> gf;fk; 32. 
11. fy;ahz ytdk; : 
msT : 5fpuhk;> nea;Ald; Fioj;J ,UNtis cz;zTk; 
jPUk; Neha;fs; : %y Neha;fs; jPUk; 
- ruNge;jpuH itj;jpa Kiwfs>; gf;fk; 83. 
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12. fw;flhf rpq;fpr; #uzk; : 
ruf;Ffs; : 
rpj;jpu %yk; - 1 gyk; 
fw;flhf rpq;fp  -  1 gyk; 
rpW Njf;F  - 1 gyk; 
 
nra;Kiw: ruf;Ffis ed;whf cyHj;jpg; nghbj;Jf; nfhs;sTk;. 
cgNahfk;: Ntisf;F 2 fpuhk; thiof;fpoq;Fr; rhw;wpy; nfhLf;fTk;. 
jPUk; Neha;fs; : tpf;fy; jPUk; 
- ruNge;jpuH itj;jpa Kiwfs;> gf;fk; 203 
 
13. rHthq;f thj #uzk;: 
msT : 1-2 fpuhk; ,UNtis 
JizkUe;J : ,Q;rpr;rhW> Njd;> nte;ePH. 
jPUk; Neha;fs;: rHthq;fthjk; thj#iy> Fly;thjk;> fHg;g#iy> 
,uj;jgpj;jk;> #iy. 
- jkpof rpj;j itj;jpa FUFyk;> gf;fk; 366. 
 
14. kfhtPu nkOF : 
msT: 100 - 200 kp.fp. gid nty;yj;Jld; jpdk; 1 Ntis kl;Lk; 15 
ehl;fSf;Ff; nfhLj;J ,ilntsptpl;L Neha; jPUk; tiu nfhLf;fTk;. 
jPUk; Neha;fs;: khHGNeha;> typg;G> Kfthjk;> rd;dp> cjWthjk>; 
#jf#iy> miuahg;G>; Nkf Neha;. 
- jkpof rpj;j itj;jpa FUFyk;> gf;fk; 416. 
 
15. jpg;gpyp urhadk; : 
msT : 3-6 fpuhk; R+uzk>; 100 kp.fp. jhk;gpur;nre;J}uj;Jld; jpdk; ,UNtis. 
jPUk; Neha;fs;: rak;> fhrk;> ke;jhufhrk;> ,isg;G> <is 
- jkpof rpj;j itj;jpa FUFyk;> gf;fk; 502. 
16. fypq;fhjp ,sfk; : 
msT: 5fpuhk;> jpdk; ,UNtis. 
jPUk; Neha;fs;: thA> #iy> thAj;jpul;rp. 
 - capH fhf;Fk; rpj;j kUj;Jtk;> gf;fk; 449. 
17. fe;jf tlfk; : 
msT: 5 fpuhk;> ,UNtis. 
jPUk; Neha; : NkfNeha; 
- capH fhf;Fk; rpj;j kUj;Jtk;> gf;fk; 473. 
MATERIALS AND METHODS 
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Senkodiveliver chooranam was taken as a single drug for treating 
Azhal keel vayu in this dissertation. 
 
Collection of Senkodiveliver: 
Senkodiveliver (Dried root of Plumbago rosea) was collected from the 
Drug store,Pharmacy, Govt. Siddha Medical College, Palayamkottai. 
 
Purification of Senkodiveliver : 
Senkodivelivar was soaked in calcium hydroxide solution for an 15 
minutes and then dried in shadows. 
 
Preparation of Senkodiveliver chooranam: 
Senkodiveliver was made into a fine powder (chooranam) and filter 
by a pure white cloth (vasthirakayam) 
 
Purification of Senkodiveliver chooranam: 
Senkodiveliver chooranam was moistured with cow’s milk.  An 
earthern pot was taken and half filled with a mixture of cow’s milk and 
water.  The mouth of the pot was covered with a cotton cloth and tied 
around its neck.  The chooranam was placed on the cloth and another 
earthern pot was placed over the mouth of the pot completely covering the 
chooranam and edges of the pots were covered with a moistured cloth.  
Then the contents were boiled till the chooranam was fully cooked 
(pittaviyal). Then it was taken and dried in shade and preserved. The 
preparation was used within 3 months,since the lifetime of the chooranam is 
3 months from the date of manufacturing. 
 
Route of Administration: 
Enteral 
 
Dose:  
1 gram,twice a day with luke warm water before food. 
Anupanam (Vehicle): 
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      Luke warm water. 
“mDghdj;jhNy atpo;jk; gypf;Fk; 
,dpjhd Rf;F fd;dypQ;rp gpDKjfq;” 
 
mDghdq;fspd; Nrh;f;ifapy; jhd; mtpo;jq;fs; Neha; ePf;Fk; 
jd;ikailfpd;wd. mtw;wpy; fha;e;jhwpa nte;ePUk; xd;W 
- Njiuah; ntz;gh> gf;fk; 210. 
 
 The prepared Senkodiveliver chooranam used for the treatment of 
Azhal keel vayu was analysed by the following methods, 
1. Biochemical analysis  
2. Pharmacological analysis 
3. Microbiological analysis 
4. Toxicological analysis 
5. Clinical assessment 
6. Biostatistical analysis 
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BIO - CHEMICAL ANALYSIS OF  
SENKODIVELIVER  CHOORANAM  
 
Preparation of the Extract : 
5grams of Senkodiveliver  Chooranam was weighed accurately and 
placed in a 250ml clean beaker. Then 50ml distilled water is added and 
dissolved well. Then it is boiled well for about 10 minutes. It was cooled and 
filtered in a 100ml volumetric flask and then it is made up to 100ml with 
distilled water. This fluid is taken for analysis 
 
QUALITATIVE ANALYSIS : 
S. 
No 
Experiment Observation Inference 
1. Test for calcium 
2ml of the above prepared extract 
is taken in a clean test tube. To 
this add 2 ml of 4% ammonium 
oxalate solution. 
No white precipitate is 
formed 
Absence of 
calcium 
2. Test for sulphate 
2ml of the extract is added to 5% 
barium chloride solution. 
No white precipitate is 
formed 
Absence of 
sulphate 
3. Test for chloride 
The extract is treated with silver 
nitrate solution. 
No white precipitate is 
formed 
Absence of 
chloride 
4. Test for carbonate 
The substance is treated with 
concentrated Hcl. 
No brisk effervescence Absence of 
carbonate 
5. Test for Starch 
The extract is added with weak 
iodine solution. 
Blue colour is 
formed 
Presence of 
starch 
6. Test for iron Ferric 
The extract is treated with 
concentrated glacial acetic acid 
and potassium ferro cyanide.
No blue colour is 
formed 
Absence of 
ferric iron 
7. Test of iron Ferrous 
The extract is treated with 
concentrated Nitric acid and 
ammonium thio cynate. 
 
Blood red colour is 
formed 
Presence of 
Ferrous 
iron 
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8. Test for phosphate 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
No yellow precipitate is 
formed 
Absence of 
phosphate 
9. Test for albumin 
The extract is treated with 
Esbach's reagent. 
No yellow precipitate is 
formed 
Absence of 
albumin 
10, Test for Tannic acid 
The extract is treated with ferric 
chloride reagent. 
No blue black 
precipitate is formed 
Absence of 
tannic acid 
11. Test for unsaturation 
Potassium permanganate solution 
is added to the extract. 
It gets decolourised Indicates 
the 
presence of 
unsaturated 
compound 
12. Test for the reducing sugar 
5ml of benedict's qualitative 
solution is taken in a test tube and 
allowed to boil for 2 mts and added 
8-10 drops of the extract and again 
boil it for 2 mts. 
No colour change  
occurs 
Absence of 
reducing 
sugar 
13. Test for amino acid 
One or two drops of the extract is 
placed on a filter paper and dried # 
well. After drying, 1% ninhydrin is 
sprayed over the same and dried  
well. 
Violet colour is formed Presence of 
amino acids
 
INFERENCE : 
The given sample of Senkodiveliver  Chooranam contains Starch, 
Ferrous iron, unsaturated compound and amino acids. 
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PHARMACOLOGICAL STUDIES 
ANALGESIC STUDY OF SENKODIVELIVER  CHOORANAM 
ON ALBINO RATS BY TAIL-FLICK METHOD 
 
AIM : 
To study the analgesic effect of Senkodiveliver Chooranam on 
albino rats by Tail-flick method. 
 
MATERIAL AND METHODS: 
PREPARATION OF THE TEST DRUG: 
1 gm of Senkodiveliver  Chooranam was suspended in 10ml of 
distilled water using as suspending agent. This 1ml contains l00mg of the 
test drug.  
 
INSTRUMENT: 
Hot water bath maintained at 55°c + 0.5°c was used as the source of 
stimulus.  
 
PROCEDURE: 
Healthy albino rats weighing 100-200gms of both sexes were 
selected. The tail of each rat was dipped in the hot water bath and time 
taken for the rat to remove the tail from the water bath was noted. The rats 
that take more than 5 seconds to remove the tail are excluded form the 
equipment. Then the rats were dividend into 3 equal groups, each group 
having 2 rats. The first group was given the solvent used to suspended the 
drug and kept as untreated control. The second group was given the 
standard drug and kept as treated control. The third group was given the 
test drug 100mg/100gm, 1/2  hr and 1hr after drug administration the rats 
are again tested by dipping the tail in the hot water bath. The time taken for 
the rat to remove the tail was noted as done initially. 
 
The result of control group standard group and treated group were 
tabulated and compound. 
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ANALGESIC EFFECT OF SENKODIVELIVER  CHOORANAM 
Serial 
No. 
Name of 
Drugs / 
Groups 
Dose 
/100 
gram 
body 
weight
Initial 
Reading
After Drug Administration Mean 
 ½  hr. 
Average
Ihr. 
Average
1 ½  hr. 
Average Difference
1 Control 2ml 2.5secs 2.5secs 2.5secs 2.5secs 2.5sec 
2 
Standard 
Paracetamol 
20mg 2.5secs 3.5sees 5secs 6.5secs 6.5secs 
3. 
Test Drug 
Senkodiveliver  
Chooranam 
200mg 2.5secs 3 secs 4secs 5.5secs 5.5 sees 
 
INFERENCE: 
The test drug Senkodiveliver Chooranam has got significant 
Analgesic Activity. 
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ANTI - INFLAMMATORY STUDIES, ACUTE ANTI-INFLAMMATORY 
STUDIES CARRAGEENIN INDUCED HINDPAW EDEMA METHOD  
 
METHOD: 
Carrageenin induced Hind paw edema method in Albino rats. 
 
AIM: 
To evaluate the acute anti - inflammatory effect of Senkodiveliver  
Chooranam by carrageenin induced oedema method in albino rats.  
 
DRUG PREPARATION: 
1 gm of Senkodiveliver  Chooranam  was suspended in 10ml of 
distilled water using as suspending agent. This 1ml contains 100 mg of the 
test drug.  
 
PROCEDURE: 
Six healthy albino rats of either sex weighing between 100-120gm 
were selected. The volume of each hind paw was measured by using the 
mercury plethysmograph. 
 
After the measurement of hindpaw of all the rats, they were divided 
into three groups each containing two rats. 
 
First group was kept as control by giving distilled water of 2ml/100mg 
of body weight. The second group was given ibuprofen 20mg/100gm body 
weight and kept as standard. Third group was given test drug 
Senkodiveliver  Chooranam  200mg/100gm body weight. 
 
The drugs were administered orally, one hour after drug 
administration, 0,1ml 1% (W/V) of carrageenin suspension in water was 
injected in the plantar surface of hind paw of rats. 
 
All the animals were given carrageenin injection subcutaneously. 
Three hour after carrageenin injection, the hindpaw volume was measured 
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from the differences in the initial and final hind paw volume, the degree of 
the inflammation was calculated by taking the volume in the untreated 
control group as 100%. 
 
The percentage of inflammation of the other group was calculated 
from the degree of anti - inflammatory effect of the treated and the test 
groups were calculated.  
 
RESULTS 
The details of the experiment results are shown in the table 
 
ACUTE ANTI INFLAMMATORY EFFECT OF  
SENKODIVELIVER  CHOORANAM 
Group Drug 
Dose 
100gm 
of 
body 
weight
Initial 
Reading 
average
Final 
reading 
average
Mean 
difference
Percentage 
inflammation 
Percentage 
inhibition 
Control Water 2ml 0.55 1.4 0.85 100 - 
Standard Ibuprofen 20mg 0.55 0.85 0.3 35.2 64.8 
Test 
Drug 
Senkodiveliver  
Chooranam 
200mg 0.8 0.65 0.25 29.4 70.6 
 
INFERENCE: 
Thus Senkodiveliver  Chooranam has got significant Acute Anti 
Inflammatory effect. 
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CHRONIC ANTI - INFLAMMATORY EFFECT OF SENKODIVELIVER  
CHOORANAM IN RATS BY COTTON PELLETS GRANULOMA METHOD  
 
AIM: 
Chronic Anti - Inflammatory effect of Senkodiveliver  Chooranam.  
 
DRUG PREPARATION: 
1 gm of Senkodiveliver  Chooranam was suspended in 10ml of 
distilled water. This 1ml contains l00mg of the test drug.  
 
PROCEDURE: 
Six healthy albino rats weighing 100 - 150gms were taken and 
divided in to three groups, each consisting of two rats. 
 
In this procedure, the drugs were given daily for 7 days. Before giving 
the drug cotton pellets each weighing l0mg were prepared and sterilised in 
the autoclave for about I hr under 15Hg atmospheric pressures on the day 
of experiment, each rat was anasthetised with ether to implant l0mg of 
sterlised cotton pellets subcutaneous in the lower abdomen two on each 
side after making suitable incision and sutured carefully. 
 
First group was kept as control by giving distilled water of 2ml/100gm 
of body weight. To the second group, the standard drug Ibuprofen in a dose 
of 20mg/100gm body weight was given. The third group of animals was 
given tested drug Senkodiveliver  Chooranam in a dose of 200mg/100gm 
of body weight. On the 8lh day of the experiment, all the rats were  
sacrificed and cotton pellets found to be surrounded by granulation tissue 
were removed and dried in hot air Oven un at 55°C -60°C. 
 
The average weight of granuloma of control group and treated group 
gives an estimation of degree of Inhibitory activity of test drug.  
 
RESULTS: 
The details of the experiment result are shown in the table. 
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CHRONIC ANTI INFLAMMATORY EFFECT SENKODIVELIVER  
CHOORANAM 
Sl.no Group 
Dose/l00gm 
of body 
weight 
Cotton 
Pellet 
weight
Pellet 
weight to 
the 
Granuloma 
of drugs 
Percentage 
of 
Inflammation 
Percentage 
of 
Inhibition 
1 Control  (water) 1ml 10mg 250mg 100 - 
2 
Standard 
(Ibubrufen) 
20mg 10mg 55mg 22 78 
3 
Test drug 
(Senkodiveliver  
Chooranam) 
200 mg 10mg 99mg 40 60 
 
INFERENCE: 
The test drug Senkodiveliver Chooranam has got significant 
Chronic Anti- Inflammatory effect. 
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ANTIPYRETIC STUDY OF SENKODIVELIVER  CHOORANAM IN 
YEAST INDUCED HYPER PYREXIA ALBINO RATS 
 
The test drug Senkodiveliver  Chooranam was screened for its 
antipyretic activity with the help of yeast induced hyperpyrexia albino rats.  
 
AIM: 
To evaluate antipyretic activity of Senkodiveliver  Chooranam.  
 
PREPARATION OF THE TEST DURG: 
1 grn of Senkodiveliver  Chooranam was dissolved in 10ml of 
water. 1ml of this preparation contains 100mg of the test drug.  
 
YEAST INDUCED HYPERPYREXIA: 
Six healthy albino rats of either sex, weighing between 80-100gm 
were selected. They were divided into 3 groups of 2 rats in each group. All 
the rats were made hyperthermic by giving subcutaneous injection of 12% 
of yeast in distilled water 1ml/100 gm of body weight. 
 
After 10 hours, the initial temperature (0 hr) was taken for all the rats. 
First group of rats were given 2ml of water and kept as control. The second 
group received 20mg/100gm of body weight of Paracetamol and the third 
one received the test drug Senkodiveliver  Chooranam 200mg/100gm 
body weight. 
 
The mean rectal temperatures for all the rats were recorded at 1 1/2 
hr, 3hr, and 41/2 hours after the drug administration. 
 
The difference between the 3 groups are measured and compared.  
 
RESULTS : 
The details of the experiment and the results were shown in the table. 
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ANTIPYRETIC EFFECT OF SENKODIVELIVER  CHOORANAM: 
Serial 
No. 
Name of Drug 
/ Groups 
Dose 
/100 
gm 
body 
weight
Initial 
Temperature 
in 
centigrade 
After Drug 
Administration 
Remarks1 ½  
hour
3.0 
hour 
4 ½ 
hour 
1 .  
Control 
(Water) 
1ml 
36.0  
37.0 
36.0 
37.0
36.0 
38.0 
37.0 
39.0 
38.0 - 
2. 
Standard 
(Paracetamol) 
20mg 
37.0  
38.0 
37.0 
37.0
36.5 
36.5 
35.0 
34.0 
34.5 - 
3. 
Test drug 
Senkodiveliver  
Chooranam 
200mg
37.0  
37.0 
36.5 
37.0
36.0 
36.5 
35.0 
36.0 
35.5 - 
 
INFERENCE: 
The test drug Senkodiveliver Chooranam has got significant Anti 
Pyretic activity 
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ANTIMICROBIAL ACTIVITY OF SENKODIVELIVER 
CHOORANAM BY KIRBY BAUER METHOD 
 
AIM: 
To determine the Antimicrobial activity of Senkodiveliver 
Chooranam.  
 
Components of medium: 
 Beef extract  : 300gms/lit 
Agar   : 17gms/lit 
Starch  : 1.5gms/lit 
Casein hydroxylate: 17.5gms/lit 
Distilled water : 100ml 
pH   : 7.6 
 
Procedure : 
The method of antimicrobial activity study is disc diffusion method. 
The principle of antibiotic sensitivity test is simple. Antibiotic discs are 
prepared with known concentration of antibiotic (1gm/10ml of distilled 
water) and placed on agar plates that has been inoculated with the test 
organism. The antibiotic diffuses through the agar producing an antibiotic 
concentration. Gradient effectiveness of susceptibility is proportional to the 
diameter of the inhibitory zone around the disc organism which grows upto 
the edge of the disc are resistant. 
 
The recommended medium in this method is Muller Hinton Agar, its 
pH should be between 7.2 – 7.4 and should be poured to uniform thickness 
of 4mm in the Petri plate (25 ml) for certain fastidious microorganism. 
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Methodology: 
@ Muller Hinton Agar plates are prepared and Pseudomonas, Vibrio 
cholerae, E.coli, Bacillus, Klebsiella, Micrococcus, Streptococcus is 
inoculated separately. 
@ The prepared discs of antibiotics Senkodiveliver Chooranam are 
placed over the incubated plate using sterile forceps and incubated 
for 24 hours at 370 Celsius. 
@ The plates after 24 hours incubation are observed for the zone of 
inhibition. 
 
Result: 
The diameter of zone of inhibition Senkodiveliver Chooranam as 
Styphylo coccus aureus   - 3 mm 
Candida albicans           - 8 mm 
 
KIRBY BAUER ANTIMICROBIAL SUSCEPTIBILITY METHOD 
S.No. Test Drug Organisms (cultures) Susceptibility 
Zone 
size 
(mm) 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
 
 
 
Senkodiveliver 
Chooranam 
Escherichia coli 
Klebsiella 
Proteus 
Styphylo coccus aureus 
Strepto coccus pneumoniae 
Pseudomonas aeroginosa 
Candida albicans 
Resistance 
Resistance 
Resistance 
Moderate sensitivity 
Resistance 
Resistance 
Sensitivity 
 
 
 
3 mm 
 
 
8 mm 
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ACUTE TOXICITY STUDY 
Animals Used For The Study : 
Wister albino rats bred in the animal house attached to the post 
Graduate Pharmacology Department Government Siddha Medical College, 
Palayamkottai were used.  
 
Sex: 
Animals of both sex were used. 
 
Weight: 
Animals weighing 100-120gms were selected. 
 
Food and Water: 
The animals were maintained with standard laboratory pellet feed 
and water ad-Libitum.  
 
Preparation of Animals: 
The animals were randomly selected and were marked with picric 
acid on fur and kept in their cases for five days prior to dosing, to allow 
acclimatization to the laboratory conditions.  
 
Separation of animals in groups: 
10 rats were divided into 5 groups each consisting of 2 rats.   1st 
group is kept as control group by giving water alone. 
 
Dose Levels: 
The following dose levels were arbitrarily fixed by presuming range of 
least toxic to high toxic doses. 
I  Group      - 100mg/kg Body weight of animal 
II Group     - 200mg/kg Body weight of animal 
III  Group    - 400mg/kg Body weight of animal 
IV  Group    - 800mg/kg Body weight of animal 
V Group     - 1600mg/kg  Body weight of animal  
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Route of administration:  
The drug was administered orally.  
 
Test Dose Preparation:  
The preparation was done in such a way as 1ml of the suspension 
contained 100mg of test drug and administered as given above in each 
group. The drug was administered once on the day of the experiment and 
after 24 hour parameters were used.  
 
Experimental Set up: 
All the five groups were fastered for over night prior to dosing. 
Following the period of fasting the animals were weighted and the test 
substance was administered through "Rat oral intubation tube " 
After the administration of the test drug, food was with held for 1-2 hrs 
 
Observation : 
The following parameters were noted. 
 
Central effects : 
1. Stimulation : 
• Hyper activity 
• Piloerection 
• Twitching 
• Rigidity 
• Irritability 
• Jumping 
• Clonic Convulsion 
• Tonic convulsion  
 
II. Depression: 
• Ptosis 
• Sedation 
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• Sleep 
• Loss of traction 
• Loss of Pinna reflex 
• Ataxia 
• Catatonia 
• Loss of muscle tone 
• Analgesia 
 
III. Autonomic effect: 
• Straub's tail flicking 
• Laboured respiration 
• Cyanosis 
• Blanching 
• Reddening 
• Abnormal secretions 
 
At the end of 24hrs, the number of animals dead in each group was 
noted and the approximate LD50 was determined. The animal were 
morphologically examined for any toxic symptoms. 
 
Result: 
The drug Senkodiveliver Chooranam did not produce any mortality 
upto 1600 mg / animal. So, it was inferred that the drug is safe upto 1600 
mg / animal. 
 
 45
 CLINICAL ASSESSMENT 
  Azhal keel vayu is a disease mainly affecting the major weight 
bearing joints Normally there is a change is the joint at certain age group.  It 
affects the knee joint, which do a lot of functions like flexion, extension etc. 
 
In order to assess the efficacy of the Senkodiveliver Chooranam for 
‘Azhal Keel Vayu’ according to the selection criteria and ‘Siddha 
literatures’. Among them 30 patients were treated in out-patient department 
and 10 patients were treated in in-patient department. 
 
Immediately after the admission, full clinical data were recorded and 
diagnosis on the basis of data were recorded and diagnosis on the basis of 
siddha principles such ‘Envagai thervu’ Mukkutrami etc., The admitted 
patients had different signs and symptoms of varying severity. 
 
The routine blood investigations were done in each case, radiological 
investigations were also carried out.  Radiological investigations were 
mainly used to rule out the other causes and diseases. 
 
The cases were screened as per the following criteria and selected 
from the Out-patient and In-patient P.G Gunapadam, Department of the 
G.S. M.C. & H, Palayamkottai. 
 
Including Criteria for case selection: 
• Age group: Above 40 years. 
• Pain in major joints (like knee joint) 
• Morning stiffness 
• Limitation of movements 
• Swelling 
• Restricted movement 
• Aggregated pain during walking, sitting and squatting position 
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• Crepitation of the joints 
• Obesity 
• Radiological findings 
 
Sign and symptoms vary in severity from patient to patient. 
 
Excluding criteria: 
• Migrating joint pain 
• Mantous test positive 
• Age group : younger age group below 30 years 
• Sudden onset of excruciating pain, marked swelling and 
redness of bigtoe. 
• Raised level of uric acid 
• Involvement of small joints 
• RA factor positive 
• STS positive 
• Osteosarcoma 
• Haemarrhagic effusion 
• Traumatic cause 
• Osteomyelitis. 
• Psoriatic arthritis 
 
Diet and Advice: 
1) To avoid vayu patharthams like potato, dal, banana and sour items 
viz, curd and tomato etc. 
2) To avoid cold, dump, climate. 
3) The patients were advised to take easily digestible foods like rice 
kanjee, bread etc. 
4) To avoid tamarind 
5) To avoid mechanical stress 
6) To avoid pungent, bitter tastes 
7) To avoid prolonged standing and walking 
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8) Obese patients were advised to reduce their body weight in order to 
avoid stress  
9) Advise to change their occupation 
10) Advise to do  quadriceps exercise 
11) Advise to take rest but prolonged immobilisation should be avoided 
as it leads to the stiffness of the joint further in capacitating the 
patient. 
 
Drug and Dosage: 
The test drug ‘Senkodiveliver Chooranam’ was given to the patients 
at a dose of two time a day with lukewarm water as the vehicle. The drug 
was given for a maximum for 45 days. The drug was well accepted by the 
patients. During administration, no adverse reaction were noted.  
 
Observation : 
Routine investigations were done before and after treatment. 
Radiological investigation were also done before and after treatment.  If 
patient complained of any other complaints  during the treatment period 
they were treated with other siddha medicines. For both Out-patient and In-
patient time was noted for walking to a distance of 100 feets, on admission 
and after treatment. 
 
The result were assessed on the basis of the symptomatic relief 
obtained by the patients and by clinical examinations daily in In-patient 
Department and once in three days in Out - patient Department. 
 
In the study of 40 patient, 15 were males  and remaining 25 were 
females. Almost all the patients were laboures and farmers of poor socio 
economic status. 
 
Drug response: 
The course of the treatment varied from 35-48 days. Most of the 
patient got no improvement with in 3 days.  Mostly pain and stiffness were 
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relieved from 5th, 9th day of treatment and other symptoms subsided and 
relieved simultaneously during the further course of treatment. 
 
27 cases had good response, 10 cases had fair response and 3 
cases showed no response. 
 
Clinical assessment of ‘Azhal keel vayu’ are tabulated in the 
following tabular columns  
 
Tabulations showing (Age wise / Sex wise) 
Distribution of patients 
Sl.No. Age in years Sex Total Male Female 
1. 30-40 1 - 1 
2. 41 - 50 6 11 17 
3. 51 - 60 2 6 8 
4. 61 - 70 4 9 13 
5 71 -80 2 - 2 
 Total 15 25 40 
 
Tabular aspect: 
Results No. of patients Percentage (%) 
Complete Relief 27  67.5 
Partial Relief 10  25 
No. Relief 3 7.5 
Total 40 100 
 
Of 40 cases, 67.5% of cases had significantly relief of symptoms, 
25% of cases respond moderately and 7.5% of cases respond poorly.  
 
In this study, it was found that the test drug ‘Senkodiveliver 
Chooranam’ possess effective anti-inflammatory, analgesic action there by 
reducing pain and swelling which was found clinically.  
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BIOSTATISTICAL ANALYSIS 
 
 The age and sex  wise classification  of clinical trials were analysed in 
testing of the statistic mean and std devotions (S.D) The effectiveness of 
the drug was interpreted by the students paird ‘t’ test. The prognosis of the 
effectiveness of the drug was analysed in testing percentages.  The above 
statistical  applications, analysis and interpretations were performed by the 
statistical package S.P.S.S. (13.0) at 5% level of significance (P=0.05). 
 
Results and Discussion : 
Drug  - Senkodiveliver  Chooranam   
Disease - Azhal keel vayu 
 
 The study testing were classified according to their sex and age. 
They were analysed and interpreted.   
 
Table – 1 Sex and Age wise classification 
Sl.No Age Group Male Female Total No % No % No % 
1 30-39 1 7.2 0 0 1 2.5
2 40-49 5 35.7 6 23.1 11 27.5 
3 50-59 3 21.4 9 34.6 2 30.0
4 60-69 3 21.4 9 34.6 12 30.0
5 70-79 2 14.3 2 7.7 4 10.0
 Total 14 100.00 26 100.00 40 100.00
 Mean 55.00 57.7 56.75 
 Std Deviation  12.4 9.2 10.3
 ‘t’  0.732  
 Significance P>0.05  
  
The above table -1 explains  the clinical trail of testing  of their age 
and rest. The male study subjects participated in the study were having to 
mean age of  55 ± 12.4 years and the female mean age of 57.7±9.2 years. 
There was a difference of  2.7 years observed between the two sexes. But 
the difference was not statistically significant (t=0.732 d.f = 38 and P>0.05). 
 
The mean age of the total sample was 56.75 ± 10.3  
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Effectiveness of the drug 
 The effectiveness of the drug was analysed by collecting and 
computing  the data of pain, stiffness, measurement, tenderness, swelling 
and time taken for 100 feet. The before administration drug the above 
details regarding  their both legs were collected and the same after 
completing the course of treatment were collected. The results was 
furnished  in the below table . 
 
Table – 2 Before and after administration drug in respect  or certain 
variables 
Sl.No Variables N Before After Mean Difference ‘t’ 
Significa
nce Mean S.D Mean S.D 
1 Pain rt. Leg 40 1.7 0.6 0.325 0.5 1.375 12.338 P<0.01 
2 Pain left leg 40 1.425 0.7 0.275 0.5 1.15 10.984 P<0.001 
3 Stiffness Right 40 0.525 0.71 0.075 0.3 045 4.201 P<0.001 
4 Stiffness Left 40 0.3 0.5 0.1 0.3 0.2 3.122 P<0.001 
5 Measurement Right 40 36.3 3.6 35.1 3.32 1.275 7.85 P<0.001 
6 Measurement Left 40 36.1 3.5 35.0 3.33 1.04 6.957 P<0.001 
7 Tenderness Right 40 1.5 0.7 0.3 0.6 1.2 9.595 P<0.001 
8 Tenderness Left 40 1.1 0.7 0.2 0.5 0.85 8.640 P<0.001 
9 Swelling Right 40 0.975 0.8 0.15 0.43 0.825 6.983 P<0.001 
10 Swelling Left 40 0.675 0.73 0.10 0.3 0.575 6.119 P<0.001 
11 Time taken 40 59.2 10.7 53.9 10.6 5.35 15.206 P<0.001
 
 The above table – 2 clearly explains the  reduction  of the related 
variables of the disease before and after treatment of Azhal keel vayu by 
the drug Senkodiveliver Chooranam. The mean pain reductions  of both 
legs. Right and Left were 1.375 and 1.15 respectively. The mean reductions 
from the before treatment to the after treatment were statistically highly 
significant (right ‘t’ =12.338, d.f = 39 and P<0.001 and left t=10.984, d.f =39 
and P<0.001) The mean reductions of stiffness in right and left were 0.45 
and 0.2 respectively. These difference of reducing were statistically 
significant (rt=4.201, d.f= 39 and P<0.0001) (lt t = 3.122, d.s= 39 and 
P<0.0010 
 
 The measurements in both were reduced as 1.275 abd 1.04 in right 
and left respectively . The reductions were also statistically significant (Rt ‘t’ 
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= 7.82 d.f= 39 and P<0.001) and Lt ‘t’ = 6.957, d.f. = 39 and P<0.0001) 
similarly, the tenderness and swelling were also significantly  reduced as 
shown in the table – 2. The time taken for walking. 100 feet was also 
reduced considerably from before ‘t’ after treatment as 5.35. This reduction 
was also statistically significant (‘t’=15.206, d.f= 39 and P<0.001). The 
statistically significant reductions of related variable life pain stiffness, 
measurement tenderness, swelling and Time taken for 100 feet were 
attributed  to the effectiveness of drug,  Senkodiveliver Chooranam in 
curing Azhal keel vayu. 
 
Response of the drug: 
 The response of the drug was progonosized as good, fair and poor 
based on the observations of the selected variables and attributes  
 
Table – 3 Percentage distribution of response of the drug : 
Sl.No. Prognosis  Number Percentage 
1 Good 27 67.5 
2 Fair 10 25.0 
3 Poor 3 7.5 
 Total 40 100.00 
 
 The above table 3 shows that the drug was cured 67.5% with  good 
response and the remaining 25% and 7.5% were fair and poor respectively. 
 
 The above discussed effectiveness and good response of the drug 
was considered as the drug was effectively curing the disease Azhal keel 
Vayu. 
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DISCUSSION  
 The single drug Senkodiveliver Chooranam was selected in this 
dissertation to study its therapeutic efficacy in the management of Azhal 
keel vayu. 
 
 According to Siddha literatures,  the basic abnormality in Azhal keel 
vayu is the derangement of vatha humour. 
 
 “vwpaey; thj nkwpf;Fq;Fzq; NfS 
 Fwpnadf; iffhy; Fsr;Rtpyhr; re;J 
 gwpnad nehe;J ……………………..” 
- jpU%yh;ehb> rpj;j kUj;Jt Neha; ehly;  
Neha; Kjdhly; jpul;L Kjy; ghfk>; gf;fk; - 173 
 
 
 “Nktpa thjQ; nra;Aq; 
  Fze;jid tpUk;gpf; NfS 
 jhtpa tapW ke;jQ; 
  re;Jfhy; nghUj;J Nehthk;. 
 Nrtpa jhJ ehrQ;……………..” 
- ,uj;jpdr;RUf;fehb> Neha; ehly; 
 Neha; Kjdhly; Kjy;ghfk;> gf;fk; - 174 
 
Thus the affected vatha humour manifests symptoms like pain in all 
the joints like wrist joint, knee joint etc., general weakness of the joints & 
body and loss of appetite etc. 
 
From the review of literatures, it is inferred that the drug 
Senkodiveliver Chooranam selected for this study has the antivatha 
action is stated as follows,  
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“#iyAk; tha;TQ; rfrd;dp khe;jRuQ; 
rPy;rpu Neha;thje; jPUq;fhz; - Nfhykape; 
 …………………………………………….” 
     - Fzghlk; - %ypif tFg;G> gf;fk; 383 
 
All the patients were given Senkodiveliver Chooranam with 
lukewarm water as vehicle (Anupanam) for the drug. The lukewarm water is 
one of the Anupanams told by Theraiyer and it assists in improving  the 
efficacy of the drug as stated below, 
 
 “mDghdj;jhNy atpo;jk; gypf;Fk; 
 ,dpjhd Rf;F fd;dypQ;rp gpDKjfq”; 
   - Njiuah; ntz;gh> gf;fk; 210 
 
All these factors seem to neutralize the vitiated vatha humour. This 
explanation is arrived on the basis of the analysis of the Gunapadam aspect 
of the drug which correlates with that of the following scientific analysis 
done on the drug. 
 
Bio chemical analysis shows the presence of starch, ferrous iron. 
unsaturated compound and amino acids. Their presence augments the 
therapeutic value of this drug by providing indispensable nutrition. 
 
Pharmacological analysis shows that the drug has got significant 
analgesic, anti inflammatory and antipyretic activity. 
 
Microbiological analysis shows that the drug has got sensitivity to 
Candida albicans and moderate sensitivity to Staphylococcus aureus. 
 
Acute toxical study reveals that the drug has no adverse and toxic 
effects in albino rats upto the concentration of 1600mg /kg of body weight. 
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In the clinical assessment of the 40 cases selected 67.5% of cases 
showed good response 25 % of cases showed fair response and 7.5% of 
cases showed poor response. The improvement was proved by the 
alleviation of signs and symptoms present before the treatment. 
 
Bio statistical analysis shows that the drug is efficient in controlling 
Azhal keel vayu  
 
During the clinical trial, the patients showed to adverse reactions. 
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SUMMARY 
 
The single drug Senkodiveliver Chooranam has been taken to 
establish its efficacy in treating Azhal keel vayu. The dose of 
Senkodiveliver Chooranam is 1 gram twice daily with Luke warm water 
before food. 
 
A brief description pertaining to botanical aspect, phytochemical 
constituents and Gunapadam aspect has been done. 
 
A review of literatures about the drug and its significance in medicine 
since ancient period has been done. 
 
Colleted information from various literature and websites has been 
referred. 
 
Bio chemical analysis shows the presence of starch, ferrous iron, 
unsaturated compound and amino acids. 
 
Pharmacological analysis shows that the drug has got significant 
analgesic anti inflammatory and antipyretic activities. 
 
Microbiological analysis shows that the drug has got sensitivity to 
Candida albicans and moderate sensitivity to staphylococcus aureus. 
 
 Toxicological analysis shows that the drug has no adverse and toxic 
reactions.  
 
From the clinical assessment, It is inferred that Senkodiveliver 
Chooranam possesses remarkable efficacy in treating Azhal keel vayu 
and the drug has got no adverse reactions. 
 
Biostatistical analysis also shows that the drug is effective in 
controlling Azhal keel vayu. 
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CONCLUSION 
It is concluded that the drug Senkodiveliver Chooranam is an 
effective drug in treating Azhal keel vayu and it has no adverse reactions. 
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INTRODUCTION 
 
 The field of medicine is progressing forward day by day and helps 
man to acquire new knowledge even during the period of “ Rig Veda” man 
been found using drugs in one way or other that is to say that drugs have 
been in use even about 4500 years ago. Life is not a mere living but living 
with good health. The health of the individual as of nation is of primary 
concern to one and all. 
 
 In spite of great and spectacular advances in modern medical 
sciences, in the fight against diseases a considerable proportion of world’s 
population especially in developing countries like India is still  without 
proper care.  
 
 The spreading of various diseases has been constantly growing 
proportional to the increasing population. It is a well known fact that 
eventhough we have made some progress in health care facilities after 
independence, it is most in adequate to meet the need of increasing 
number of the poor and sick. 
 
 Thousands of years before the advance of modern medicine, Indian 
medicine was prominently prevalent in our country. Indian medicine is an 
ancient science. Various excavations, historical and literary evidence 
confirm this fact. When we go through the oldest books regarding Indian 
medicine. which were written by our ancestors, we can under stand the 
superiority of our system of medicine. They have their  own fundamental 
principles, anatomy, physiology, pharmaceuticals, surgery etc., 
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AIM AND OBJECTS 
 
 The revival of the Indian system of medicine at the present day is one 
of the welcoming sign. The Siddha system of medicines dates back to 
several centuries. It has become in the course of time the parent source of 
all the other medicinal system of the world, like Ayurveda, Unani etc. All 
other systems of medicine have their own defined origin and period unlike 
our siddha system. The origin and time period of Siddha system is 
uncertain. Siddhars have used herbs, minerals, metals, and animal 
products etc. knowing their medicinal value to cure diseases. 
 
 The Siddhars were efficient in calcinations and oxidation of 
metals,minerals, and made them fit for human consumption. 
 
 Paandu Noi (Anaemia) is a well known blood disorder, commonly 
occurring disease, found all over the world, invariably in all classes of 
society even in these days of tremendous medical advancement. This 
disease will be expected to be in the top three ranks among the diseases, in 
future. 
 
 Accordingly in various Siddha literatures cited the Siddhars gave 
importance to iron and its related elements. The author also observed that 
iron, iron slag and steel are frequently used by various traditionally 
experienced Siddha physicians skillfully in treating anaemia. So the author 
wants to make a thorough study regarding the pharmaceutical and 
therapeutical applications of Thiriloga Chendooram with proper bio-
Chemical, pharmacological and clinical approach.   
 
 Out of all minerals, iron and it’s related elements are commonly used 
by various traditional practitioners. So the author decided to take “Thiriloga 
Chendooram” for his dissertation subject. 
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CHEMICAL ASPECT 
IRON 
 
 Iron is a metal of universal use. Iron is one of the nine elements, in 
Group VIII in the old Mandaleev’s periodic table. It is the fourth most 
abundant element in the earth’s crust after O, Si and Al. It makes up 62,000 
ppm or 6.2% by weight of the earth’s crust, where it is the second most 
abundant metal. In addition, iron and nickel made up most of the earth’s 
core. 
 
The chief ores are, 
1. Hematite, Fe2 O3 
2. Magnetite, Fe3 O4 
3. Limonite, FeO (OH)  
4. Siderite FeCo3 and 
5. Smaller amounts of pyrites FeS2 (Fool’s Gold) are also found. 
 
Occurrence: 
 Iron ore occurs on a large scale in India chiefly in the form of oxides. 
Common mode of occurrence is a laminated hematite, micaceous  hematite 
and hematite breccia, laterite, lateritic  hematite also forms large deposits 
together with hematite magnetic quartz schists, the metamorphosed 
products of original femigious sands and clays. The largest and richest 
deposits of iron in the world are found in magnitude of the lake superior 
(USA) ores. 
 
 62
3Fe2O3+CO Æ 2Fe2O3+CO2 
Fe2O3+CO Æ 3FeO+CO2 
C+CO2 Æ 2CO 
FeO + CO Æ Fe+ CO2 
Extraction of Iron : 
 
 
In industrial extraction coke is used instead of charcoal. It is much 
cheaper and easier to produce coke from coal rather then make charcoal by 
party burning wood. The greater mechanical strength of coke made it 
possible to blow air through a mixture of coke and iron ore in a blast furnace 
and thus extract iron on a much larger scale. Iron is extracted from its 
oxides in a blast fumace.    
- Minerals of India, Page 104 -107 
- Concise inorganic Chemistry, Page 753-782 
 
Biological importance of Iron: 
 Iron is the most important transition element in plants and animals. Its 
biological importance is as an electron carrier in plants and animals   
(cytochromes & ferrodoxins) as haemoglobin, the iron carrier in the blood of 
mammals, as myoglobin for oxygen storage, for iron scavenging and 
storage (ferritin and transferritin) and in nitrogenase (the enzyme in nitrogen 
fixing bacteria). Iron form several unusual complexes including ferrocane. 
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Commercial forms of Iron: 
      There are three forms of Iron which differ in their carbon content. 
1. Wrought Iron or Metallic Iron 
2. Steel 
3. Cast Iron or Pig Iron 
 
General Prosperities: 
 Chemical Symbol  : Fe 
 Atomic Number  : 26 
 Mineral   : Iron Oxides (eg) hematite and magnetite  
 Relative Density  : 7.87 
 Malleability    : High 
 Ductility    : High 
 Melting Point  : 1535o C  
 Atomic Mass  : Transition metals 
 Group, Period, Block : 8,4,d 
 Hardness   : 4 
 Appearance   : Lustrous, metallic with a grayish tinge 
 
Bio Chemical Aspect:  
 Total content of iron in an adult body is 3 - 5.gm. Above 70% of this 
occurs in the erythrocytes of blood as a constituent of haemoglobin. Haeme 
is the most  predominant iron containing substance. It is a constituent of 
several proteins / enzymes . 
- Biochemistry – Sathya Narayana, Page 457.  
 
Bio – Chemical functions of Iron: 
1. Iron mainly exerts its functions through the compounds in which it 
is present. Haemoglobin and myoglobin are required for the 
transport of O2 and CO2. 
2. Cytochromes  and certain non – haeme proteins are necessary for 
electron transport chain and oxidative phosphorylation. 
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3. Perodoxidase, the lysosomal enzyme is required for phagocytosis 
and killing of bacteria by neutrophils.  
4. Iron is associated with effective immuno competence of the body. 
 
Toxicity of iron: 
       It is less common. But when the iron tablets are taken in over dose. 
They induce, 
• Vomiting 
• hemetemesis  
• Abdominal pain 
• Coma 
• Convulsions 
• Shock 
• Metabolic acidosis 
• Hepatic failure 
- Davidson’s principles and practice of Medicine, Page 212 
 
Limit Test for Iron: 
Standard Iron Solution: 
 Weigh accurately 0.1726g of ferric ammonium sulphate and dissolve 
in 10ml of 0.1N sulphuric acid and sufficient water to produce 1000ml. Each 
ml of this solution 0.02mg of Fe. 
 
Method: 
 Dissolve the specified quantity of the substance being examined in 
40 ml of water, or use 10 ml of the solution prescribed in the monograph 
and transfer to Neissler cylinder. Add 2ml of a 20% w/v solution of iron free 
citric acid and 0.1ml of thioglycollic acid, mix make alkaline with iron free 
ammonia solution dilute to 50ml with water and allow to stand for five 
minutes. Any colour produced is not more intense than the standard colour. 
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Standard colour: 
 Dilute 2ml of standard iron solution with 40ml of water in a Neissler 
cylinder. Add 2ml of a 20% w/v solution of iron free citric acid and 0.1ml of 
thioglycollic acid, mix, make alkaline with iron free ammonia solution, dilute 
to 50ml with water and allow to stand for five minutes. 
 - Ayurvedic pharmacopoeia of India Part – I, Vol-I page 228 
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CHEMICAL ASPECT 
STEEL 
Steel Making : 
Steel is made by removing most of the C and other impurities from 
pig iron. The process involves melting and oxidising the C, Si, Mn and P in 
the pig iron, so that the impurities are given off as gases or converted into 
slag . 
 
Puddling: 
Originally steel was made by puddling which involved mixing molten 
pig iron with haematite Fe3O4 and burning off all the C and other impurities 
to give wrought iron. 
 
Composition of various steels: 
Percentage of C Name 
0.15 – 3 
0.3 – 0.6 
0.6 – 0.8 
0.8 – 1.4 
Mild steel 
Medium steel 
High carbon steel 
Tool steel 
- Modern inorganic chemistry, page 758-59. 
 
Steel classes: 
Carbon steel (<  2.1% carbon, low alloy) 
Stainless steel ( + chromium) 
Maraging steel  ( + Nickel) 
Alloy Steel (Hard) 
Tool steel (Harder) 
 
Steel – Definition : 
Steel is an alloy consisting mostly of iron, with a carbon content 
between 0.2% and 2.14% by weight (C: 110- 10Fe), depending on grade. 
Carbon is the most cost effective alloying material for iron but various other 
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alloying elements are used such as manganese, chromium, vanadium and 
tungsten. Carbon and other elements act as a hardening agent preventing 
dislocations in the iron atom crystal lattice from sliding past one another.  
Varying the amount of alloying elements and form of their presence in the 
steel controls qualities such as hardness, ductility and tensile strength of 
the resulting steel. Steel with increased carbon content can be made harder  
and stronger than iron but it also more brittle steel is also to be 
distinguished from wrought iron containing only a very small amount of 
other elements but containing 1-3% by weight of slag in the form of particles 
elongated in one direction, giving the iron a characteristic grain. Further 
refinements in the process, such as basic oxygen steelmaking, further 
lowered the cost of production while increasing the quality of the metal. 
Even in the narrow range of concentrations that in the narrow quality of the 
metal. Even in the narrow range of concentrations that make up steel, 
mixtures of carbon and iron can form into a number of different structures 
with very different properties. 
 
The most important polymorphic form is martensite, a chemically 
metastable substance with about four to five the strength of ferrite, A 
minimum of  0.4% weight of carbon (α iron) (C:54Fe) is needed to form 
martensite. When austenstie (γ iron) is quenched to form martensite, the 
carbon is frozen in place when the cell structure changes from FCC ( face 
centered cubic) to BCC (Body  centered cubic) martensite and austenite 
have an identical chemical composition. 
 
Steel undergoes further heat treatment at a lower temperature to 
destroy some of the martensite and help to settle the internal stresses and 
defects. This soften the steel, producing a more ductile and fracture 
resistant metal. Nickel and manganese in steel add to its tensile strength 
and make austenite more chemically stable, chromium increases hardness 
and melting temperature and vanadium also increases hardness while 
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reducing the effects of metal fatigue. Large amounts of chromium and 
nickel (18% & 8% respectively) are added to stainless steel so that a hard 
oxide form on the metal surface to inhibit corrosion.  On the other hand 
sulphur, nitrogen and phosphorus make steel more brittle so these 
commonly found elements must be removed from the ore during 
processing. 
 
Ancient Steel: 
First steel comes from East Africa dating back to 1400 B.C. In the 4th 
century B.C steel weapons were produced in the Iberian peninsula,while 
Noric steel was used by Roman military.  The Chinese of the warring stages 
(403-221 BC) had quench-hardened steel, while Chinese of the Han 
Dynasty (202 BC – 220 AD) created steel by melting together wrought iron 
with cast iron. 
 
Modern steelmaking: 
The modern era in steel making began with the introduction of Henry 
Bassemar’s ‘Bessemer process’ in 1858. This enabled steel to be produced 
in large quantities cheaply so that mild steel is now used for most purposes 
for which wrought iron was formerly used. 
 
Recycling: 
The steel industry has been actively recycling for more than 150 
years, in large part because it is economically advantages to do so. It is 
cheaper to recycle steel than to mine iron ore and manipulate it through the 
production process to form new steel.  In recent years about three quarters 
of the steel produced annually has been recycled 
 
Different types of steel and their composition 
(1) High strength low alloyed steel – 1.5% manganese. 
 
(2) Low alloy steel – 10% molybdenum, manganese chromium and 
nickel 
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(3) Stainless steel and surgical steel – 10% chromium 
 
(4) Tool steel – Large amounts of tungsten and cobalt. 
 
(5) Dual phase steel – Ferritic and martensitic microstructures. 
 
(6) Maraging steel –Nickel and other elements with no carbon 
 
(7) Eglin steel – over a dozen of  elements 
 
(8) Hadfield or manganese steel – 12–14% manganese  
 
(9) A 36 steel – Has defined alloys, the most commonly used structural 
steel in USA. 
 
(10) Galvanized steel – Hot dipped or electroplated in Zinc 
- Wikipedia, the free encyclopedia. 
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CHEMICAL ASPECT 
IRON SLAG 
 
Definition: 
Slag is the by product of smelting ore to puify metals. They can be 
considered to be a mixture of metal oxides, however can be considered to 
be a mixture of metal oxides, however they can contain metal sulphides, 
metal silicates and metal atoms in the elemental form. While slags are 
generally used as a waste removal mechanism in metal smelting, then can 
also serve other purposes, such as assisting in smelt temperature control 
and minimizing re-oxidation of the final liquid metal product before casting. 
 
Slag was removed by liquation that is the solid gangue was 
converted into liquid slag. The size, shape, chemical composition and 
microstructure of slag are related to the iron working process. During 
smelting when the ore is exposed to high temperature, these impurities are 
separated from the molten metal and can be removed. There are two 
common methods for this smelting process. They are (1) Bloomery process 
and (2) Blast furnace. 
 
Whatever, the methods of removing slag are somewhat different, 
some slag may be leaved inside the furnace rather than being tapped. 
Therefore  result in various morphologies of slag ,which serves as an 
indicator to investigate the smelting process and furnace type. While 
smelting, the flux the charcoal ash and the furnace lining may also 
contribute to the chemical composition of slag, which could be useful to 
infer the yield of production. 
 
Ferrous and non-ferrous smelting processes produce different slags. 
The smelting of copper and lead in non-ferrous smelting, for instance is 
designed to remove the iron and silica that often occurs with those ores and 
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separates it as an iron silicate based slag. Slag from steel mills in ferrous 
smelting, on the other hand is designed to minimize iron logs and so mainly 
contain oxides of calcium magnesium and aluminum. 
 
Here the iron slag is a metallic oxide–cum–silicate of iron, 
generally having composition, Fe2Si04 and commonly called slag. 
 
Occurrence: 
Iron is the main constituent of Iron slag(Manduram) followed by silica 
with minor amounts of Cu,S, Pb, Zn, Ag, Cd & Au. Iron slag (manduram) is 
known since ancient times in India and occurs in over 500 years old slag 
dumps near village Singhana (khetri) district, Jhunjhunu (Rajastan). 
 
Physical properties: 
Nature   :  Lumpy masses, exhibiting voids all over 
rough 
Color    :  Black  
Streak   :  Black 
Cleavage   :  None 
Fracture   :  Conchoidal 
Tenacity   :  Brittle but hard 
Transparency  :  opaque 
Magnetism   :  Non – magnetic 
Hardness   :  6 – 6.5 
Specific gravity  :  3 – 3.8 
 
Chemical properties: 
(a) Assay : 
(1) Iron slag contains not less than 30% iron (Fe). 
(2) should contains not less than 30% silica (Si). 
(3) silica shows not less than 80% fayalite. (2FeO Si02). 
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(b) Presence of heavy metals: 
 Iron slag should not contain more than the stated limits for the 
following, Pb = 0.35 ppm, Cd = 8 ppm. 
 
(c) Presence of other elements: 
 Cu = 0.45%, S = 0.20% Zn = 50 ppm, Ag = 7 ppm, Au = 0.10 ppm 
 
Acid insoluble : 
Should not be more than 40% (in Hcl) 
 
Fracture specification : 
Fierro (Fe203)  :  58 - 65% 
Cal (Cao)  : 7.5 -  11% 
Silico (Si02)  : 10.7 – 14.2% 
Aluminio (Al2O3)  : 0.6 – 1.5% 
Azufre (S)  : 22 -  5% 
Zinc (Zno)  : 1 – 3.5% 
Plomo (Pbo) : 0.5 – 1.4% 
Sodio (Na2o) : 0.2 – 1.0% 
Potasto (K2o) : 0.2 – 0.5% 
Magnesio (Mgo) : 2.5 – 5% 
Manganese (Mno) : 2.5 – 5% 
Cadmio (Cdo) : 0.001 – 0.005 % 
 
Slag analysis: 
Macro analysis: 
 The macroscopic analysis of slag mainly focuses on the size, shape 
or external appearances to achieve an initial inference though microscopic 
analysis the furnace type or iron working process could be recognized. The 
furnace could be figured out  by measuring the diameter of the slag. The 
shape of slag also serves as an evidence for identifying the furnace type 
due to various ways of removing slag. 
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Slag of the bowel furnace, in which the slag does not be tapped, 
usually has a plano convex shape because the slag inside the bowel.  For 
the slag being tapped out of the furnace the V form or circular shape is the 
most common case.  The smelting slag may have different shape from 
smithing slag; appears in plano convex, convano-convex or in small 
droplets. 
 
The interpretation of the external appearance of slag is useful as well. 
Blast furnace slag is usually glassier in appearance and lighter in colour. 
Slag from the bowel furnace tends to be smooth because the slag is molten 
during the smelting process and not be tapped. On the other hand, tapped 
slag usually appears in lava following surface and few large bubbles. This is 
because the hot and liquid slag is removed along a channel and colled 
outside the furnace. 
 
Micro analysis: 
The microstructural and chemical analysis could provide more 
supportive and accurate information. 
 
Microstructural analysis is to identify the material phase, crystal 
structure and mineralogical composition of slag by x-ray diffraction or 
microscope such as scanning electron microscope. 
 
Many factors such as cooling rate may affected the formation and 
composition of different  phases. Therefore  through the investigation of 
microstructure archeologists could figure out the iron working process, for 
example Whiteman and Okafor predicted the solidification process of 
smelting slag in Nigeria by the investigation of microstructural type phase 
composition and form  and by the  combination of ternary phase diagram. 
Similarly Gordon recognized the iron working process by identifying the 
phase of fayalite (2Fe0, Si02), which is the main phase of slag, magnetite 
and residual glass. 
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Chemical analysis  is utilized to identify the chemical composition of 
slag, for the condition within the furnace could affect the composition of 
slag. The smelting of iron ore to metal must be conducted  in a high 
temperature and reducing environment during the reduction process, the 
type of iron oxide changes from Fe3O4 to FeO3 (magnetite) from Fe3O4 to 
FeO (wustite) and consequently become metal iron.  Therefore study of the 
relative amount of magnetite, wustite and metal iron could infer the 
reduction condition inside the furnace. In addition, during the smelting 
process it is very often that a certain proportion of iron in the ore is remove 
with the gangue. Tylecote et al, suggested that the ore trends to reduce to 
metal in a more reducing, condition,  while the less reducing condition 
results in the production of less iron rich slag. 
 
Ore + furnace lining + charcoal + flux = slag + iron 
• wikipedia the free enclylopedia 
• U.S Geological survey 
Pharmacopieal monograph of metals and minerals used in ayuirveda.
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GUNAPADAM ASPECT 
mak; 
 mak; gjpNdhUtif cNyhfq;fspy; xd;W. ,J ,aw;if 
cNyhfg;gphpitr; Nrhe;jJ. ,jd; G+jhk;rk; thAthFk;. 
 
NtWngah;fs;: 
 thjg;gr;ir> epUk;nghd;> fUk;nghd;. JUk;nghd;> fjfk;. jhk;gurq;fk;> 
jpUk;gd;. 
- gQ;rfhtpa epfz;L> gf;fk; 109. 
 
Mjp> maR> mapy;> ,b> ,Uk;G> <rnrak;> fUq;nfhy;> fUg;gp> fUk;G> 
fUg;G> fUkzy;> tho;G+kpehjk;> fUe;jhJ> fUk;nghd;> faR> fpU~;zitak;> 
fhypy; nefpsk;> Mjp> rj;J> rpNuhruk;> rpl;lk;> jpUk;gp> Jz;lk;> nghd;kzy;> 
Nghfk;. 
- Nghfh; epfz;L> gf;fk; 105. 
maR> Nyhfk; 
- ,uruj;d rKr;rak;> gf;fk; - 62. 
 
maR. fUg;G> fUkzy;> tho;G+kpehjk;> faR> rNuhrk;> fhypy; nefpsk; 
  - rl;il Kdp epfz;L> gf;fk; - 65. 
 
Vernacular names: 
 Sans  : lauha, hyam 
 Eng  : Iron 
 Arab  : Hadida 
 Pers  : Ahana 
 Urudu : Lohchun 
 Hindi  : Loha 
 Ben&Duk : Loha 
 Mahar&koh:  Lokhand 
 Tam  : Irumbu 
Tel  : Inumu 
  sinh  : Yehada 
  Burm  : Than 
  Malay  : Basi 
- Indian Materia Medica, Page 54 
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Njhw;wk;: 
1. mak; vy;yh kiyfspYk;> epyq;fspYk; mNefkhff; fe;jfk; 
Nghd;w rpW nghUl;fSld; fyg;Gw;Wf; fpilf;fpd;wJ. ,J jhJ 
jhtu> [Ptg; nghUs;fspy; rpwpjsT fye;Jk; ,Uf;fpd;wJ. 
Fw;wKs;s ,urk; rpWmstpYk;> Fw;wKs;s fe;jfk; ngUkstpYk; 
Nru maKz;lhFk;.  
- Fzghlk; - jhJ rPt tFg;G> gf;fk; - 89 and 244 
 
2. Iron is not found in the metallic form sometimes it is obtained as a 
by product in the working of pyrites and ilemenite. In India it 
occurs in Mayurbunj, Singbhum, Mysore, Madhyapradesh, 
Bombay, Madras & Andrapradesh. Iron is widely distributed in 
both the organic and inorganic kingdoms. It is found as carbonate 
in spathi iron. It is found in the ashes of plants red corpuscles of 
the animal blood, also in the bile, chyle, gastric juice, lymph, milk, 
pigment of the eye and in the urine. 
- Wealth of India, Page 256. 
- Modern inorganic Chemistry Page 735. 
- Indian Materia Medica, Vol – II page 54. 
maf;fyg;G nfhz;l gh~hzq;fs;:  
1 nfshpghlhzk; 
2 rt;tPughlhzk; 
3 fhh;Kfpy; ghlhzk; 
4 nfe;jf ghlhzk; 
5 njhl;bg; ghlhzk; 
6 jhu ghlhzk; 
7 Jj;jg; ghlhzk; 
8 Nfhopj;jiyf;nfe;jp ghlhzk; 
9 ,ytz ghlhzk; 
10 ehf ghlhzk; 
11 kNdhrpiy ghlhzk; 
12 maj;njhl;b ghlhzk; 
13 thznfe;jp ghlhzk; 
14 JUR ghlhzk;. 
- caph;fhf;Fk; rpj;j kUj;Jtk;> gf;fk; 567 
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Organoleptic Characters :  
 Rit (Taste)   - Jth;g;G (Astringent) 
 tPhpak; (Potence)   - ntg;gk; 
 gphpT (Post disgestive effect) - fhh;g;G 
 
nra;if (Therapeutic action) : 
 FUjpg;ngUf;fp (haematinic) 
 grpAz;lhf;fp (Stomachic)  
 cly; cukhf;fp (Tonic) 
 cly; Njw;wp (Alteraative) 
 
mak; FUjpapd; jd;ikia Nkk;gLj;Jk; mak; rk;ge;jg;gl;l kUe;Jfs; 
kyf;fl;il czL gz;Zk;. mij jtph;f;f Kg;giy $l;bf; nfhLg;gJ 
tof;fk;. clypd; vy;yh cWg;Gfspd; njhopy;fisAk; J}z;Ltpf;Fk;. 
,jdhy; ,J cly; Njw;wpahf njhopy; Ghpfpd;wJ. 
 
nghJf;Fzk;: 
 “ghz;L ntz;Fl;lk; gUe;J}y Neha; Nrhig 
 khz;blr;nra; ke;jq;fh khiyFd;kk; - G+z;l 
 ngUe;jhJ el;lKk;Nghk; Ngjpgrp Az;lhq; 
 fUe;jhJ el;lkpUq; fhy;” 
 
 ,Uk;gpdhy; ghz;L> ntz;Fl;lk;> mjpJ}yNeha;> Nrhig. ke;jk;> 
fhkhiy> Fd;kk;> jhJel;lk; ,itePq;Fk.; grpAz;lhFk;. 
- Fzghlk; - jhJrPt tFg;G> gf;fk; 90 
 
,Uk;gpdhy; jhfk;> ntl;il> mdy;> ghz;L> fgk; jPUk;. 
- mfj;jpah; kzp 4000> gf;fk; 296 
 
maj;jpdhy; fhkhiy> fhrk;> fak;> kNfhjuk; jPUk;. 
- mkph;jrhfuk; gjhh;j;j #lhkzp. gf;fk; 100 
 
maj;jpd; Njhlq;fSk; ePf;Fk; KiwfSk; : 
 rufk;  - #jj;jhy; ePq;Fk; 
 jpiu  - tPuj;jhy; ePq;Fk; 
 rtpL  - fy;Yg;ghy; ePq;Fk; 
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 cilr;ry; - Rf;fhy; ePq;Fk; 
 Cwy;  - etr;rhuj;jhy; ePq;Fk; 
 
Rj;jp Kiwfs;: 
1. maj;ij jflhfj; jl;b> nfhy;yd; ciyapypl;L Cjp ed;F 
gOj;jg;gpd; ey;nyz;nza;> mhprpf;fhb> gRtpd;ePh;> nfhs;FbePh; 
,tw;wpy; KiwNa Kk;%d;W Kiw Njha;j;njLf;fr; Rj;jpahFk;. 
 
2. xUgyk; (35fpuhk;)mag;nghbf;F MW gyk; (210 fpuhk;) 
,Yg;igg;G+r;rhW tpl;L fhiy Kjy; khiy tiu nta;apypy; 
itf;fNtz;Lk;. ,t;tpjk; MWehs; nra;J ,uz;L ehs; rhW tplhky; 
cyh;j;jp gpd;Dk; ,ijg;Nghy; ,UKiw nra;J 25k; ehs; Kjy; 10 
ehl;fs; ,iltplhky; Nkw;gb rhWtplhky; ,uz;Lehs; cyh;j;jp 
ePh;tpl;Lf; fOtp vLf;fr; Rj;jpahFk;. 
 
3. ,Uk;gpd; mug;nghbia fhb> vYkpr;rk;gor;rhW> ehl;Lf;fhl;lhkzf;Fg; 
ghy; ,it xt;nthd;wpYk; %d;W ehs; Cw itj;Jf; fOtNtz;Lk;. 
,t;thW MWKiw nra;a Ntz;Lk;. 
- Fzghlk; – jhJ  rPt tFg;G> gf;fk; - 92. 
 
4. ,Uk;gpid muhtpg; gor;rhw;wpy; %d;W ehs; Cw Nghl;liuj;J fOtpf; 
nfhs;s Rj;jpahFk;. 
- rpfpr;rhuj;djPgk;> gf;fk; 39. 
 
5. maj;jpd; kPJ fwpAg;igf; Fioj;Jg;G+rp mf;fpdpapw; fha;r;rp jphpgyh 
FbePhpy; Njha;f;f Rj;jp MFk;. 
 
6. ney;ypf;fdp urj;jpyhtJ jphpgyh f~haj;jpyhtJ. maj;ijf; fha;r;rp 
Kd;Nghy; tWj;J Rj;jp nra;ayhk;. 
- ,uruj;d rKr;rak;> gf;fk; - 68 
 
7. To get rid of impurities, boil one and half seer of water, reducing to 
quarter and then soaking in it half a seer of thin plates of cast iron 
which have been previously heated. Repeat the process seven times. 
- Indian Materia Medica, page – 57. 
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mak; NrUk; ghz;L Neha;f;fhd kUe;Jfs; 
1. majq;f nre;J}uk;: 
msT :65 – 130 kp.fp.> ,UNtis 
mDghdk;: Njd; 
 - fz;Zrhkp guk;giu itj;jpak;> gf;fk; 358. 
2. tPumar;nre;J}uk;: 
msT :65 – 130 kp.fp.> ,UNtis 
mDghdk; : Njd;> nea;. ntz;nza; 
- fz;Zrhkp guk;giu itj;jpak;> gf;fk; 315. 
3. rj;Jr; nre;J}uk;: 
msT : 32kp.fp> ,UNtis 
mDghdk;: Njd; 
- fz;Zrhkp guk;giu itj;jpak;> gf;fk; 315 
4. tpl;LZuhrG+gjp: 
msT : 1-2 khj;jpiu> %d;WNtis 
mDghdk;: ,Q;rpr;rhW 
- mfj;jpah; itj;jpa fhtpak; 1500> gf;fk; 821. 
5. #rpfhguzk;: 
msT : 1-2 fpuhk;> ,UNtis 
mDghdk;: nte;ePh; 
- mfj;jpah; itj;jpa fhtpak; 1500> gf;fk; 737. 
6. ma gpUq;fuh[ ghzpjk;: 
msT : 2-5 fpuhk;> ,UNtis 
- Fzghlk; jhJrPt tFg;G> gf;fk; - 93 
7. fLf;fha; nea; :  
msT : 4-5 kpyp> ,UNtis 
- mfj;jpah; itj;jpa rpe;jhkzp> gf;fk; 286 
8.vYkpr;rq;fLF : 
 msT: 5 fpuhk;> ,UNtis 
- mfj;jpah; kzp 4000> gf;fk; 229 
9. ghz;LthPurk;:  
 msT: 130-260kp.fp> %d;WNtis 
 - mDgt itj;jpa Njtufrpak;> gf;fk; 371 
10. kfhuh[ kpUfhq;fk;: 
msT: 1 khj;jpiu> ,UNtis 
mDghdk;: nte;ePh; 
- rpj;j itj;jpaj; jpul;L> gf;fk; - 63 
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11 jhthf;fpdp gw;gk;: 
msT: 450kp.fp.> ,UNtis 
mDghdk;: Njd; 
 - mfj;jpah; - 2000 %d;whk;ghfk;> gf;fk; 366 
12. ma nkOF: 
msT : 2-3 fpuhk>; ,UNtis 
JizkUe;J : rhf;fiu> Njd;> nea; 
- mDNghf itj;jpa etePjk;> gf;fk; 33. 
13. mag;nghb ,sfk;: 
msT : 2-5 fpuhk;> ,UNtis 
- mDNghf itj;jpa etePjk;> ghfk;-4 gf;fk; 37. 
14. mar;#uzk; : 
msT: 1.3fpuhk;> ,UNtis 
mDghdk;: Njd;> nea; 
 - mDNghf itj;jpa etePjk;> gf;fk; 36. 
15. kfhrTghf;fpa Rz;b: 
msT : 5 fpuhk; ,UNtis 
- mDNghf itj;jpa Njtufrpak;;;> gf;fk; 379. 
16. mafhe;jhjp Fspif: 
msT : 1 khj;jpiu> ,UNtis 
mDghdk; : nte;ePh; 
- mfj;jpah; 2000> gf;fk; 379 
17 kfhtre;j FRkhfuk;: 
msT : 1 khj;jpiu> ,UNtis 
mDghdk; : nte;ePh; 
 - mDgt itj;jpa Njtufrpak;> gf;fk; - 65. 
18. Ragw;gk; :  
msT : 65kp.fp> ,UNtis 
mDghdk;: jf;Nfhyhjpf;fsp 
- Fzghlk; jhJrPt tFg;G> gf;fk; - 93. 
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mak; NrUk; gpwNeha;f;fhd kUe;Jfs; 
 
1. Uj;jpu nre;J}uk;: 
 
msT> mDghdk;: 65kp.fp> ,UNtis Njdpy; nfhLf;fTk;.  
jPUk; Neha;fs;: Nkfk;> #iy> Fl;lk;> Ruk; 
- gpuhz ul;;rhkph;j rpe;J> gf;fk; - 193. 
2. ,urtPu nre;J}uk;: 
ruf;Ffs;: 
Rj;jpj;j mug;nghb  - 5 tuhfd;  
Rj;jpj;j tPuk;  - 4 tuhfd; 
Rj;jpj;j ,urk;  - 4 tuhfd; 
Rj;jpj;j ethr;rhuk; - 1 tuhfd; 
nra;Kiw: 
 ,itfis fy;tj;jpypl;L nghbj;J xUrhkk; miuj;J xU 
GJr;rl;bapy; Nghl;L jPghf;fpdpaha; vhpj;J njd;idaPh;f;Ffshy; Jshtp 
tWf;fTk;. ,t;tpjkha; 3 jlit miuj;J tWf;fr; nre;J}ukhFk;. vhpf;Fk; 
NghJ mjd; Gif fz;fspYk;> thapYk; Nghfhky; [hf;fpuijaha; 
,Uf;fTk;. 
msT    : 65kp.fp.> ,UNtis 
mDghdk;   : nty;yk;> rPdp 
jPUk; Neha;fs; : kfhthjq;fs;> rd;dp 
 
3. mankOF: 
ruf;Ffs;: 
maf;fl;b     – 1gyk; 
%d;W tUlk; nrd;w Gsp  –  2 Nrh;  
 fpshg;gor;rhW    –  1 gb 
nra;Kiw: 
ruf;Ffis xd;whfr; Nrh;j;J rl;bapy; itj;J Nky;rl;b nfhz;L %b 
rPiykz; nra;J fhw;wpy;yhj ,lj;jpy; mirahky; chpapy; itf;fTk;. 
xUkz;lyk; nrd;W ghhf;f nkOF NghypUf;Fk;. 
 msT   : 130 kp.fp. ,UNtis 
  jPUk; Neha;fs; : Nrhif> fhkhiy> gpj;jntl;il 
- gpuhzul;rhkph;jrpe;J> gf;fk; 215 
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4. mafhe;j tlfk;: 
 msT   : 10 fpuhk;> ,UNtis 
 mDghdk;  : Njd; 
 jPUk; Neha;fs; : Nrhif> tPf;fk;> Fd;kk;> rd;dp> thA 
- gpuhzul;rhkph;jrpe;J> gf;fk; 225 
 
5. Rth;z Nyhfj; jpuhtfk;: 
 msT  :  6fpuhk;> ,UNtis 
mDghdk; : jpuhtfj;jpd; vilf;F 10 gq;F jz;zPhpy; fye;J nfhLf;fyhk.; 
jPUk; Neha;fs; : NkfRuk;> Fsph;Ruk; 
- mDNghf itj;jpa etePjk;> ghfk; - 80. 
6. gQ;rNyhf mQ;rdk; : 
 msT   :  32 kp.fp.> ,UNtis> mThpapiyr;rhw;wpy;  
      ,iof;fTk; 
 jPUk; Neha;fs; :  fz;jbg;Gfs; 
- mfj;jpah; 2000> 3k;ghfk;> gf;fk; - 357. 
7. rq;fu igut urk; : 
 msT   : 130 kp.fp> ,UNtis 
 mDghdk;  : jpg;gpyp#uzk;> Njd; 
 jPUk;Neha;fs;  : Uj;jhfrd;dp 
- mDgt itj;jpa Njtufrpak;> gf;fk; - 94 
8. mNahu[hjp #uzk;: 
 msT   : 130.kp.fp – 260 kp.fp> ,UNtis 
 mDghdk;  : Njd;> nea;> my;yJ nty;yk; 
 jPUk;Neha;  :  fhkhiy 
- mfj;jpah; 2000> ghfk; 3> gf;fk; 383 
9. F~;lf[Nfrhp : 
 msT   :  1 khj;jpiu> ,UNtis 
 mDghdk;  : rh;f;fiu> Njd; 
 jPUk;Neha;fs; : Fl;lk;> Nkfk; 
- rpj;j itj;jpaj;jpul;L> gf;fk; -13. 
10. Fz;lyhjp Nyfpak;: 
msT   : 4 - 5fpuhk;> ,UNtis 
jPUk;Neha;fs; :  vd;GUf;fp> Fd;kk;> Fly;thjk;> 
- mfj;jpah; itj;jpa rpe;jhkzp; 4000> gf;fk; 245. 
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11. ,uhrkNfRuk; Fspif: 
msT   :  130kp.fp> ,UNtis 
jPUk;Neha;fs; :  vd;GUf;fp> Fd;kk;> Fly; thjk;> 
 - mfj;jpah; itj;jpa fhtpak; 1500> gf;fk; 790 
12. tq;fr; re;jpNuhjak;: 
msT   :  32 – 65 kp.fp> ,UNtis 
mDghdk;  :  jphpfLF #uzk; 
jPUk;Neha;fs; : thA> fhkhiy 
- tPukhKdpth; thflj;jpul;L> gf;fk; 75. 
13. cj;jkkhf;fpdp Fkhud;: 
msT   :  65kp.fp> ,UNtis 
mDghdk;  : Njd; 
jPUk;Neha;fs; :  thjk;> Ruk; 
 - mfj;jpah; itj;jpa rpe;jhkzp 4000> gf;fk; 350. 
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GUNAPADAM ASPECT 
cUf;F  
 
NtW ngaHfs; : 
maf;fbR  ,uj;jNyhfk; 
muk;   jPÑk; 
cUf;F  kiyf;FNlhhp 
vOF   tw;wy; Nyhfk; 
xOfiw 
kzpths; 
fpl;lNyhfk; 
 
fpilf;Fkplk; : 
,/J ,e;jpahtpy; ikR+H Nghd;w gy ,lq;fspy; ,Uk;gpypUe;J 
nra;ag;gLfpd;wJ. ,J ,Uk;gpypUe;J rpwpJ NtWgl;ljhFk; tlE}yhH 
,jid MW tifahff; $WtH. 
 
Organoleptic characters: 
Rit (Taste)    :  JtHg;G 
tPhpak;  (Potence)    : ntg;gk; 
gphpT (Post digestive effect )  : fhHg;G 
 
nghJFzk;: 
“je;jke;j %yTU jhJel;lQ; Nrhigfz;Nzha; 
 te;jke;jk; ghz;Ltpid td;ikFd;wy;-Ke;jg; 
 ngUf;fpilaha; ePl;Lfg Ngj kpitfl; 
 FUf;fpilah Njhl;L Kiu.” 
 
nghUs;: 
cUf;fhdJ je;jNuhfk; %yNeha;> Rf;fpyel;lk>; tPf;fk;> fz;Nzha;> 
myrk>; cly;ntSg;G> Jh;g;gyk; gLf;ifNa fjpahf tPo;j;jhepd;w rafhr 
Nuhfq;fs; ,tw;iwg; Nghf;Fk;. 
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Rj;jp Kiwfs;: 
(1) cspiag; Gspapiy fdj;jpy; jflhf mbj;Jf; nfhy;yDiyapy; 
rptf;ff; fha;r;rp fhb> vs;nea;> gRtpd; ePH> nfhs;FbePH ,itfs; 
xt;nthd;wpYk; Kk;%d;W Kiw Njha;j;J muj;jhy; muhtpj; 
J}sf;fp cgNahfpf;fTk;. 
 
(2) xU gyk; (35 fpuhk;) cUf;Fg; nghbapy; MW gyk; (210 fpuhk;) 
nfhl;il Ke;jphpifg; g+r;rhW tpl;L> fhiy Kjy; khiy tiu 
nta;apypy; itf;f Ntz;Lk;. ,t;tpjk; MW ehs; nra;J ,uz;L 
ehs; rhWtplhky; cyHj;jp gpd;Dk; ,J Nghy ,U Kiw nra;J 
25 Mk; ehs; Kjy; gj;Jehs; ,iltplhky; Nkw;gb rhWtpl;L 
nta;apypy; cyHj;jp ePHtpl;Lf; fOtp vLj;Jf; nfhs;sr; 
Rj;jpahFk;. 
 
(3) Nja;e;j gioa cspia ciyapypl;Lf; fha;r;rp nts;shl;Lg; 
gpr;rpy; Njha;f;f ntl;ilahFk;. ntl;ilahFk; tiu Njha;f;fTk;. 
xt;nthU KiwAk; Gjpa gpr;ir cgNahfpf;f Ntz;Lk;. 
  
cUf;F gw;g Nrhjid: 
njd;dq;fs;> gdq;fs>; <r;rq;fs; ,itfSs; VjhtJ xd;wpy; vs;ssT 
gw;gj;ijg; Nghl;lhy; clNd fs; rhwha; khwptpLk;. 
 
gw;g kfpik: 
,J jhkpugw;gj;ijg; Nghd;W Mz;ikiaAk;> Fzj;ijAk; 
fhz;gpf;Fk;. Mjyhy; jhkpugw;gj;jpw;F tud;Kiwg; gj;jpak; vg;gbNah 
mg;gbNa ,jw;Fk; ghHj;Jf; nfhs;s Ntz;Lk;. 
 
tpy;iy fha itf;Fk; Kiw: 
tpy;iyia ,utpapy; itg;gJ Nghy; gdpapYk; itf;fNtz;Lk;. 
gdpapy; mtpo;jq;fis itf;fhtpl;lhy; gf;Ftg;glhJ nfl;LtpLk; vd;W 
jpU%yUk; ,ilf;fhlUk; $Wfpd;wdH. 
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cUf;F NrUk; ghz;L; Neha;f;fhd kUe;Jfs; 
 
(1) ghz;LkNjg rpk;k R+jk;: 
msT : 130kp.fp.> ,UNtis 
mDghdk; : Njd;> nea; 
- mDgt itj;jpa Njt ufrpak>; gf;fk; 364. 
 
(2) ,ujhjpf; Fkhp gw;gk; : 
msT : 488 kp.fp.> ,UNtis 
mDghdk; : Njd; 
- ruNge;jpuH ghz;LNuhf rpfpr;ir> gf;fk; 25. 
 
(3) v/F nre;J}uk;: 
msT : 32-65kp.fp.> ,UNtis 
mDghdk; : Njd; 
- gjhHj;j Fz tpsf;fk; (jhJ)> gf;fk; 70. 
 
(4) v/F gw;gk;: 
 msT : 32-65kp.fp.> ,UNtis 
 mDghdk; :  Njd>; nea;> ntz;nza; 
- mDNghf itj;jpa etePjk; ghfk;-1> gf;fk; 51. 
 
(5) v/F nre;J}uk;: 
msT : 65-260kp.fp.> ,UNtis 
mDghdk; : ntz;nza; nea; Njd; 
- mDNghf itj;jpa etePjk; ghfk; - 1> gf;fk; 55. 
 
(6) v/F RtHzr; nre;J}uk;: 
msT :  65-130 kp.fp.> ,UNtis 
mDghdk; : Njd;> ghNyL> ghy;my;th 
- mDNghf itj;jpa etePjk; ghfk; - 1> gf;fk; 57. 
 
(7) v/Fr; nre;J}uk;: 
msT : 244.kp.fp.> ,UNtis 
mDghdk; : Njd;> nea;> 
- rpfpr;rhuj;jpdjPgk;> gf;fk; 233 
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(8) v/F gw;gk;: 
msT : 65 kp.fp.> ,UNtis 
mDghdk; : Gspg;G> Gspg;Gila nghUl;fs>; ngz;Nghfk; ePf;fTk; 
- Fzghlk; - jhJ rPt tFg;G> gf;fk; 111. 
 
(9) v/F nre;J}uk;: 
msT : 200–300 kp.fp.> ,UNtis. 
mDghdk; : ntz;nza;> nea;> Njd; 
-  Fzghlk; - jhJ rPt tFg;G> gf;fk; 115. 
 
(10) jphpNyhfr; nre;J}uk;: 
msT : 488 kp.fp.> ,UNtis 
mDghdk; : rQ;rPtp R+uzk; kw;Wk; nea; 
-  Fzghlk; - jhJ rPt tFg;G> gf;fk; 115. 
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cUf;F NrUk; gpw Neha;;fSf;fhd kUe;Jfs; 
 
(1) cUf;Fr; nre;J}uk;: 
msT : 488 kp.fp.> ,UNtis 
   mDghdk; : jphpgyh R+uzKk; nty;yKk; fye;jJ 
    jPUk; Neha;fs; : gykpd;ik jPUk.; eiu> jpiu khWk;. 
- capHfhf;Fk; rpj;j kUj;Jtk;> gf;fk; 489. 
      
(2) `uUj;jpu urk;: 
msT : 130 kp.fp.> ,UNtis 
   mDghdk; : Njd; my;yJ nea; 
  jPUk; Neha;fs; : vy;yhtpj raNuhfq;fs; 
 - mDgt itj;jpa Njt ufrpak;> gf;fk; 356 
 
(3) v/F nre;J}uk; : 
msT : 32-65kp.fp.> ,UNtis 
mDghdk; : Njd; my;yJ nea; 
jPUk; Neha;fs; : R+iy> ,rpT> fhrk;> Ruk; 
- mDgt itj;jpa Njt ufrpak;> gf;fk; 380. 
 
(4) igj;jpahd;jf urk;: 
msT : 130 kp.fp.> ,UNtis 
mDghdk; : Njd;> ghy;> mjpkJufpahok; 
jPUk; Neha;fs; : ,UgJ gpj;jNeha;fs;> gpj;j vhpr;ry; 
- mDgt itj;jpa Njt ufrpak>; gf;fk; 452. 
 
(5) ghzpgj;j urk;: 
msT: 130kp.fp.> ,UNtis 
mDghdk; : jpg;gpypr; R+uzk;> nea;> Njd; 
jPUk; Neha;fs; : fHg;gpj;j Nuhfk; vy;yh tif gpj;jq;fs.; 
- mDgt itj;jpa Njt ufrpak>; gf;fk; 455. 
 
(6) v/F gw;gk;: 
msT : 195-390kp.fp.> ,UNtis 
mDghdk; : rHf;fiu> nea;> Njd;. 
jPUk; Neha;fs; : fUNkfk;> Gs;spNkfk;> Nkfg;Gz; 
- mDgt itj;jpa etePjk; ghfk; 1> gf;fk; 53 
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(7) v/F nre;J}uk;: 
msT : 65-130 kp.fp.> ,UNtis 
mDghdk; : $o;g;ghz;l ,sfk;> Riuf;fha; ,sfk; 
jPUk; Neha;fs; : typg;G> gf;fthjk>; nehpfl;Lk;Ruk>; 
ahidf;fhy;thjk; 
- mDgt itj;jpa etePjk; ghfk; 1>  gf;fk; 56. 
(8) cUf;F gw;gk;: 
ruf;Ffs;: 
Rj;jp nra;j cUf;F – 1 gyk; 
MfhrfUlf; fpoq;F – Njitahd msT 
nra;Kiw :  
Rj;jp nra;j cUf;if jfLfshf;fp Mfhrf;fUlf;fpoq;fpy; nghjpe;J 
rPiykz; nra;J tuhfg; Glk; Nghl gw;gkhFk.; 
gad; : 
Njf gyKk; eiu jpiu khWjYk; cz;lhFk;  
- gpuhzul;rhkph;jrpe;J> gf;fk; 187. 
(9) v/F nre;J}uk;: 
msT : 32-65 kp. fp.> ,UNtis 
mDghdk; : thjrhPuj;jpw;F NjdpYk>; gpj;jrhPuj;jpw;F nea;apYk; 
nfhLf;fTk;. 
gad;: 
 Njf gykpd;ik khWk;. Eiu> jpiu khWk;. 
- gjhh;j;jFz tpsf;fk; (jhJ)> gf;fk; 71. 
 
(10) v/F gw;gk;: 
msT : 65 – 130 kp.fp.> ,UNtis 
mDghdk; : rljhhpg; nghbAld; nea;> Njd; $l;bf; nfhLf;fTk.;  
jPUk; Neha;fs; : Fe;jNkNywy>; tapw;iwg; gw;wpa Neha; mWgJ 
Mfpa ,it ePq;Fk; 
- Fzghlk; - jhJ rPt tFg;G> gf;fk; 112. 
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GUNAPADAM ASPECT 
kz;^ uk; 
 
NtW ngaHfs;: 
fpr;Rf;fpl;lk; 
,Uk;Gf;fpl;lk; 
,Uk;Gj;JU 
,Uk;Gj;Jfs; 
goQ;nrq;fw;jpl;lk; 
- jkpo; Mq;fpy mfuhjp> gf;fk; 410 
fpl;lk; 
rpl;lk; 
mNahkyk; 
Nyhf kz;^ uk; 
maf;fpl;lk; 
mar;rpl;lk; 
rpl;lhd; 
- Fzghlk; - jhJ rPt tFg;G> gf;fk; 195. 
 
Vernacular names: 
Sans  :  Manduram 
Eng.   :  Iron rust 
Bom   :  Loheka janga 
Hind   :  Lohaka lang 
Beng   :  Loha – ga 
Tel      :  Innupu chittu 
Tam   : Irumbu chittam 
- Indian pharmacopoeia, page 62. 
 
Organoleptic characters: 
,jd; Rit> jd;ik> gphpT> nra;if maj;jpid xf;Fk;. 
Rit (Taste)    :  JtHg;G 
jd;ik (potence)   :  ntg;gk; 
gphpT (post digestive effect)  :  fhHg;G 
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nra;if: 
cly; cukhf;fp  
FUjpg;ngUf;fp 
cly; Njw;wp 
 
Njhw;wk;: 
,Uk;G epyj;jpy; Gije;J R+l;bdhYk;> kioapdhYk; rpije;J 
gy;yhz;LfSf;Fg; gpd; kz;^ uk; MfpwJ. Ehw;whz;LfSf;F Nkw;gl;l 
kz;^ uk; rpwe;j kUe;Jg; nghUshff; nfhs;sg;gLk;. 
- rufrk;fpij IIIk; ghfk;> gf;fk; 149. 
 
nfhy;yd; ciyapy; ,Uk;gpdhy; tplg;gl;L mf;fpdpapy; nte;J 
nkOfpd; gjj;jpNy fl;bahfpd;wJ. 
- Fzghlk; - jhJ rPt tFg;G> gf;fk; 195. 
 
The black forge scales which collects around the blacksmiths anvil 
are called mandura. 
- Indian pharmacopoeia, page 26. 
 
Rj;jp Kiwfs;: 
(1) fpl;lj;ijf; fy;Yuypypl;L ,bj;J thafd;w xU rl;bapypl;L mjd; 
Nky; ehd;F gq;F vil Gspapiyiag; Nghl;L vz; klq;F ePHtpl;L 
xU rhkk; Ntfitj;J Mwpa gpd; ,iyiaAk;> nghbiaAk; 
NrHj;J ed;wha;j; Nja;j;Jf; fOtp cyHj;jp Kwj;jpypl;Lg; Gilj;J 
,iyia ePf;fptp;lNtz;Lk;. gpwF fpl;lg; nghbia mk;kpapypl;Lg; 
nghbj;J xU rl;bapypl;L vl;Lg;gq;F Nfh%j;jpuj;ij tpl;L 
mLg;Ngw;wpr; rpWjPahy; vhpj;J %j;jpuk; Rz;bagpd; ,wf;fp ePHtpl;Lf; 
fOtp vhpj;Jf; nfhs;sr; Rj;jpahFk; 
 
(2) maf;fpl;lj;ij cuypypl;L ,bj;J t];jpufhak; nra;J. xU 
gPq;fhd; ghj;jpuj;jpypl;L mjd; Nky; ehd;F mq;Fyk; 
epw;Fk;gbahff; fhukhd rPikj; jpuhl;irf; fhbia tpl;L ,uz;L 
thuk; Cwitj;J> nts;isG+z;il ,bj;Jg; gpope;j rhw;iw 
Kd;Nghy Cw;wp xU thuk; Cwitf;f Ntz;Lk;. Cw itf;Fk; 
NghJ %d;W ehisf;F xU Kiw Cwitj;j rhw;iw 
,ilapilNa Cw;wptpl;L mr;rhw;iwNa Gjpjha; tpl Ntz;Lk;. 
gpd;G thJik nea;apy; my;yJ gRtpd; nea;apy; ed;wha; tWj;Jg; 
nghbj;Jf; nfhs;tNj Rj;jpahFk;. 
- Fzghlk; - jhJ rPt tFg;G> gf;fk; 195. 
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(3) ,ij neUg;gpy; fha;r;rp Nfh%j;jpuj;jpy; VOKiw Njha;j;njLf;fr; 
Rj;jpahFk;. 
- mDgt itj;jpa Njt ufrpak>; gf;fk; 176. 
 
(4) Ie;Jgyk; kz;^ uj;ij nts;shl;L ePhpy; xU ehs; Cwitj;J 
kQ;rs;fhprhiyr;rhW> gor;rhW rkd; NrHj;J Rz;lg; 
nghhpj;njLf;fTk;. 
- rpNuhuj;d itj;jpa g+rzk>; gf;fk;. 30. 
 
(5) fpl;lj;ij fUkhd; ciyapy; itj;J jhd;wptpwFf; fhpahy; 
rptf;ff; fha;r;rp gidkuj;njhl;bapy; Nfh%j;jpuk; tpl;L mjpy; VO 
jlit Jitj;jhy; Rj;jp 
- mDgt itj;jpa Njt ufrpak;> gf;fk; 177. 
nghJf; Fzk;: 
“rpl;lnkd;whw; Nrhig fpistPf;f kj;jpRuq; 
  Jl;ltpl ghfQ; Rthrikaq; - nfl;lnfhLk; 
  ghz;bUky; ePuhik ghOk; gpukpaKd; 
jhz;btpL Kz;buj;j jhJ” 
 
kz;^ uj;jpdhy; thjNrhig Kjypa tPf;fq;fs;> mj;jpRuk>; nfhba 
tplghfk>; ,iug;G> fgNfhgk;> ghz;L> fhrk;> ePuhikf;fl;b> gpukpak; ,it 
ePq;Fk;. ,uj;jk; tpUj;jpahFk; 
 
ehl;gl;l Neha;fspYk; grpke;jj;Jld; kyf;fl;bUf;Fk; NghJ fhZk; 
fdy; Ntfk; (cl;fha;r;ry;) ,Uf;Fk; NghJk; kz;^ uj;ij cgNahfpf;ff; 
$lhJ. 
- Fzghlk; - jhJ rPt tFg;G> gf;fk; 195 
 
kz;^ uj;jhy; tplghfk;, tPf;fk;, ghz;L ,it ePq;Fk;. 
 
- mfj;jpaH kzp 4000 ,uz;lhk; ghfk>; gf;fk; 295. 
J}a;ikahd kz;^ uj;ijg; gw;gkhf;fpg; gad;gLj;jpdhy; ,uj;jj;ijj; 
J}a;ikahf;Fk;. 
- rufrk;fpij %d;whk; ghfk;> gf;fk; 149. 
jhUl;bafhhp nra;ifAila kz;^uj;ij mj;jpRuk;> fgNuhfk;> 
kNfhjuk;> ghz;L> Nrhig> tPf;fk;> ,iug;G ,itfSf;F nre;J}ukhf;fpf; 
nfhLf;fyhk;. 
- gpuhzul;rhkpHjrpe;J> gf;fk; 102 
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kz;^ uk; NrUk; ghz;L Neha;f;fhd kUe;Jfs; 
(1) kz;^ u fpahok;: 
maf;fpl;lk;> kQ;fs;fhprhiy> fLf;fha;> kpsF rknailahff; 
fpahok; nra;J rhg;gpl ghz;L jPUk;. 
- capH fhf;Fk; rpj;j kUj;Jtk>; gf;fk; 601 
 
(2) ghz;L fpahok;: 
msT : 300 kp.yp> ,UNtis> 3 ehs; 
- capH fhf;Fk; rpj;j kUj;Jtk;> gf;fk; 523 
 
(3) kz;^ u nre;J}uk;: 
msT : 488 kp.fp.> ,UNtis 
mDghdk; : fhpg;ghd; rhW 
- capH fhf;Fk; rpj;j kUj;Jtk>; gf;fk; 488 
(4) fhe;j ur tlfk; : 
msT : 1 fpuhk;> ,UNtis 
mDghdk; : vUikNkhH 
- capH fhf;Fk; rpj;j kUj;Jtk>; gf;fk; 474 
(5) GdHthjp fpahok;: 
msT : 30kp.yp.> ,UNtis 
- mDgt itj;jpa Njt ufrpak;> gf;fk; 369 
(6) fhe;jty;yg urk;: 
msT : 130 kp.fp.> ,UNtis 
mDghdk; : Njd; 
- mDgt itj;jpa Njt ufrpak;> gf;fk; 357 
(7) GdHdthjp tlfk; : 
msT : 1–2 khj;jpiu> ,UNtis 
mDghdk; : NkhH 
- mDgt itj;jpa Njtufrpak;> gf;fk; 374 
(8) kz;^ u ytzk;: 
,Uk;G rpl;lj;ij rpfg;ghff; fha;r;rp Nfh%j;jpuj;jpy; Njha;f;fTk;. 
,e;jg;gpufhuk; gy jlit nra;J gpwF me;j rpl;lj;jpw;F rkvil 
,e;Jg;Gr; NrHj;J Nfh%j;jpuj;jpypl;L mLg;Ngw;wp jhd;wpf;fha; 
tpwFfspdhy; Gifahky; vhpj;jhy; ‘gpyPjytzk;’ my;yJ 
‘kz;^uytzk’; vd;W ngaH. 
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msT : 5fpuhk;> ,UNtis 
mDghdk; : NkhH my;yJ Njd; 
jPUk; Neha;fs; : ,ijtpl ghz;LNuhfj;ij ehrg;gLj;Jk;gbahd 
kUe;J Ntnwhd;Wk; cyfpy; fpilahnjd;W $wg;gLfpd;wJ. 
- mDgt itj;jpa Njtufrpak;> gf;fk; 372. 
 
(9) fdkz;^u nre;J}uk;: 
msT : 65kp.fp.> ,UNtis 
mDghdk; : Njd; 
- mDNghf itj;jpa gpuk;k ufrpak> gf;fk; 35 
(10) RaNyhfhf;fpdp: 
msT : 130kp.fp.> ,UNtis> 3-5 ehs; nfhLf;fTk;. 
mDghdk; : gidnty;yk; 
- fz;Zrhkp guk;giu itj;jpak>; gf;fk; 451 
(11) ehuhaz kz;^ u nre;J}uk;: 
cgNahfk; : 488 kp.fp.> ,UNtis> Njd;  
- gpuhzul;rhkpHjrpe;J gf;fk; 192 
(12) kz;^ u nre;J}uk; 
cgNahfk;: 980kp.fp.> ,UNtis> Njd; 
- gpuhzul;rhkpHjrpe;J> gf;fk; 195. 
(13) ,uh[ kz;^ u nre;J}uk;: 
cgNahfk;: 488 kp.fp.> ,UNtis> Njd; 
- gpuhzul;rhkpHjrpe;J> gf;fk; 387 
(14) kz;^ u gw;gk;: 
ruf;Ffs;: 
Rj;jp nra;J ,Uk;G flg;ghiuahy;   
,bj;J t];jpufhak; nra;j kz;^ uk;     
 
fhQ;NrhhpRzq;ifr; rhW – Njitahd msT 
 
nra;Kiw : 
kz;^ uj;ij 3 rhkk; rhw;wpyiuj;J tpy;iyjl;b Xl;bypl;L rPiykz; 
nra;J f[Glk; ,l gw;gkhFk; 
 
msTk;> mDghdKk;: 488kp.fp.> ,UNtis> Njdpy; 
 
- gpuhzul;rhkpHjrpe;J> gf;fk; 44 
1 gyk;
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kz;^uk; NrUk; gpw Neha;f;fhd kUe;Jfs; 
(1) fdkz;^ unre;J}uk;: 
 msT   : 65kp.fp.> ,UNtis  
mDghdk;   : Njd; 
jPUk; Neha;fs; : Rthrfhrk;>  cg;Grk>; rak;> fpuhzp> mjprhuk;> 
        cl;fha;r;ry;> Nrhif> tPf;fk;.     
- Nfhrhap  Kjy; ghfk>; gf;fk; 35. 
(2) kQ;rs; fhkhiyf;F kUe;J: 
 msT : 4 fpuhk;> ,UNtis> VOehl;fs;. 
- gpukKdp itj;jpa R+j;jpuk; II, gf;fk; 42 
(3) FspHRuf; fpahok;: 
 msT : 30 – 60 kp.yp.> ,UNtis. 
- fz;Zrhkpak>; gf;fk; 65 
(4)  cjpuf;fl;L eQ;Rf; FbePH: 
msT   : 30 – 60 kp.yp.> ,UNtis 
mDghdk;   : Njd; 
jPUk; Neha;fs;  : #jfr;R+iy> #+jfge;jk; 
- mfj;jpaH gs;S 200> gf;fk; 691. 
(5) rz;lkhUjr; nre;J}uk;: 
 msT   : 488 kp.fp.> ,UNtis 
mDghdk;   : Njd; 
jPUk; Neha;fs;  : fhkhiy> Nrhif> Ruq;fs;. 
- mfj;jpaH itj;jpa fhtpak; 1500> gf;fk; 691. 
(6) mkpHj rQ;rPtp Fspif: 
 msT   : 130 kp.fp.> ,UNtis 
mDghdk;   : ghy; 
jPUk; Neha;fs;  : rd;dp> Kj;Njhlq;fs; 
- mfj;jpaH itj;jpa fhtpak; 1500> gf;fk; 786 
(7) kfhNkf urk;: 
msT   : 130kp.fp.> ,UNtis 
mDghdk;   : Njd;> nea;> ntz;nza; 
jPUk; Neha;fs;  : fgNeha;fs;  
- mfj;jpaH itj;jpa fhtpak; 1500 gf;fk; 742. 
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(8) fUq;Fok;G: 
msT   : 244 kp.fp.> ,UNtis 
mDghdk;   : gidnty;yk; 
jPUk; Neha;fs;  : kNfhjuk;> fhkhiy> thjNeha;fs;. 
- Fzghlk; - jhJ rPt tFg;G> gf;fk; 202 
 
(9) kz;^ u milf;f~hak;: 
msT   : 30 – 60 kp.yp.> ,UNtis 
jPUk; Neha;fs;  : tapWnghUky;> tPf;fk;> tapw;wpYz;lhFk;      
                fl;bfs;> cg;Grk; 
- Fzghlk; - jhJ rPt tFg;G> gf;fk; 203 
(10) cNyhf kz;^ ur; nre;J}uk;: 
 msT   : 130 kp.fp.> ,UNtis 
 mDghdk;   : Njd; 
 jPUk; Neha;fs;  : Kg;gpzp Kjyhd mrPuzke;jk>; Ruk;. 
- Fzghlk; - jhJ  rPt tFg;G> gf;fk; 198. 
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GUNAPADAM ASPECT 
ehty;gl;il – Syzygium cumini 
 
NtW ngaHfs;: 
et;ty;> ek;G> rk;G> rhjtk;> MUfjk;> NeNuL> NeNulk;> rhl;Ltyk;> 
rhk;gy;> Rugpgj;jpiu 
 
Vernacular names: 
Eng   :  Jambul 
Tel.   :  Neradu 
Mal   :  Gnaval 
Kan   :  Neralu 
Sans   :   Jambu 
Hin   :  Jamuns 
Duk   :  Jamoon 
 
Taxonomy: 
Kingdom  :  Plantae 
Division   :  Flowering plants 
Class   :  Dicotyledenae 
Sub-class  :  Polypetalae 
Order   :  Myrtales 
Family   :  Myratales 
Genus   :  Syzygium 
Species  :  Cumini 
 
tiffs;: 
,k;kuk; ,e;jpah KOtJk; tpisfpd;wJ. ,jd; tiffshtd>  
(1) nts;is ehty; 
(2) nfhb ehty; 
(3) Fop ehty; 
(4) fU ehty; 
(5) rk;G ehty; 
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gad;gLk; cWg;G: 
vy;yhg; nghUSk; 
 
Organolepic characters: 
Rit (Taste ) : JtHg;G 
jd;ik (Potence) : jl;gk; 
gphpT (Post digestive effect) : fhHg;G 
 
nra;if: 
nghJ: 
JtHg;gp - Astringent  
gok;: 
grpj;jPj;J}z;b  - Stomachic 
rpWePHg;ngUf;fp  - Diuretic 
clYukhf;fp  - Tonic 
FUjpg; ngUf;fp -  Haematinic 
 
nghJf;Fzk;: 
ehty;gl;ilapdhy; thapy; gpwf;Fk; Neha;fs;> ,Uky;> ngUk;ghL> 
<is> Foe;ijfSf;Fz;lhFk; Gs; Kjypa Njhlq;fs; FzkhFk;. 
 
gad;fs; 
(1) ehty;gl;ilf;Ff; FWk;ghl;bd; FUjpia tpl;L Cwitj;J 
vl;Lg;gq;F nfhz;L mj;Jld; gbfhuk;> ,e;Jg;G ,uz;L gq;F 
$l;baiuj;J cUz;il nra;J ,ul;ilg; gpukpr;rhWk;> NjDk; 
NrHj;Jf; nfhLf;f ngUk;ghL NghFk; (NjiuaH ntz;gh) 
 
(2) gl;ilia Kiwg;gb FbePH nra;J cl;nfhs;s ePhpopT> 
fopr;ry;tif NghFk;. tha;g;Gz;Zf;Fk; ,ijf;nfhz;L tha; 
nfhg;Gspf;f cyUk;. 
 
(3) ,ij miuj;J mbgl;l tPf;fk;> fl;b Kjypatw;wpd; Nky;Nghl 
mit mKq;Fk;. 
 
(4) gl;ilapd; rhw;iwg; ngUk;ghl;Lf;F toq;fyhk;. 
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(5) ,J vl;b eQ;Rf;F khw;whFk;. 
 
(6) ehty;gl;ilr; rhw;wpdhy; ,Uk;G nre;J}ukhFk;. 
 
(7) gl;ilapdhy; fLtd>; fug;ghd;> khe;jk; ,it cz;lhFk;. ePhpopT> 
ntg;gk;> thA> fLg;G> ePHNtl;if ,itfs; ePq;Fk;. 
 
Composition: 
Stem bank contains betullinic acid (m.p. 306-100), β - sitosterol 
friedelin (C30 H50O : m.p. 256 – 600) and a substance (C58 H106 O2 : m.p 
169– 720) which is an ester of epi-friedelanol (C30 H51 OH) with a fatty acid 
(C27 H55 COOH). It also contains tannins (10-12%) gallic acid, ellagic acid 
and myricetin; a resin is reported to be present. 
 
USES: 
Extracts of bark, stem, leaves, buds and flowers possess moderate 
antibiotic activity against Micrococcus pyogense var aureus. The bark is 
astringent and is used in the preparation of gargles and mouth washes.  A 
decotion of the bark is useful in diarrhoea and dysentery. Extract of bark is 
useful in diabetes. The bark extract is reported to have an effect on 
glycogenolysis and glycogen storage in animals. Extracts of bark are toxic 
Piricularia oryzae cav. and Physalospora tucumanensis speg. 
- Wealth of India, page 101-104. 
 
ehty;gl;ilia #+uzpj;jhtJ> FbePhpl;lhtJ mUe;jptu rPjNgjp> 
,uj;jNgjp> ngUk;ghL Kjypad FzkhFk;. 
- mDgt itj;jpa Njt ufrpak>; gf;fk; 59. 
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MATERIALS  AND METHODS 
 
 Thiriloga Chendooram is taken as a compound drug for treating Paandu 
Noi in this dissertation. 
 
Collection of the drug. 
 Iron and steel were bought at private raw drug store, Madurai. Iron slag 
(Manduram) was collected in and around Alangulam Tirunelveli. Syzigium 
(Naaval) bark was collected in and around Vannarpettai, Tirunelveli. All the three 
minerals were identified correctly by head of the department of Geo-chemical 
sciences, Manaomaniam Sundaranar University, Tirunelveli. 
 
Purification of the raw drugs 
 Irumbu plates were blowed in heat and were dipped in gingly oil, rice kaadi, 
cow’s urine and Dolichos decoction respectively for three times subsequently. The 
plates were changed into small soft particles after dipping in the above liquids. 
Then the iron was washed with fresh water and dried in sunlight. The same method 
employed for the purification of Urukku. Powdered Mandooram is taken in a pot 
and added four parts of tamarind leaves and eight parts of water. This mixture was 
boiled for 3 hours and then the powder was washed and dried in sunlight. Tamarind 
leaves were removed. The Mandooram was grinded and put into a pot. Eight parts 
of cows urine was added into the  pot and boiled upto the cow’s  urine disappeared. 
Then the Mandooram was washed with fresh water and was dried is sunlight.  
 
Preparation of Thiriloga Chendooram : 
 Drugs required   
 Irumbu   - 250 gm 
 Urukku   - 250 gm 
 Mandooram   - 250 gm 
Juice of Naaval pattai - 1.2 liters 
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 All the three things were kept in apathetical mortar and were ground upto 
thorough mixing. The juice is poured in the above mixture, and was ground 3 hours 
(one saamam) . The ground mass is made into small pieces (villai-coin like 
structure) and dried in sunlight (sooriyapudam). The process was repeated for 5 
times. Finally the villais were placed in an earthern pot (agal) and the agal was put 
within the small castor leaves which was taken in  an used mudpot and closed by a 
mud plate. After 3 days, the villais were taken out from pot and were ground to a 
fine powder. 
 
Dose : 
 250mg of Thiriloga Chendooram with honey twice a day before food. 
 
Route:  
 Enteral  
 
 The prepared Thiriloga Chendooram was used for the treatment of Paandu 
noi and analysed by the following methods, 
1. Biochemical analysis  
2. Pharmacological analysis 
3. Microbiological analysis 
4. Geochemical analysis 
5. Toxicological analysis 
6. Clinical  assessment  
7. Biostatistical analysis 
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BIO - CHEMICAL ANALYSIS OF  
THIRILOGA CHENDOORAM 
 
Preparation of the Extract : 
100mg of  Thiriloga Chendooram  was weighed accurately and 
placed in a clean beaker  and added a few drops of conc. Hydrochloric acid 
and evaporated it well. At the evaporation cooled the content and added a 
few drops of conc. Nitric acid and evaporated it well. After cooling the 
content add 20ml distilled water and dissolved it well. Then it is transferred 
to 100ml volumetric flask and made up to 100ml with distilled water. Mix 
well. Filter it. Then it is taken for analysis . 
 
QUALITATIVE ANALYSIS: 
S. No Experiment Observation Inference 
1. Test for calcium 
2ml of the above prepared extract 
is taken in a clean test tube. To 
this add 2 ml of 4% ammonium 
oxalate solution. 
White precipitate is 
formed  
Presence of 
calcium 
2. Test for sulphate 
2ml of the extract is added to 5% 
barium chloride solution.
White precipitate is 
formed 
Presence  
of sulphate 
3. Test for chloride 
The extract is treated with silver 
nitrate solution. 
White precipitate is 
formed 
Presence of 
chloride 
4. Test for carbonate 
The substance is treated with 
concentrated Hcl. 
No brisk effervescence Absence of 
carbonate 
5. Test for Zinc 
The extract is added with weak 
iodine solution. 
No white precipitate  
is formed 
Absence  of 
zinc 
6. Test for iron Ferric 
The extract is treated with 
concentrated glacial acetic acid 
and potassium ferro cyanide.
Blue colour is formed Presence of 
ferric iron 
7. Test of iron Ferrous 
The extract is treated with 
concentrated Nitric acid and 
ammonium thio cynate.
Blood red colour is 
formed 
Presence of 
Ferrous 
iron 
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8. Test for phosphate 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
No yellow precipitate is 
formed 
Absence of 
phosphate 
9. Test for albumin 
The extract is treated with 
Esbach's reagent. 
No yellow precipitate is 
formed 
Absence of 
albumin 
10 Test for Tannic acid 
The extract is treated with ferric 
chloride reagent. 
No blue black 
precipitate is formed 
Absence of 
tannic acid 
11. Test for unsaturation 
Potassium permanganate solution 
is added to the extract. 
It does not gets 
decolourised 
Absence the 
presence of 
unsaturated 
compound 
12. Test for the reducing sugar 
5ml of benedict's qualitative 
solution is taken in a test tube and 
allowed to boil for 2 mts and added 
8-10 drops of the extract and again 
boil it for 2 mts. 
No colour change  
occurs 
Absence of 
reducing 
sugar 
13. Test for amino acid: 
One or two drops of the extract is 
placed on a filter paper and dried # 
well. After drying, 1% ninhydrin is 
sprayed over the same and dried  
well. 
No violet colour is 
formed 
Absence of 
amino acids 
 
INFERENCE : 
The given sample of Thiriloga Chendooram  contains Calcium, 
Sulphate, chloride, Ferric iron and  Ferrous iron.  
 104
PHARMACOLOGICAL ANALYSIS 
 
Pharmacological Analysis of trial medicine: 
Study on the haematinic effect of Thiriloga Chendooram  on Albino 
rats. To prove its haematinic effect of Thiriloga Chendooram  an attempt 
was made to study its effect using "Albino rats". For this purpose rats are 
made anaemic by the following procedure.  
 
Artificially induced iron deficiency : 
The albino rats taken for this experiment were kept in aluminum 
cages and provided with drinking water and milk, free from iron. The 
administration of the iron preparation under investigation was started when 
the haemoglobin level fall  to 6-6.5gram/100mL At the beginning of the 
experiment Hb mg % were determined.  
 
Study on rats : 
The albino rats were first divided into 2 equal groups with five rats in 
each group. The first group received Thiriloga Chendooram  20mg/100gm 
body weight with hot water. The second group received normal diet. All the 
above procedures were continued for five weeks in once a day the 
haemoglobin levels of rats were measured for I,II,III,IV,V weeks. The result 
observed are tabulated in the following chart. 
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Study of Haematinic effect of using the drug of Thiriloga Chendooram 
Sl.No Drugs Initial reading 
After drug administration 
Remarks 1st 
Week 
2nd 
week 
3rd 
week 
4th 
week 
5th 
week 
6th 
week 
1 Control 2ml 
5.8 5.8 5.6 5.5 5.3 5.1 
5.6 
6.5 6.5 6.2 6.0 5.7 6.4 
6.8 6.8 6.5 6.2 6.0 5.7 
6.4 6.4 6.2 6.0 5.7 5.2 
7.1 7.1 6.9 6.6 6.4 6.0 
6.9 6.9 6.7 6.5 6.1 5.7 
6.5 6.5 6.3 6.1 6.0 5.6 
2 Thiriloga Chendooram 20mg 
5.2 5.3 6.0 6.9 7.5 8.6 
10.2 
6.5 6.7 7.2 8.0 8.9 9.9 
6.8 7.0 7.5 8.7 9.5 10.5 
7.2 7.3 7.7 8.5 9.5 10.5 
7.5 7.7 8.2 9.0 9.9 10.7 
7.2 7.3 8.0 8.9 10.0 10.9 
6.7 6.9 7.4 8.4 9.2 10.2 
 
 
Result : 
The trial drug Thiriologa Chendooram has got significant 
Haematinic action. 
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ANTIMICROBIAL ACTIVITY OF THIRILOGA 
CHENDOORAM  BY KIRBY BAUER METHOD 
 
AIM: 
To determine the Antimicrobial activity of Thiriloga Chendooram.  
  
Components of medium: 
 Beef extract  : 300gms/lit 
Agar   : 17gms/lit 
Starch  : 1.5gms/lit 
Casein hydroxylate: 17.5gms/lit 
Distilled water : 100ml 
pH   : 7.6 
 
Procedure : 
The method of antimicrobial activity study is disc diffusion method. 
The principle of antibiotic sensitivity test is simple. Antibiotic discs are 
prepared with known concentration of antibiotic (1gm/10ml of distilled 
water) and placed on agar plates that has been inoculated with the test 
organism. The antibiotic diffuses through the agar producing an antibiotic 
concentration. Gradient effectiveness of susceptibility is proportional to the 
diameter of the inhibitory zone around the disc organism which grows upto 
the edge of the disc are resistant. 
 
The recommended medium in this method is Muller Hinton Agar, its 
pH should be between 7.2 – 7.4 and should be poured to uniform thickness 
of 4mm in the Petri plate (25 ml) for certain fastidious microorganism. 
 
Methodology: 
@ Muller Hinton Agar plates are prepared and Pseudomonas, Vibrio 
cholerae, E.coli, Bacillus, Klebsiella, Micrococcus, Streptococcus is 
inoculated separately. 
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@ The prepared discs of antibiotics Thiriloga Chendooram  are placed 
over the incubated plate using sterile forceps and incubated for 24 
hours at 370 Celsius. 
@ The plates after 24 hours incubation are observed for the zone of 
inhibition. 
 
Result: 
 The drug Thiriloga Chendooram is resistance to any of the 
orgainsems tested. 
 
KIRBY BAUER ANTIMICROBIAL SUSCEPTIBILITY METHOD 
 
S.No. Test Drug 
Organisms 
(cultures) 
Susceptibility 
1 
Thinloga 
chendooram 
Escherichia coli Resistance 
2 Klebsiella Resistance 
3 Proteus Resistance 
4 Styphylococcus aureus Resistance 
5 Streptococcus pneumoniae Resistance 
6 Pseudomonas aeroginosa Resistance 
7 Candida albicans Resistance 
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METHODOLOGY FOR ANALYSIS OF METALS BY 
ATOMIC ABSORPTION SPECTROMETER 
Principle: 
Atomic absorption is the process that occurs when a ground state 
atom absorbs energy in the form of light of a specific wavelength and is 
elevated to an excited state. The amount of light energy absorbed at this 
wavelength will increase as the number of atoms of the selected element in 
the light path increase. The relationship between the amount of light 
absorbed and the concentration of analyses present in known standards 
can be used to determine unknown sample concentration by measuring the 
amount of light they absorb. 
 
The absorption of light is proportional to the concentration of free 
atoms in the flame is given by Lambart-beer law.  
Absorbance = log 10 I0/It = k.c.I 
Where,  I0  = intensity of incident radiation emitted by the light source.  
It = intensity of transmitted radiation.  
C  = concentration of sample (free atoms),  
k  = constant  
I  = path length  
Methodology for Metal Analysis : 
a) Sample collection: 
The samples will be cleaned and dried under shade. The dried 
samples will be then grinded and powdered in an agate pestle and mortar. 
Samples will be labeled and stored in pre-cleaned polyethylene bottles for 
further analysis. 
 
b) Reagents and apparatus: 
All the reagents such as HNO3, and H2O3 purchased from MERCK 
(Analytical Grade). De-ionized water will be used for all analytical work and 
all the glasswares,  polyethylene bottles, pipette tips and others will be 
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washed with 1% HCL, rinsed with de-ionized water before preparing 
standards, reagents and samples. 
 
c) Digestion of samples( Sample preparation): 
A mulitwave 3000 micro oven system (from Anton paar, USA) with 16 
position Teflon vessels with capping is being used here. The digestion 
vessels are provided with a controlled pressure, temperature and release 
valve. Before use, all Teflon vessels are soaked with 10% HNO3. The 
system is initially programmed by giving gradual rise of 20%, 40%, and 50% 
power for 5, 15 and 20 minutes respectively for the due warming up. The 
powder samples are being used without any further treatment for sample 
preparation. 0.2 g of sample is weighed into the Teflon vessels followed by 
digestion mixture of HNO3, and H2O2 in the ratio of 3:1, according to the 
nature of samples are being applied. 
 
The resulting solution after microwave digestion is filtered through 
whatman # 40 filter paper (if necessary) and diluted to 5 ml with de-ionized 
water. A sample blank containing only acid mixture is prepared at the same 
time. The method of standard addition is generally adapted to calibrate the 
instrument before going for the observation of the samples. 
 
Determination of metals: 
All the atomic measurements are carried out with Perkin Elmer model 
400/HGA900/AS800 coupled with mercury hydride system - 15 (MHS-15) 
and Flame Photometer. The lamps of Hallow cathode lamp (HCL) for Fe, 
Cu, Mn, Zn, Ni,Co and Electrodeless Discharge Lamp(EDL) for Cd, Pb, Hg 
and As, analysis are used as a light source to provide specific wavelength 
of the elements to be determined and high purity (99.999%). Acetylene, 
Nitrous oxide are used to provide constant thermal energy for atomization 
process and Argon gas used for carrier gas purging purposes for Graphite 
furnace.  
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Calibration of instruments: 
More then three working standard solution of elements to be 
determined are prepared, covering the concentration range as 
recommended by the manufacturer of the instrument for the elements to be 
determined. Before the analysis of samples, the instruments will be 
calibrated with prepared working standard solution. The calibration curves 
will be obtained for concentration vs. absorbance data statistically analyzed. 
Calibration of the instrument will be repeated periodically during operations 
and blanks will be carried with each set of 10 samples or aspirate any one 
of the prepared working standard for every 10 samples to check the 
instrument drift and to validate analytical procedures and performance. 
Recent blank reading will be taken and necessary correction will be made 
during the calculation of concentration of various elements. 
 
Standard Certified Reference (SRM) of National Institute of Standard 
and Technology (NIST) will be used for day-to-day for the evaluation of 
methods of analysis or test and for long-term quality assurance of 
measurements. A recent blank reading will be taken and necessary 
corrections will be made during the calculation of concentration of various 
elements. Fe, Cu, Mn, Zn, Mg, Mo etc., metals analysis (Flame 
AAS/Graphite furnace). 
 
After calibrating the instrument with prepared working standard, the 
digested liquid sample's solution is subjected to analysis of Fe, Cu, Mn, Zn, 
Ni, Co by AAS flame and As by furnace with specific instrumental 
conditions as given by instruments manufacturer. Introduce the solution into 
flame, record the reading, using the mean of the three reading and 
quantified the concentration of the metals in the given samples against the 
standard calibration curve obtained from concentration vs. Absorbance of 
the prepared known concentration on the day of the analysis. 
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Hg analysis by cold vapour method: 
After calibrating the instrument with prepared working standard, the 
10 ml of digested liquid sample's pipette out to a specific container of 
mercury Hydride system analyzer followed by adding 1,5% of Hcl of 10 ml 
as diluent for each flask and blank, 3% of NaBH4 solution in 1% of NaoH is 
run through the reaction flask to quartz cell with out heating against the 
calibration curve obtained from concentration vs absorbance of the 
prepared known concentration on the day of the analysis.  
Reference: 
1. Analysis, 2000,28,850-854. © EDP Sciences, Wiley - VCH 2000 
2. Analytical Sciences April 2000 Vol.16, © The Japan Society for 
Analytical Chemistry. 
3. The Sciences, (2); 74-77 March-April 2001. 
Heavy Metal Analysis of the Thiriloga Chendooram was done in the 
Bio-Technology Department of Sastra University using AAS(Atomic 
Absorption Spectrometer) and the results are given below. 
Inference: 
From the above Heavy Metal Analysis it is concluded that Thiriloga 
Chendooram contains, 
Fe - 38.16  C u  -  2 . 0 9 2 8  
M n  - 1 . 4 9 2 0   Zn  -  4.8480 
N i  - 0.2736  Co -  0.2536 
C d  - 0.1684  P b  -  4 . 9 2 8 0  
H g  - 0.1648  As - 2.5300 
 
GEO CHEMICAL ANALYSIS 
Instrument used : Atomic absorption spectrometer – Model A Analyst  
     400/HGA 900 / AS / 800-perkin Elmer 
Name of the Trial drug : Thiriologa Chendooram  Units in ppm 
Sample 
name Fe Cu Mn Zn Ni Co Cd Pb Hg As 
Thiriologa 
Chendooram 38.16 2.0928 1.4920 4.8480 0.2736 0.2536 0.1684 4.9280 0.1648 2.5300
WHO Limit 25 15 5 15 10 1 0.3 10 1 10 
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ACUTE TOXICITY STUDY 
 
ANIMALS USED FOR THE STUDY: 
Wister albino rats bred in the animal house attached to the post 
Graduate Pharmacology Department Government Siddha Medical College, 
Palayamkottai were used. 
 
Sex: 
Animals of both sex were used. 
 
Weight: 
Animals weighing 100-120gms were selected.  
 
Food And Water: 
The animals were maintained with standard laboratory pellet feed 
and water ad-Libitum.  
 
Preparation Of Animals: 
The animals were randomly selected and were marked with picric 
acid on fur and kept in their cases for five days prior to dosing, to allow 
acclimatization to the laboratory conditions.  
 
Separation Of Animals In Groups: 
10 rats were divided into 5 groups each consisting of 2 rats.   1st 
group is kept as control group by giving water alone. 
 
Dose Levels: 
The following dose levels were arbitrarily fixed by presuming range of 
least toxic to high toxic doses. 
 
I Group      - 40mg/kg Body weight of animal 
II Group     - 80mg/kg Body weight of animal 
III   Group    - 160mg/kg Body weight of animal 
IV  Group    - 320mg/kg Body weight of animal 
V Group  - 640mg/kg Body weight of animal 
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Route of administration: 
The drug was administered orally.  
 
Test Dose Preparation: 
The preparation was done in such a way as 1ml of the suspension 
contained 40mg of test drug and administered as given above in each 
group. The drug was administered once on the day of the experiment and 
after 24 hour parameters were used.  
 
Experimental Set up: 
All the five groups were fastered for over night prior to dosing. 
Following the period of fasting the animals were weighted and the test 
substance was administered through “Rat oral intubation tube" 
  
After the administration of the test drug, food was with held for 1-2 hrs. 
 
Observation: 
The following parameters were noted. 
 
Central effects : 
1. Stimulation: 
• Hyper activity 
• Piloerection 
• Twitching 
• Rigidity 
• Irritability 
• Jumping 
• Clonic Convulsion 
• Tonic convulsion  
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II. Depression: 
• Ptosis 
• Sedation 
• Sleep 
• Loss of traction 
• Loss of Pinna reflex 
• Ataxia 
• Catatonia 
• Loss of muscle tone 
• Analgesia 
 
III. Autonomic effect: 
• Straub's tail flicking 
• Laboured respiration 
• Cyanosis 
• Blanching 
• Reddening 
• Abnormal secretions 
 
At the end of 24hrs, the number of animals dead in each group was 
noted and the approximate LD50 was determined. The animal were 
morphologically examined for any toxic symptoms. 
 
Result:  
The drug Thiriloga Chendooram  did not produce any mortality upto 
640 mg / animal. So, it was inferred that the drug is safe upto 640 mg / 
animal. 
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CLINICAL ASSESSMENT 
 
      An open clinical trial on Paandu Noi is carried out at the Govt. 
Siddha Medical College & Hospitals, Palayamkottai in order to assess the 
efficacy of Thiriloga Chendooram. 
 
35 cases with clinical signs and symptoms of paandu Noi of the 
sexes with age ranging from 15-71 years are selected and treated. 
 
Case selection: 
The patients are selected as Paandu Noi according to the following criteria: 
• 7-10gms% of haemoglobin 
• Loss of appetite 
• Triedness 
• Breathlessness 
• Dyspnoea on exertion 
• Palpitation 
• Pallor of conjuctiva and nail beds 
• Ulceration of mouth 
• Emasciation 
• Fatigue 
 
Excluding criteria: 
• Chronic liver diseases . 
• Chronic renal diseases 
• Thalassemia  
• Myxoedema 
• Worm infestation 
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Clinical Pathological examination: 
Blood Test: 
Total count 
Differential count 
Polymorphs 
Lymphocytes 
Eosinophils 
Haemoglobin 
Erythrocyte sedimentation rate 
PCV 
MCV 
Blood sugar 
Blood urea 
Serum cholesterol 
 
Urine Examination : 
 Albumim 
 Sugar 
 Deposit 
 
Motion examination :  
 Ova 
 Cyst 
 Occult blood 
 
Line of treatment : 
The trial drug ‘Thiriloga Chendooram’ was administrated orally in a 
dose of 250 mg two times a day with honey before meals. 
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Diet and Medical advice : 
• Iron rich diet 
• Green leaf vegetables 
• Sea foods 
• Meat 
• Nuts 
• Fruits 
• Egg 
• Cereals 
• Fresh uncooked vegetable and fruits 
• Increased dietary fibre prevent constipation 
• Foods high in vitamin C like citrus  fruits, tomatoes helps the 
body absorbing iron from food.  
 
Observation: 
The haematinic action of ‘Thiriloga Chendooram’  was observed on 
the basis of the relief of symptoms and this was ruled out by routine lab 
investigations. 
 
Among the complaints of Paandu Noi giddiness, dyspnoea on 
exeration were reduced significantly within 15 days. Other symptoms were 
gradually subsided during the remaining course of the treatement. 
 
The clinical improvements were recorded for every seven days in Out 
- patients Department and daily is In-patients Department. The laboratory 
investigations were done for the patients before and after treatment. Almost 
the prognosis was noted. 
 
Result: 
Among 35 patients 26 cases (74%) showed good response, 7 cases 
showed fair responsible (20%) and 2 cases showed poor response (6%). 
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Table illustrating the (Age wise, Sex wise, Distribution) 
Sl.No. Age in years 
Sex 
Total 
Male Female 
1 10-20 - 1 1 
2 21-30 1 3 4 
3 31-40 - 10 10 
4 41-50 - 11 11 
5 51-60 2 3 5 
6 61-70 2 - 2 
7 71-80 1 - - 
 Total   35 
 
Table illustrating the prognosis 
Sl.No. Prognosis No. of patients Percentage (%) 
1. Good 26 74 
2. Fair 7 20 
3. Poor 2 6 
 Total 35 100 
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BIOSTATISTICAL ANALYSIS 
Drug :  Thiriloga Chendooram   Diagnosis :- Paandu noi 
Table - 1  distribution of subjects according to their sex and age 
Sl.No Age Group Male Female Total No % No % No % 
1 <20 0 - 1 3.5 1 2.9 
2 20-29 - - 4 13.8 4 11.4
3 30-39 - - 6 20.7 6 17.1
4 40-49 - - 13 44.8 13 37.1
5 50-59 1 16.7 2 6.9 3 8.6 
6 60-69 4 66.6 3 10.3 7 20.0
7 70 + 1 16.7 - - 1 2.9
 Total 6 100.0 29 100.0 35 100.0
 Mean 56.0 40.7 43.3 
 Std Deviation  17.4 11.5 13.7 
 ‘t’ 2.490  
 Significance P<0.05  
 
The table 1 explains the age and sex distributions of the clinical trails 
of Paandu noi.  
 
The mean age of the male age was 56±17.4 and the female age was 
40.7±11.5. The mean ages were statistically significant. This interpretations 
revealed that male patiens were eleder than the female patients. The 
female were affected by Paandu noi in their younger age. The total mean 
age of them was 43.3±17.7 years. 
 
Effetiveness of the drug : 
The effectiveness of the drug was ascertained by the collection and 
computation of the haemoglobin (Hb) level before and after the 
administration of the drug Thiriloga Chendooram.   
 120
Table – 2  Levels of Hb, MCV, PCV before and after treatment of 
Paandu noi  
S.No Variable n 
Before After Mean 
difference 
‘t’ Significant
Mean S.D Mean S.D
1 Hb 35 9.4 0.42 10.8 0.57 1.4 17.46 P<0.001 
2 MCV 5 87.8 0.45 91.2 0.45 3.4 13.88 P<0.001 
3 PCV 5 36.0 0.71 39.2 0.45 3.2 8.55 P<0.001 
 
The table 2 shows the effectiveness of the drug in increase to Hb, 
MCV and PCV after treatment. The haemoglobin level was increased fom 
9.4g to 10.8gm. The mean increase was 1.4gm. The increase was 
statistically highly significant(t=17.46, d.f. =34, P<0.001). Similarly the MCV 
and PCV were increased by 3.4% and 3.2% respectively from before 
treatment to the after treatment. The increase of Hb and MCV and PCV 
were attributed to the effectiveness of the drug Thiriologa Chendooram. 
 
Response of the drug : 
 The response of the drug was tabulated as follows, 
 
Table -3: Percentage distribution of response of the drug 
S.No Prognosis Responded No % 
1 Good 26 74.3 
2 Fair 7 20.0 
3 Poor 2 5.7 
 Total 35 100.0 
 
The above table - 3 gives the percentage of response of the drug. 
Nearely 75% of the patients had showed good response. The remaining 
20% and 5.7% were showing fair and poor response. 
 
 The above results and discussions clearly explains the effectiveness 
of the drug and the response of the drug, Thiriloga Chendooram in curing 
Paandu noi. 
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DISCUSSION 
 
The drug Thiriloga Chendooram was selected in this dissertation to 
study its therapeutic efficacy in the management of Paandu Noi 
 
 According to Siddha literatures, Humoral pathology ascribes Paandu 
noi  to the morbid condition of the Pitha humour 
 
“MNkjhd; mj;jpRuk; ghz;L Nrhif 
  Mokhd tplr;RuKk; gpuNkfe;jhd; 
NghNkjhd; fhkhiy…………………….. 
……………………………………………. 
ehNkjhd; nfhd;NdhNk gpj;jf;$W” 
- mfj;jpah; ghly;> rpj;j kUj;Jt  
Neha; ehly; Neha; Kjdhly; jpul;L> gf;fk; 177 
 
 Thus the affected Pittha humour manifests as clinical symptoms like 
Anaemia anasarca, jaundice etc. 
 
 From the review of literatures, it is inferred that the constituents of the 
drug Thiriologa Chendooram i.e. Irumbu, Urukku and Mandooram (Iron, 
Steel and Iron slag) selected for this study posses astringent taste 
(Thuvarppu) and hot property. They also have the haematinic activity  
 
 Thuvarpu has the tendency to mitinga harmful effects of vitiated 
pittah humour and acts as a blood purifying agent 
 
  “FUjp Rj;jpahf;Fg; 
   nfhbagpj;jk; Nghf;Fk; 
  ……………… 
  Fsph;e;j Jth;g;gpd; Ntiy” 
 
 - rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 36 
 All these factors seem to neutralize the vitated pittha humour. 
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 All the patients were given Thiriloga Chendooram 250mg Bd with 
honey as vehicle (Anupanam). This honey acts on  the pittha humour, 
thereby assist in reducing the increased thosham and improving the 
efficacy of the drug. This has been stated in Siddha Literature as,  
 
“murd; Kjy;Nth iuAkhl;L tpj;jhNy 
 gpurj; jpdhw;Nghk; gpzp” 
 
 This explanation is arrived on the basis of the analysis of the 
Gunapadam aspect of the drug which correlates with that of the 
pharmacological analysis and the clinical assessment.  
 
 Biochemical analysis shows the presence of calcium, chloride, 
sulphate, ferrous and ferric irons. This presence augments the therapeutic 
value of the drug by providing indispensable iron value. Pharmacological 
analysis shows that the drug got significant haematinic activity.  
 
Geochemical analysis using Atomic Absorption Spectrometer shows 
the heavy metals and trace elements like Lead, Mercury, Cadmium, Arsenic 
etc. present in the drug are well with in the normal WHO limits except iron. 
 
 Acute toxicological study exhibits the drug upto 640mg/ kg body 
weight of albino rats as got no adverse and toxic effects 
 
In the clinical assessment of the 35 cases selected, 74% of cases 
showed good response, 20% of cases showed fair response and 6% of 
cases showed poor response. The improvement was proved by the 
alleviation of signs and symptoms present before the treatment.  
 
Bio statistical analysis shows that the drug is efficient in controlling 
Paandu noi.  
During the clinical trial, the patient showed no adverse reactions. 
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SUMMARY 
 
 The drug Thiriloga Chendooram has been taken to establish its 
efficacy is treating Paandu noi. The dose of Thiriologa Chendooram and is 
250 mg twice daily with honey before food. 
 
 A brief description pertaining to botanical aspect, chemical 
constituents and Gunapadam aspect has been done. 
 
 A review of literatures about the drug and its significance in medicine 
since ancient period has been done. 
 
 Collected information from various literatures and websites has been 
referred 
 
 Biochemical analysis shows the presence of calcium, chloride, 
sulphate, ferrous  and ferric irons.  
 
 Pharmacological analysis shows that the drug has got significant 
haematinic activity  
 
 Microbiological analysis shows that the drug has got resistance to 
any of the organisms tested. 
 
 Toxicological analysis shows that the drug has no adverse and toxic 
effects 
 
From the clinical assessment, it is inferred that Thiriloga 
Chendooram possesses remarkable efficacy in treating Paandu noi and 
the drug has got no adverse reaction  
 
 Biostatistical analysis shows that drug is effective in controlling 
Paandu noi. 
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CONCLUSION 
 
 It is concluded that the drug Thiriloga Chendooram is an effective 
drug in treating Paandu noi and it has no adverse reactions 
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OUT PATIENTS  
Name:Mr. Mariyappan Age/Sex:50/M O.P.No.:73271 From:12.12.07 To:25.01.08 No. of days Treated:45 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both)  
Complaints and duration:  Occupation: Carpenter 
Pain  and  swelling in the right knee joint since 
2 months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3.Limitation of movement(30 P,30 PP-60 P,>60 P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
 
++ 
- 
II 
38 cm 
+ 
+ 
+ 
 
++ 
- 
II 
36cm 
+ 
++ 
- 
 
+ 
- 
- 
37cm 
+ 
- 
- 
 
- 
- 
- 
34cm 
- 
+ 
- 
TC : 9600 cells/cumm 
DC : P 68% L30% E 2% 
ESR:  
½ hour- 4  mm 
1 hour-  8 mm 
Hb: 68% 
Bl. Sugar (R)  :  77mg% 
Bl. Urea           : 22mg% 
S. Cholesterol  : 176 mg% 
 Impression: 
  Bilateral       
osteoarthritis 
TC :    9600 cells/cumm 
DC : P 65% L.34% E1% 
ESR: 
½ hour-   2mm 
1 hour  -  6mm 
Hb  70% 
Bl. Sugar (R)  :  78 mg% 
Bl. Urea           : 22mg% 
S.Cholesterol  :  170 mg% 
Impression: 
Bilateral 
osteoarthritis 
Urine : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : Few 
epithelial cells   
                   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
58sec 
 
43sec 
Response:  GOOD 
 
Name:Mr. Subbaiya Age/Sex:73/M O.P.No.:73617 From:14.12.07 To:25.01.08 No. of days Treated:49 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Retired Teacher 
Pain  and  swelling in the right knee joint since 
3 months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
 
+ 
- 
I 
35cm 
- 
++ 
++ 
 
++ 
- 
I 
34cm 
- 
+ 
+ 
 
- 
- 
- 
33cm 
- 
+ 
+ 
 
- 
- 
- 
32cm 
- 
- 
- 
TC : 7000 cells/cumm 
DC : P 60% L36% E 4% 
ESR:  
½ hour- 6  mm 
1 hour - 12 mm 
Hb: 71% 
Bl. Sugar (R)   : 80mg% 
Bl. Urea           : 14mg% 
S. Cholesterol  : 155mg% 
1. Soft tissue 
swelling 
 2. Narrowed joint 
space 
 Impression: 
Bilateral 
osteoarthitis 
TC :    7100 cells/cumm 
DC : P 61% L.35% E4% 
ESR: 
½ hour-   3mm 
1 hour   -  6mm 
Hb  72% 
Bl. Sugar (R):  84 mg% 
Bl. Urea         : 15mg% 
S.Cholesterol : 160mg% 
1. Reduced soft 
tissue swelling 
2.Narrowed joint 
space  
Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : 1-2 pus     
cells 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
60sec 
 
50sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms  
OUT PATIENTS  
Name:Mrs. Sornam Age/Sex:54/F O.P.No.: 75135 From:25.12.07 To:15.2.08 No. of days Treated:43 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: House Wife: 
Pain  and  swelling in both the knee joints since   
6 months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
 
 
8. Taking time to walk for 100 feet distance 
 
++ 
- 
III 
40 cm 
++ 
++ 
++ 
 
++ 
- 
III 
42cm 
++ 
+ 
++ 
 
+ 
- 
III 
40cm 
++ 
+ 
++ 
 
+ 
- 
II 
41cm 
+ 
+ 
+ 
TC : 8800 cells/cumm 
DC : P 58% L40% E 2% 
ESR: 
½ hour - 15  mm 
1 hour  - 30 mm 
Hb:  71% 
Bl. Sugar (R)  :  72mg% 
Bl. Urea          : 19mg% 
S. Cholesterol : 175 mg% 
 1. Subchondral 
sclerosis 
 2. Marginal  
osteophytes  
Inpression: 
Bilateral 
osteoarthritis 
TC :    8900 cells/cumm 
DC : P 60% L.42% E2% 
ESR: 
½ hour - 12mm 
1 hour  -  24mm 
Hb  72% 
Bl. Sugar (R) : 74 mg% 
Bl. Urea          : 20mg% 
S.Cholesterol  : 175 mg% 
1. Subchondral 
sclerosis  
2. Marginal 
osteophytes 
Impression: 
Biletral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : Few 
epithelial cells   
                   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
73sec 
 
43sec 
Response:  POOR 
 
Name:Mr.Karuppasamy Age/Sex:75/m O.P.No.:75141 From:25.12.07 To:5.12.08 No. of days Treated:43 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water Diagnosis: AZHAL KEEL VAYU(right)
Complaints and duration:  Occupation: Retired Teacher 
Pain  and  tenderness in  right knee joint since 3 
months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
 
++ 
- 
I 
38cm 
+ 
- 
+ 
 
- 
- 
- 
38cm 
- 
- 
- 
 
- 
- 
- 
38cm 
- 
- 
- 
 
- 
- 
- 
38cm 
- 
- 
- 
TC : 8200 cells/cumm 
DC : P 70% L28% E 2% 
ESR:  
½ hour- 3  mm 
1 hour - 9  mm 
Hb:  73% 
Bl. Sugar (R)  :  86mg% 
Bl. Urea          :17mg% 
S. Cholesterol  :200 mg% 
1. Reduced joint 
space 
Impression : 
Right knee 
osteoarthritis 
TC :    8400 cells/cumm 
DC : P 71% L.26% E3% 
ESR: 
½ hour-2mm 
1 hour -7mm 
Hb  74% 
Bl. Sugar (R) :  90 mg% 
Bl. Urea          : 20mg% 
S.Cholesterol  :  180mg% 
1. Reduced joint 
space   
Impression: 
 Right knee 
osteoarthitis  
Urine : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : NAD 
Urine : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
53sec 
 
43sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms  
OUT PATIENTS  
Name:Mrs. Meena Age/Sex:50/F O.P.No.:389 From:21.1.08 To:15.2.08 No. of days Treated:44 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: House Wife 
Pain & Swelling in both the knee joints since  2 
months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
 
 
8. Taking time to walk for 100 feet distance 
 
+ 
- 
I 
37cm 
+ 
+ 
+ 
 
++ 
- 
I 
40cm 
++ 
+ 
++ 
 
- 
- 
- 
36cm 
- 
- 
- 
 
+ 
- 
I 
37cm 
+ 
- 
+ 
TC :9200 cells/cumm 
DC : P 71% L28% E 3% 
ESR : 
½ hour- 20  mm 
1 hour -45 mm 
Hb:  76% 
Bl. Sugar (R):   92mg% 
Bl. Urea         :  22mg% 
S. Cholesterol:  184 mg% 
 1. Soft tissues 
swelling   
2. Subchondral 
sclerosis 
Impression: 
Bilateral 
osteoarthritis  
TC :    9000 cells/cumm 
DC : P 70% L.25% E5% 
ESR: 
½ hour -  10mm 
1 hour   -   15mm 
Hb:  75% 
Bl. Sugar (R) :  90 mg% 
Bl. Urea          : 23mg% 
S.Cholesterol  : 190mg% 
1. Reduced Soft 
tissues swelling 
2. Subchondral 
sclerosis 
Impression: 
Bilateral 
Osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : Few Pus 
cells   
                   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
73sec 
 
68sec 
Response:  FAIR 
 
Name:Mr..Showkath Ali Age/Sex:54/M O.P.No.:949 From:3-1-08 To:14.2.08 No. of days Treated:43 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water Diagnosis: AZHAL KEEL VAYU(both)
Complaints and duration:  Occupation: Daily Wages 
Pain & Swelling in both the knee joints since 3 
months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation 
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
 
++ 
++ 
I 
36cm 
+ 
+ 
+ 
 
+ 
+ 
I 
38cm 
+ 
+ 
++ 
 
+ 
- 
- 
34cm 
- 
- 
- 
 
- 
- 
- 
34cm 
- 
- 
- 
TC : 100000 cells/cumm 
DC : P 68% L30% E 2% 
ESR:  
½ hour- 1  mm 
1 hour-  3  mm 
Hb:  82% 
Bl. Sugar (R)   :  120mg% 
Bl. Urea            : 30mg% 
S. Cholesterol  : 190 mg% 
1. Subchondral 
sclerosis 
Impression: 
Bilateral 
osteoarthritis 
TC :  10200 cells/cumm 
DC : P 66% L.32% E2% 
ESR: 
½ hour -  1mm 
1 hour   - 3mm 
Hb:  84% 
Bl. Sugar (R) : 110 mg% 
Bl. Urea          :31mg% 
S.Cholesterol  : 195mg% 
1. Subchondral 
sclerosis 
Impression: 
Bilateral 
osteoarthitis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : NAD 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
55sec 
 
45sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms  
OUT PATIENTS  
Name:Mr.Lakshmanan Age/Sex:48/M O.P.No.:3963 From:11.01.08 To:23.2.08 No. of days Treated:44 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Bus ticket Checker 
Pain & tendelness in both the knee joints since  
1 month 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation 
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
 
++ 
- 
I 
38cm 
++ 
+ 
+ 
 
++ 
- 
I 
37cm 
+ 
+ 
- 
 
+ 
- 
- 
36.5 
+ 
- 
- 
 
+ 
- 
- 
35.5 
- 
+ 
- 
TC: 8300 cells/cumm 
DC : P 65% L33% E 2% 
ESR : 
½ hour -15  mm 
1 hour - 25  mm 
Hb:  75% 
Bl. Sugar (R)  :   90mg% 
Bl. Urea           : 26mg% 
S. Cholesterol  : 190 mg% 
 Impression: 
Bilateral 
osteoarthritis  
TC :    8500 cells/cumm 
DC : P 60% L.35% E5% 
ESR: 
½ hour -  10mm 
1 hour   - 15mm 
Hb:  70% 
Bl. Sugar (R) : 91 mg% 
Bl. Urea          : 25mg% 
S.Cholesterol  : 191 mg% 
Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  :NAD  
                   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
50sec 
 
45sec 
Response:  FAIR 
 
Name:Mrs. Ajara Age/Sex: 50/F O.P.No.:5766 From:21.1.08 To:7.3.2008 No. of days Treated:47 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: House Wife 
Pain & tenderness in both the knee joints since 
6 months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
 
8. Taking time to walk for 100 feet distance 
 
+ 
- 
I 
34cm 
+ 
+ 
- 
 
++ 
- 
I 
36cm 
++ 
++ 
- 
 
+ 
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TC : 9400 cells/cumm 
DC : P 69% L29% E 2% 
ESR: 
½ hour -20  mm 
1 hour  -  37  mm 
Hb:  72% 
Bl. Sugar (R):   102mg% 
Bl. Urea         :  19mg% 
S. Cholesterol:  190 mg% 
1. Marginal 
osteophates 
2. Subchondral 
sclerosis 
Impression: 
Bilateral 
osteoarthritis 
TC :    9300 cellscumm 
DC : P 70% L.28% E2% 
ESR: 
½ hour- 15 mm 
1 hour  - 35 mm 
Hb:  74% 
Bl. Sugar (R): 110 mg% 
Bl. Urea         : 20mg% 
S.Cholesterol : 185mg% 
1. Marginal 
osteophytes 
 2. Subchondral 
sclerosis 
Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : NAD 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
70sec 
 
68sec 
Response:  POOR 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms  
OUT PATIENTS  
Name:Mr. Rajan Age/Sex:42/M O.P.No.:7056 From:25.1.08 To:8.3.2008 No. of days Treated:44 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: LIC Agent 
Pain & Swelling in right knee joints since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC 8400 cells/cumm 
DC : P 69% L30% E 1% 
ESR:  
½ hour -2  mm 
1 hour  -4  mm 
Hb: 80 % 
Bl. Sugar (R) :  212mg% 
Bl. Urea          : 24mg% 
S. Cholesterol  : 129 mg% 
 Impression: 
Normal Study  
TC :    8500 cells/cumm 
DC : P 70% L.28% E2% 
ESR: 
½ hour- 2mm 
1 hour  - 4mm 
Hb: 81 % 
Bl. Sugar (R):  200 mg% 
Bl. Urea         : 25mg% 
S.Cholesterol : 130 mg% 
  
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  :NAD  
                   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
45sec 
 
40sec 
Response:  GOOD 
 
Name:Mr. Ahamad Meeran Age/Sex:33/M O.P.No.:8710 From:1.2-08 To:14.3.08 No. of days Treated:42 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Rikshaw Divert 
Pain & Swelling in right knee joints since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8400 cells/cumm 
DC : P 69% L30% E 1% 
ESR:  
½ hour- 2  mm 
1 hour -4  mm 
Hb  81% 
Bl. Sugar (R):  112mg% 
Bl. Urea         :  24 mg% 
S. Cholesterol:   205 mg% 
1.Soft tissues 
swelling 
Impression: 
Bilteral 
osteoarthritis 
TC :    8500 cells/cumm 
DC : P 70% L.28% E2% 
ESR: 
½ hour-   2 mm 
1 hour  -    4 mm 
Hb:  82% 
Bl. Sugar (R):100 mg% 
Bl. Urea         : 24mg% 
S.Cholesterol :  200mg% 
1.Reduced Soft 
tissues swelling 
Impression: 
Bilteral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  :1-2 
puscell 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
48sec 
 
40sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms  
 
OUT PATIENTS  
Name:Mrs.Sivagami Age/Sex:67/F O.P.No.:9362 From:04.02.08 To: 20.03.08 No. of days Treated:46 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Fish merchant 
Pain & Swelling in right knee joints since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8200 cells/cumm 
DC : P 56% L40% E 4% 
ESR : 
½ hour- 7 mm 
1 hour -15 mm 
Hb : 71% 
Bl. Sugar (R):   87mg% 
Bl. Urea:        18mg% 
S. Cholesterol:   174 mg% 
 Impression : 
Normal study 
TC :    8300 cells/cumm 
DC : P 56% L.38% E6% 
ESR: 
½ hour-   5mm 
1 hour -     8mm 
Hb  :75% 
Bl. Sugar (R):  90 mg% 
Bl. Urea:          20mg% 
S.Cholesterol:    200 
mg% 
  
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : Few 
epithelial cells   
                   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
60sec 
 
50sec 
Response:  GOOD 
 
Name:Mrs. Nesamani Age/Sex:42/F O.P.No.:9586 From:05.02.08 To:23.2.08 No. of days Treated:45 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: House Wife 
Pain & Swelling in boyh the knee joints since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
 
 
8. Taking time to walk for 100 feet distance 
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TC : 9200 cells/cumm 
DC : P 60% L 35% E 5% 
ESR : 
½ hour- 9  mm 
1 hour -18  mm 
Hb:  68% 
Bl. Sugar (R): 92 mg% 
Bl. Urea        :  20  mg% 
S. Cholesterol: 238mg% 
1. Subchondral 
sclerosis 
 2. Narrowed joint 
space 
 Impression: 
Bilateral 
osteoarthritis 
TC :    9300 cells/cumm 
DC : P 61% L.36% E3% 
ESR: 
½ hour-   3 mm 
1 hour  -   8 mm 
Hb  70% 
Bl. Sugar (R) :90 mg% 
Bl. Urea          :25mg% 
S.Cholesterol  : 200mg% 
1. Subchondral 
sclerosis  
2. Narrowed joint 
space  
Impression: 
Bilaterl 
osteoarthritis  
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : 
Occastional pus 
cells 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
52sec 
 
47sec 
Response:  FAIR 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms  
OUT PATIENTS  
Name:Velammal Age/Sex:55/F O.P.No.:10441 From:08.2.08 To:24.3.08 No. of days Treated:46 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(left) 
Complaints and duration:  Occupation: Farmer 
Pain Swelling & Stiffness in left knee joint since 
8 months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood Radiological findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
 
8. Taking time to walk for 100 feet distance 
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TC : 9000 cells/cumm 
DC : P 58% L34% E 8% 
ESR: 
½ hour- 6  mm 
1 hour- 12  mm 
Hb:  68% 
Bl. Sugar (R):  80mg% 
Bl. Urea         : 17  mg% 
S. Cholesterol:  190mg% 
 1. Soft tissues 
swelling 
 2. Narrowed joint 
space 
 Impression: 
Left knee 
osteoarthritis  
TC :  9200 cells/cumm 
DC : P 58% L.35% 
E7% 
ESR: 
½ hour -  4 mm 
1 hour   -  8 mm 
Hb:  75% 
Bl. Sugar (R) :90 
mg% 
Bl. Urea          :20mg%
S.Cholesterol  : 
180mg% 
1.Reduced soft 
tissues swelling  
2. Narrowed joint 
space   
Impression: 
 Left knee   
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  :Occasional 
pus cells                 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD 
 
70sec 
 
64sec 
Response:  FAIR 
 
Name:Mrs.Chellammal Age/Sex:50/F O.P.No.:11220 From:12.2.08 To:1.4.08 No. of days Treated:49 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(right) 
Complaints and duration:  Occupation: Farmer 
Pain & Swelling in right knee joint since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
 
8. Taking time to walk for 100 feet distance 
 
++ 
- 
II 
29cm 
+ 
+ 
- 
 
- 
- 
I 
39cm 
+ 
++ 
++ 
 
- 
- 
- 
29cm 
- 
- 
- 
 
 
- 
- 
- 
29cm 
- 
- 
- 
 
TC : 8000 cells/cumm 
DC : P 55% L 38% E 7% 
ESR:  
½ hour- 7  mm 
1 hour -14  mm 
Hb:  90% 
Bl. Sugar (R):  85mg% 
Bl. Urea         :  20  mg% 
S. Cholesterol:  205mg% 
1. Subchondral 
sclerosis  
2. Soft tissues 
swelling 
Impression : 
Right knee 
osteoarthritis 
TC :  8500 cells/cumm 
DC : P 60% L.35% E5% 
ESR: 
½ hour  - 3 mm 
1 hour    - 7 mm 
Hb:  72% 
Bl. Sugar (R) :90 mg% 
Bl. Urea          :25mg% 
S.Cholesterol  : 207mg% 
1. Subchondral 
sclerosis  
2. Soft tissues 
swelling 
Impression: 
 Right knee 
steoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : 
Occastional pus 
cells 
URINE  : 
Albumin : NIL 
Sugar     : NIL 
Deposi  : NAD  
65sec 
 
62sec Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms  
Poor Response – Insignificant relief of symptoms  
OUT PATIENTS  
Name: Mrs.Muthammal Age/Sex:60/F O.P.No.:14322 From:25.02.08 To:07.04.08 No. of days Treated:42 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: House Wife 
Pain & Swelling in both the knee joints since 1 
year 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
8. Taking time to walk for 100 feet distance 
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TC : 9400 cells/cumm 
DC : P 66% L28% E 6% 
ESR:  
½ hour- 5 mm 
1 hour -12 mm 
Hb:  72% 
Bl. Sugar (R):  111mg% 
Bl. Urea         :  17 mg% 
S. Cholesterol:  185mg% 
1. Subchondral 
sclerosis 
Impression: 
Bilateral 
osteoarthritis  
TC : 9600 cells/cumm 
DC : P 60% L.37% E3% 
ESR: 
½ hour -  2 mm 
1 hour   - 6 mm 
Hb:  82% 
Bl. Sugar (R) :110 mg% 
Bl. Urea          :20 mg% 
S.Cholesterol  :180 mg% 
1. Subchondral 
sclerosis 
Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  :NAD  
                   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
60sec 
 
50sec 
Response:  GOOD 
 
Name:Mr.Gandhimathinathan Age/Sex:66/M O.P.No.:14338 From:25.02.08 To:07.04.08 No. of days Treated:42 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Oil Merchant 
Pain & Swelling in both the knee joints since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 9400 cells/cumm 
DC : P 55% L40% E 5% 
ESR:  
½ hour- 6 mm 
1 hour -12 mm 
Hb:  81% 
Bl. Sugar (R):  107mg% 
Bl. Urea         : 25 mg% 
S. Cholesterol: 195mg% 
1. Subchondral 
sclerosis 
Impression: 
Bilateral 
osteoarthritis  
TC :  9500 cells/cumm 
DC : P 57% L.40% E3% 
ESR: 
½ hour-   3 mm 
1 hour -   7 mm 
Hb:  82% 
Bl. Sugar (R) :110 mg% 
Bl. Urea          :27 mg% 
S.Cholesterol  :205 mg% 
1. Subchondral 
sclerosis 
Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : 
Occastional pus 
cells 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
55sec 
 
45sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms  
 
OUT PATIENTS  
Name:Mrs. Shantha Age/Sex:44/F O.P.No.:14369 From:14.4.08 To:14.4.08 No. of days Treated:49 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Vendor 
Pain & Swelling in both the knee joints since 1 
year 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
 
 
8. Taking time to walk for 100 feet distance 
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TC : 9000 cells/cumm 
DC : P 58% L38% E 4% 
ESR:  
½ hour -5 mm 
1 hour -10 mm 
Hb;  76% 
Bl. Sugar (R)  : 92 mg% 
Bl. Urea          : 18 mg% 
S. Cholesterol:  200 mg% 
1. Narrowed joint 
space 
2.Subchondral 
sclerosis 
Impression: 
Bilateral 
osteoarthritis  
TC :  9200 cells/cumm 
DC : P 58% L.38% E4% 
ESR: 
½ hour-   3 mm 
1 hour  -  6 mm 
Hb:  80% 
Bl. Sugar (R) :90 mg% 
Bl. Urea          :20 mg% 
S.Cholesterol  :195 mg% 
1. Narrowed 
joint space 
2.Subchondral 
sclerosis 
Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  :NAD  
                   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
50sec 
 
44sec 
Response:  GOOD 
 
Name:Mrs.Muthulakshmi Age/Sex:44/F O.P.No.:14758 From:26.2.08 To:8.4.08 No. of days Treated:42 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water Diagnosis: AZHAL KEEL VAYU(left)
Complaints and duration;  Occupation: Daily Wages 
Pain & Swelling in  left knee joint since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8200 cells/cumm 
DC : P 64% L34% E 2% 
ESR : 
½ hour- 10 mm 
1 hour -22 mm 
Hb : 70% 
Bl. Sugar (R):  107mg% 
Bl. Urea         : 27 mg% 
S. Cholesterol:  210 mg% 
1. Soft tissues 
swelling 
Impression: 
 Left knee 
osteoarthritis  
TC : 8300cells/cumm 
DC : P % L.% E% 
ESR: 
½ hour -  5 mm 
1 hour   - 10 mm 
Hb:  72% 
Bl. Sugar (R) :110 mg% 
Bl. Urea          :25 mg% 
S.Cholesterol  :205 mg% 
1. Reduced Soft 
tissues swelling 
Impression: 
 Left knee 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : 
Occastional pus 
cells 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
55sec 
 
45sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms  
OUT PATIENTS  
Name: Mrs.Parvathy Age/Sex: 50/F O.P.No.: 14745 From:26.2.08 To: 15.4.08 No. of days Treated:42 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(left) 
Complaints and duration;  Occupation: Daily Wages 
Pain & Swelling in  left knee joint since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8900 cells/cumm 
DC : P 58% L38% E 4% 
ESR : 
½ hour- 10 mm 
1 hour -20 mm 
Hb:  70% 
Bl. Sugar (R):  92 mg% 
Bl. Urea:           14 mg% 
S. Cholesterol:  200 mg% 
1.Narrowed joint 
space Impression: 
Bilateral 
osteoarthritis  
TC :  9000 cells/cumm 
DC : P 55% L.40% E5% 
ESR: 
½ hour -  7 mm 
1 hour  -  15 mm 
Hb:  75% 
Bl. Sugar (R) :95 mg% 
Bl. Urea:          20 mg% 
S.Cholesterol:  190 mg% 
1.Narrowed joint 
space Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit   Few Pus 
Cells  
                   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
55sec 
 
45sec 
Response:  GOOD 
 
Name: Mr.Sakthivel Age/Sex:67/M O.P.No.:14673 From:26.2.08 To:15.4.08 No. of days Treated:48 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: House wife 
Pain & Swelling in right knee joints since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 9100 cells/cumm 
DC : P 64% L34% E 2% 
ESR:  
½ hour- 8 mm 
1 hour - 15 mm 
Hb:  76% 
Bl. Sugar (R):  120mg% 
Bl. Urea         : 29 mg% 
S. Cholesterol: 200 mg% 
1. Soft tissues 
swelling 
Impression: 
 left knee 
osteoarthritis  
TC :  9200  cells/cumm 
DC : P62 % L.35% E3% 
ESR: 
½ hour-  5 mm 
1 hour  - 10mm 
Hb:  80% 
Bl. Sugar (R) :120 mg% 
Bl. Urea          :30 mg% 
S.Cholesterol  :190 mg% 
1. Soft tissues 
swelling 
Impression: 
 left knee 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : NAD 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
65sec 
 
55sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms  
 
OUT PATIENTS  
Name:Mrs.Chandra Age/Sex: 43/F O.P.No.: 16983 From:14.12.07 To: 17.04.08 No. of days Treated:44 
Drug: Senkodiveliver Chooranam – 1gm bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Retired Teacher 
Pain &  swelling in the both the knee joints 
since 3 months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8300 cells/cumm 
DC : P 60% L34% E 6% 
ESR:  
½ hour -10 mm 
1 hour -15 mm 
Hb:  68% 
Bl. Sugar (R):   80mg% 
Bl. Urea         :  20mg% 
S. Cholesterol:  190 mg% 
1.. Naamowed 
joint space 
Impression: 
bilateral  
osteoarthitis 
TC :  8400 cells/cumm 
DC : P 58% L.40% E2% 
ESR: 
½ hour -  5mm 
1 hour   - 10mm 
Hb:  70% 
Bl. Sugar (R) : 90 mg% 
Bl. Urea          :25mg% 
S.Cholesterol  : 185 mg% 
1.Narrowed joint 
space. 
Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : 1-2 pus     
cells 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
55sec 
 
50sec 
Response:  FAIR 
 
Name: Mrs.Lakshmi Age/Sex: 65/F O.P.No.: 11125 From: 13.03.08 To: 17.14.08 No. of days Treated:44 
Drug: Senkodiveliver Chooranam – 1gm bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Farmer 
Pain  and  swelling in the right knee joint since 
2 months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8100 cells/cumm 
DC : P 58% L34% E 6% 
ESR:  
½ hour 11  mm 
1 hour 15 mm 
Hb:  72% 
Bl. Sugar (R):    70mg% 
Bl. Urea:           20mg% 
S. Cholesterol:   180 mg% 
 Impression: 
Bilateral 
osteoarthritis 
TC :  8200 cells/cumm 
DC : P 58% L.40% E2% 
ESR: 
½ hour-   5mm 
1 hour -     10mm 
Hb:  75% 
Bl. Sugar (R):  70 mg% 
Bl. Urea:          20mg% 
S.Cholesterol:    180 
mg% 
Impression: 
Bilateral 
Osteoarthiritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : Few 
epithelial cells   
                   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
63sec 
 
50sec 
Response:  FAIR 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms  
 
 
OUT –PATIENTS 
Name:Mrs.Bala Age/Sex:50/F O.P.No.:19451 From:17.3.08 To:28.4.08 No. of days Treated:43 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(right)
Complaints and duration:  Occupation: House Wife 
Pain & Swelling in right knee joint since 1 year 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 10000 cells/cumm 
DC : P 70% L28% E 2% 
ESR: 
½ hour- 10 mm 
1 hour - 20 mm 
Hb:  76% 
Bl. Sugar (R):  86 mg% 
Bl. Urea         :  19 mg% 
S. Cholesterol:  192 mg% 
1. Subchondral 
sclerosis 
Impression: 
 Right knee 
osteoarthirits 
TC :  10500 cells/cumm 
DC : P 70% L.27% E3% 
ESR: 
½ hour - 5 mm 
1 hour   -10 mm 
Hb:  80% 
Bl. Sugar (R) :90 mg% 
Bl. Urea          :20 mg% 
S.Cholesterol  :190 mg% 
1. Subchondral 
sclerosis 
Impression: 
Right knee 
osteoarthirits 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : Few Pus 
Cells  
                   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
70sec 
 
60sec 
Response:  GOOD 
 
Name:Mrs.Pechiammal Age/Sex:50/F O.P.No.:19453 From:17.3.08 To:30.4.08 No. of days Treated:43 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: House wife 
Pain & Swelling in both the knee joints since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 7800 cells/cumm 
DC : P 58% L40% E 2% 
ESR:  
½ hour- 6 mm 
1 hour -12 mm 
Hb:  72% 
Bl. Sugar (R):  76 mg% 
Bl. Urea         : 33 mg% 
S. Cholesterol:  198 mg% 
Impression: 
Bilateral 
osteoarthritis  
TC :  8000 cells/cumm 
DC : P 60% L.38% E2% 
ESR: 
½ hour-  4 mm 
1 hour  - 6 mm 
Hb:  75% 
Bl. Sugar (R) :80 mg% 
Bl. Urea          :35 mg% 
S.Cholesterol  :190 mg% 
Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : NAD 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
60sec 
 
50sec 
Response:  FAIR 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms  
 
OUT PATIENTS  
Name:Mrs.Isakiammal Age/Sex:65/F O.P.No.:20692 From:24.3.08 To:6.5.08 No. of days Treated:44 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation Vendor 
Pain & tenderness in both the knee joints since 
4 months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8700 cells/cumm 
DC : P 58% L40% E 2% 
ESR:  
½ hour -6 mm 
1 hour - 12 mm 
Hb:  70% 
Bl. Sugar (R) : 72 mg% 
Bl. Urea          : 21 mg% 
S. Cholesterol  :220 mg% 
1.Marginal 
osteophytes 
Impression: 
Bilteral 
osteoarthritis 
TC :  8900 cells/cumm 
DC : P 60% L.35% E5% 
ESR: 
½ hour -  3mm 
1 hour  -  6 mm 
Hb:  72% 
Bl. Sugar (R) :75 mg% 
Bl. Urea          :25 mg% 
S.Cholesterol  :210 mg% 
1.Marginal 
osteophytes 
Impression: 
Bilteral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit   NAD   
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
75sec 
 
70sec 
Response:  FAIR 
 
Name:Mrs.Valliammal Age/Sex:54/F O.P.No.:21824 From:29.3.08 To:13.5.08 No. of days Treated:46 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(right) 
Complaints and duration:  Occupation: Fish merchant 
Pain & Swelling in right knee jointsince  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8600 cells/cumm 
DC : P 60% L34% E 6% 
ESR  
½ hour -7 mm 
1 hour - 15 mm 
Hb: 71% 
Bl. Sugar (R)   :117 mg% 
Bl. Urea           :30 mg% 
S. Cholesterol : 240 mg% 
1. Narrowed joint 
space  
Impression: 
Bilateral 
osteoarthritis   
TC : 9000 cells/cumm 
DC : P 61% L.36% E3% 
ESR: 
½ hour-  3 mm 
1 hour  - 7 mm 
Hb : 72% 
Bl. Sugar (R) :100 mg% 
Bl. Urea          :25 mg% 
S.Cholesterol  :220 mg% 
1. Narrowed joint 
space 
Impression: 
Bilateral 
osteoarthritis   
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : 1-2 
epithlial cells 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
65sec 
 
60sec 
Response:  FAIR 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
 
OUT PATIENTS  
Name:Mrs.Isakiyammal Age/Sex:62/F O.P.No.:32049 From:20.5.08 To:1.7.08 No. of days Treated:43 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: House Wife 
Pain & Swelling in both the knee joints since 8 
months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8500 cells/cumm 
DC : P 66% L30% E 4% 
ESR:  
½ hour- 6 mm 
1 hour - 12 mm 
Hb:  72% 
Bl. Sugar (R):  82 mg% 
Bl. Urea         :  30 mg% 
S. Cholesterol: 230 mg% 
1.Marginal 
osteophytes 
Impression: 
Bilteral 
osteoarthritis 
TC :  8600 cellscumm 
DC : P 65% L.32% E3% 
ESR: 
½ hour -  3 mm 
1 hour   - 6 mm 
Hb:  75% 
Bl. Sugar (R) :85 mg% 
Bl. Urea          :30 mg% 
S.Cholesterol  :230 mg% 
1.Marginal 
osteophytes 
Impression: 
Bilteral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : Occ. 
epithelial cells  
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
60sec 
 
50sec 
Response:  GOOD 
 
Name:Mrs.Parvathy Age/Sex:45/F O.P.No.:27060 From:07.5.08 To:12.6.08 No. of days Treated:42 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: House Wife 
Pain & Swelling in right knee joint since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8800 cells/cumm 
DC : P 60% L36% E 4% 
ESR : 
½ hour- 5 mm 
1 hour -10 mm 
Hb :71% 
Bl. Sugar (R):  83 mg% 
Bl. Urea         :  30 mg% 
S. Cholesterol: 180 mg% 
1. Sub chondral 
scleosis 
Impression: 
Bilateral 
ostearthritis   
TC :  9000 cells/cumm 
DC : P 61% L.35% E4% 
ESR 
½ hour  3 mm 
1 hour   7 mm 
Hb  75% 
Bl. Sugar (R) :85 mg% 
Bl. Urea          :25 mg% 
S.Cholesterol  :185 mg% 
1. Sub chondral 
scleosis 
Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : 1-2 
epithlial cell 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
57sec 
 
47sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
 
OUT PATIENTS  
Name: Mr.Chandran Age/Sex:45/M O.P.No.:34746 From:3.6.08 To:22.7.08 No. of days Treated:49 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation Vendor 
Pain & tenderness in both the knee joints since 
1 year 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8200 cells/cumm 
DC : P 58% L38% E 4% 
ESR:  
½ hour - 9 mm 
1 hour -  18 mm 
Hb:  81% 
Bl. Sugar (R) : 72 mg% 
Bl. Urea          : 20 mg% 
S. Cholesterol :200 mg% 
1.Soft tissues 
swelling  
Impression: 
Bilteral 
osteoarthritis 
TC :  8500 cells/cumm 
DC : P 60% L.36% E4% 
ESR: 
½ hour -  5 mm 
1 hour   - 10 mm 
Hb  80% 
Bl. Sugar (R) : 80 mg% 
Bl. Urea          : 25 mg% 
S.Cholesterol  : 205 mg% 
1.Reduced soft 
tissues swelling  
Impression: 
Bilteral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit   : NAD  
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
48sec 
 
43sec 
Response:  FAIR 
 
Name:Mrs.Umml Hyr Age/Sex:61/F O.P.No.:36199 From:10.6.08 To:22.7.08 No. of days Treated:43 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: House Wife 
Pain & Swelling in both the knee joints since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
 
8. Taking time to walk for 100 feet distance 
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TC : 9100 cells/cumm 
DC : P 60% L38% E 2% 
ESR:  
½ hour- 9 mm 
1 hour - 18 mm 
Hb:  68% 
Bl. Sugar (R):  80 mg% 
Bl. Urea         : 20 mg% 
S. Cholesterol: 181 mg% 
1. Marginal 
osteophytes  
2. Narrowed joint 
space 
 Impression: 
Bilateral 
osteoarthritis   
TC : 9200 cells/cumm 
DC : P 60% L.38% E2% 
ESR 
½ hour  - 4 mm 
1 hour   - 8 mm 
Hb:  70% 
Bl. Sugar (R) : 90 mg% 
Bl. Urea          : 21 mg% 
S.Cholesterol  : 190 mg% 
1. Marginal 
osteophytes 
 2. Narrowed 
joint space 
Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : NAD 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
75sec 
 
65sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
IN PATIENTS  
Name:Mrs.Subbammal Age/Sex:60/F O.P.No.:2802 From:13.8.08 To:16.9.08 No. of days Treated:35 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Farmer 
Pain Swelling & Morning stiffness in both the 
joints since 8 months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
 
 
8. Taking time to walk for 100 feet distance 
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TC : 8200 cells/cumm 
DC : P 68% L30% E 2% 
ESR:  
½ hour- 8 mm 
1 hour -10 mm 
Hb: 72% 
Bl. Sugar (R):  78 mg% 
Bl. Urea         :  20 mg% 
S. Cholesterol: 185 mg% 
1.Soft tissues 
swelling  
2. Narrowed joint 
space 
Impression: 
Bilteral 
osteoarthritis 
TC :  8300 cells/cumm 
DC : P 65% L.32% E3% 
ESR: 
½ hour-  4 mm 
1 hour  - 5 mm 
Hb:  73% 
Bl. Sugar (R) : 80 mg% 
Bl. Urea          : 20 mg% 
S.Cholesterol  : 190 mg% 
1.Saft tissues 
swelling  2. 
Norrowed joint 
space 
Impression: 
Bilteral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit   : NAD  
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
48sec 
 
43sec 
Response:  FAIR 
 
Name:Mr.Paramasivam Age/Sex:65/M O.P.No.:2175 From:19.8.08 To:20.9.2008 No. of days Treated:33 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water Diagnosis: AZHAL KEEL VAYU(both)
Complaints and duration:  Occupation: Farmer 
Pain & Swelling in both the knee joints since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 7500 cells/cumm 
DC : P 75% L23% E 4% 
ESR:  
½ hour -2 mm 
1 hour - 4 mm 
Hb  80% 
Bl. Sugar (R):  86 mg% 
Bl. Urea         : 21 mg% 
S. Cholesterol:  190 mg% 
Impression: 
Bilateral 
Osteoarthritis 
TC :  8000 cells/cumm 
DC : P 75% L.24% E3% 
ESR: 
½ hour -  2 mm 
1 hour   - 3 mm 
Hb : 81% 
Bl. Sugar (R) : 90 mg% 
Bl. Urea          : 22 mg% 
S.Cholesterol  : 200 mg% 
Impression: 
Bilateral 
Osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : NAD 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
64sec 
 
54sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
IN PATIENTS  
Name:Mrs.Santhosammal Age/Sex:60/F O.P.No.:2183 From:20.8.08 To:22.9.2008 No. of days Treated:35 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Servant 
Pain Swelling & Morning stiffness in both the 
knee joints since 8 months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 7900 cells/cumm 
DC : P 59% L40% E 1% 
ESR:  
½ hour- 4 mm 
1 hour -8 mm 
Hb:  68% 
Bl. Sugar (R):  75 mg% 
Bl. Urea         : 15 mg% 
S. Cholesterol: 175 mg% 
1. Sub chondral 
sclerosis 
Impression: 
Bileteral 
osteoarthritis 
TC :  8000 cells/cumm 
DC : P 58% L.40% E2% 
ESR: 
½ hour-  2 mm 
1 hour -  4 mm 
Hb  70% 
Bl. Sugar (R) -80 mg% 
Bl. Urea          20 mg% 
S.Cholesterol  170 mg% 
1. Sub chondral 
sclerosis 
Impression: 
Bileteral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit   : NAD  
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
75sec 
 
65sec 
Response:  GOOD 
 
Name:Mrs.Kamayee Age/Sex:70/F O.P.No.:2387 From:20.8.08 To:22.9.2008 No. of days Treated:35 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Fish Merchant 
Pain & Swelling in both the knee joints since  
3months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8200 cells/cumm 
DC : P 69% L28% E 3% 
ESR:  
½ hour -10 mm 
1 hour - 20 mm 
Hb:  68% 
Bl. Sugar (R):  110 mg% 
Bl. Urea         : 20mg% 
S. Cholesterol: 120 mg% 
Narrowed joint 
space  
Impression: 
Bilateral 
Osteoarthritis 
TC :  8500 cells/cumm 
DC : P 70% L.27% E3% 
ESR: 
½ hour - 5 mm 
1 hour   -10 mm 
Hb  70% 
Bl. Sugar (R) : 110 mg% 
Bl. Urea          : 20 mg% 
S.Cholesterol  : 120 mg% 
Narrowed joint 
space  
Impression: 
Bilateral 
Osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : NAD 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
70sec 
 
60sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
 
INPATIENTS  
Name:Mrs.Esakkiammal Age/Sex:70/F O.P.No.:2444 From:16.9.08 To:19.10.08 No. of days Treated:34 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Vendor 
Pain Swelling & Morning stiffness in both the 
knee joints since 2 years 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. limitation of movement(30 P,30 P-60P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation 
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 7000 cells/cumm 
DC : P 55% L40% E 5% 
ESR : 
½ hour -10 mm 
1 hour -20 mm 
Hb:  68% 
Bl. Sugar (R):  120 mg% 
Bl. Urea         : 25 mg% 
S. Cholesterol: 220 mg% 
1. Sub chondral 
sclerosis 
 2. Narrowed joint 
space  
Impression: 
Bileteral 
osteoarthritis 
TC :  7200 cells/cumm 
DC : P 56% L.41% E3% 
ESR: 
½ hour - 5 mm 
1 hour  -  10 mm 
Hb:  70% 
Bl. Sugar (R) : 110 mg% 
Bl. Urea          : 25 mg% 
S.Cholesterol  : 205 mg% 
1. Sub chondral 
sclerosis 
 2. Narrowed 
joint space 
Impression: 
Bileteral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit   : NAD  
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
75sec 
 
70sec 
Response:  FAIR 
 
Name:Mrs.Sundaram Age/Sex:60/F O.P.No.:2441 From:16.9.08 To:18.10.08 No. of days Treated:33 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water Diagnosis: AZHAL KEEL VAYU(both)
Complaints and duration:  Occupation: House Wife 
Pain tenderness & morning stiffness in both the 
knee jointa its since 1 year 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 9700 cells/cumm 
DC : P 70% L37% E 3% 
ESR : 
½ hour- 4 mm 
1 hour - 6 mm 
Hb:  70% 
Bl. Sugar (R):  120 mg% 
Bl. Urea         : 30mg% 
S. Cholestero : 200 mg% 
Impression: 
Bilateral 
Osteoarthritis 
TC : 9600 cells/cumm 
DC : P69 % L38.% E3% 
ESR: 
½ hour-  2 mm 
1 hour  - 3 mm 
Hb:  71% 
Bl. Sugar (R) :110 mg% 
Bl. Urea          :25 mg% 
S.Cholesterol  :190 mg% 
Impression: 
Bilateral 
Osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  :1-2 
epithelial cells 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
63sec 
 
53sec 
Response:  GOOD 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
IN PATIENTS  
Name:Mrs.Eswari Age/Sex:45/F O.P.No.:2454 From:17.9.08 To:24.9.08 No. of days Treated:38 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Vendor 
Pain, Swelling & Tenderness in both kneethe 
joint since 2 years 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
 
 
8. Taking time to walk for 100 feet distance 
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TC : 9400 cellscumm 
DC : P 48% L48% E 4% 
ESR:  
½ hour- 20mm 
1 hour -30 mm 
Hb:  79% 
Bl. Sugar (R):  80 mg% 
Bl. Urea         : 20 mg% 
S. Cholesterol: 201 mg% 
1. Sub chondral 
sclerosis  
2. Narrowed joint 
space  
Impression: 
Bileteral 
osteoarthritis 
TC :  9500 cells/cumm 
DC : P 50% L.47% E3% 
ESR: 
½ hour-  10 mm 
1 hour  -  15 mm 
Hb:  80% 
Bl. Sugar (R) : 85 mg% 
Bl. Urea          : 25 mg% 
S.Cholesterol  : 205 mg% 
1. Sub chondral 
sclerosis  
2. Narrowed 
joint space 
Impression: 
Bileteral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit   : NAD  
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
65sec 
 
70sec 
Response:  GOOD 
 
Name:Mr.Sudalai Age/Sex:57/M O.P.No.:2474 From:18.9.08 To:25.10.08 No. of days Treated:40 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water Diagnosis: AZHAL KEEL VAYU(both)
Complaints and duration:  Occupation: House Wife 
Pain, Tenderness & Morning stiffness in both 
the knee joints since 8 months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 7200 cells/cumm 
DC : P 60% L38% E 2% 
ESR: 
½ hour- 3 mm 
1 hour - 7 mm 
Hb:74% 
Bl. Sugar (R):  90 mg% 
Bl. Urea         : 25mg% 
S. Cholesterol:  217 mg% 
Impression: 
Normal Study 
TC : 7500 cells/cumm 
DC : P 60% L.55% E5% 
ESR 
½ hour  3 mm 
1 hour   6 mm 
Hb  75% 
Bl. Sugar (R) : 91 mg% 
Bl. Urea          : 26 mg% 
S.Cholesterol  : 215 mg% 
 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  :1-2 
epithelial cells 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
52sec 
 
47sec 
Response:  FAIR 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of sy 
IN PATIENTS  
Name:Mr.Muniyasamy Age/Sex:45/M O.P.No.:2679 From:25.9.08 To:25.10.08 No. of days Treated:31 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU(both) 
Complaints and duration:  Occupation: Vendor 
Pain & Swelling in both the knee joints since 8 
months 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 10000 cells/cumm 
DC : P 65% L39% E 8% 
ESR:  
½ hour - 3 mm 
1 hour  - 6 mm 
Hb:  71% 
Bl. Sugar (R) : 100 mg% 
Bl. Urea          : 20 mg% 
S. Cholesterol : 190 mg% 
1.Narrowed joint 
space 
Impression: 
Bileteral 
osteoarthritis 
TC :  10500 cells/cumm 
DC : P 66% L.38% E6% 
ESR: 
½ hour -  3 mm 
1 hour  -  4 mm 
Hb:  72% 
Bl. Sugar (R) : 100 mg% 
Bl. Urea          : 20mg% 
S.Cholesterol  : 195 mg% 
1.Narrowed 
joint space 
Impression: 
Bileteral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit   : NAD  
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
53sec 
 
43sec 
Response:  GOOD 
 
Name:Mr.Thavasi Age/Sex:46/M O.P.No.:2680 From:25.9.08 To:25.10.08 No. of days Treated:31 
Drug: Senkodiveliver Chooranam – 1gm  bd with Luke warm water  Diagnosis: AZHAL KEEL VAYU 
Complaints and duration:  Occupation:  Carpenter 
Pain ,tenderness in both the knee joints since 1 
year 
Before 
treatment 
After 
treatment 
Investigation 
Before treatment After treatment 
Right Left Right Left Blood Radiological findings Blood 
Radiological 
findings 
 
1. Pain 
2. Stiffness 
3. Limitation of movement(30P,30 P-60 P,>60P) 
4. Measurement 
5. Tenderness 
6. Crepitation  
7. Swelling 
 
8. Taking time to walk for 100 feet distance 
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TC : 8800 cell/cumm 
DC : P 48% L48% E 4% 
ESR:  
½ hour- 4 mm 
1 hour-  8 mm 
Hb:  74% 
Bl. Sugar (R):  120 mg% 
Bl. Urea         : 25mg% 
S. Cholesterol: 190 mg% 
Impression: 
Bilateral 
osteoarthritis 
TC : 9000 cells/cumm 
DC : P 50% L.47% E3% 
ESR: 
½ hour-  3 mm 
1 hour  - 7 mm 
Hb:  72% 
Bl. Sugar (R) :110 mg% 
Bl. Urea          :30mg% 
S.Cholesterol :200 mg% 
Impression: 
Bilateral 
osteoarthritis 
Urine  : 
Albumin : NIL 
Sugar     :  NIL 
Deposit  : NAD 
Urine  : 
Albumin : NIL 
Sugar     : NIL 
Deposit  : NAD  
50sec 
 
48sec 
Response:  POOR 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of sy 
 
 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :1  OP.NO: 53163 NAME :Mrs.Shanmuga sundari AGE/SEX :30/F OCCUPATION :House wife 
FROM :02.09.2008 TO :16.10.2008 NO.OF DAYS TREATED :45   
COMPLAINTS AND DURATION INVESTIGATION 
Giddiness,Dyspnoea on exertion & 
Palpitation since 4 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9600Cells/cu mm Albumin:nil TC:9700Cells/cu mm AlbuminNil 
DC : P68   %  L 27  %  E 5  % Sugar:Nil DC:  P68   %  L27% E5 % Sugar:Nil
ESR  : ½ hr:   4  mm Deposits:NAD ESR :  ½ hr:   2  mm Deposits:NAD 
            1hr   :  8  mm MOTION            1hr :  4 mm MOTION 
Hb : 9.4 gms/dl(62 %) Ova:Nil Hb : 10.7gms/dl/(71%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:NIL 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):86 mgs%  Sugar(R)  : 90 mgs%  
Urea       :19  mgs%  Urea        :   20 mgs% RESPONSE:Good 
Cholesterol:190 mgs%  Cholesterol :192 mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :2 OP.NO :53204 NAME :Mr.Krishnan AGE/SEX :62/M OCCUPATION :Servant 
FROM :02.09.2008 TO :16.10.2008 NO.OF DAYS TREATED :45   
COMPLAINTS AND DURATION INVESTIGATION 
Tiredness,loss of appetite & 
Dyspnoea on exertion  since 
4months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC :  9400Cells/cu mm Albumin:Nil TC: 9500 Cells/cu mm Albumin:Nil 
DC:  P76   %  L20   %  E 4  % Sugar:Nil DC:  P77   %  L20   %  E3   % Sugar:Nil 
ESR :  ½ hr:  3 mm Deposits:NAD ESR:   ½ hr: 2 mm Deposits:NAD 
           1hr :  5  mm MOTION            1hr :  4    mm MOTION 
Hb : 9.6gms/dl(64 %) Ova:Nil Hb : 11.1 gms/dl( 74%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R)  :100  mgs%  Sugar(R) :  95mgs%  
Urea  : 25mgs%  Urea   :   23 mgs% RESPONSE:Good 
Cholesterol :180 mgs%  Cholesterol: 170mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
 OUT- PATIENTS 
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :4 OP.NO :51581 NAME :Mrs.Sabeena AGE/SEX :49/F OCCUPATION :Tailor 
FROM :02.09.2008 TO :16.10.2008 NO.OF DAYS TREATED :45   
COMPLAINTS AND DURATION INVESTIGATION 
Dyspnoea on exertion,giddiness  
since 6 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC :   9200 Cells/cu mm Albumin:Nil TC :9300 Cells/cu mm Albumin:Nil 
DC : P60   %  L35   %  E5   % Sugar:Nil DC:  P 65  %  L34   %  E 1  % Sugar:Nil 
ESR :  ½ hr: 5    mm Deposits:NAD ESR:   ½ hr: 3    mm Deposits:NAD 
            1hr : 10     mm MOTION 1hr : 8     mm MOTION 
Hb :   9.2gms/dl(61%) Ova:Nil Hb:11.7 gms/dl(77%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):112 mgs%  Sugar(R):110 mgs%  
Urea :23  mgs%  Urea :22    mgs% RESPONSE:Good 
Cholesterol:192  mgs%  Cholesterol:200 mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :3 OP.NO :53208 Mes.Shanthi AGE/SEX :49/F OCCUPATION :House wife 
FROM :02.09.2008 TO :16.10.2008 NO.OF DAYS TREATED :45   
COMPLAINTS AND DURATION INVESTIGATION 
Giddiness,light headedness & loss 
of appetite   since 7 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC : 9000 Cells/cu mm Albumin:Nil TC: 9200 Cells/cu mm Albumin:Nil 
DC : P60   %  L33   %  E7   % Sugar:Nil DC : P61   %  L 33  %  E8   % Sugar:Nil 
ESR:   ½ hr:4     mm Deposits:NAD ESR:   ½ hr: 3   mm Deposits:NAD 
           1hr : 7     mm MOTION             1hr : 6    mm MOTION 
Hb :  9.9  gms/dl(66 %) Ova:Nil Hb : 10.7 gms/dl(71 %) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R) :110  mgs%  Sugar(R):105  mgs%  
Urea :28  mgs%  Urea :27mgs% RESPONSE:Fair 
Cholesterol  :180mgs%  Cholesterol :185 mgs%   
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :5 OP.NO :53308 NAME :Mrs.Ramalakshmi AGE/SEX :62/F OCCUPATION :Daily wages 
FROM :03.09.2008 TO :17.10.2008 NO.OF DAYS TREATED :45   
COMPLAINTS AND DURATION INVESTIGATION 
Dyspnoea on exertion & Giddiness  
since 8 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9300Cells/cumm Albumin:Nil TC:9000 Cells/cumm Albumin:nil 
DC:  P60   %  L35   %  E5   % Sugar:Nil DC:  P 58  %  L40   %  E2   % Sugar:Nil
ESR :  ½ hr:5     mm Deposits:NAD ESR   ½ hr:  4  mm Deposits:NAD 
           1hr :10    mm MOTION               1hr : 8     mm MOTION 
Hb :10 gms/dl(67%) Ova:Nil Hb :10.2gms/dl(73%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):90 mgs%  Sugar(R) :90 mgs%  
Urea :25  mgs%  Urea:24   mgs% RESPONSE:Poor 
Cholesterol :180mgs%  Cholesterol:190 mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :6 OP.NO:53307 NAME :Mrs.Annalakshmi AGE/SEX :55/F OCCUPATION :Housewife 
FROM :03.09.2008 TO :18.10.2008 NO.OF DAYS TREATED :46   
COMPLAINTS AND DURATION INVESTIGATION 
Dyspnoea on exertion & Giddiness  
since 8 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:8000 Cells/cumm Albumin:Nil TC:8200 Cells/cumm Albumin:Nil 
DC:  P76   %  L22   %  E2   % Sugar:Nil DC:  P58   %  L 40  %  E2   % Sugar:Nil 
ESR:   ½ hr:4  mm Deposits:NAD ESR:3   ½ hr:3 mm Deposits:NAD 
          1hr : 9 mm MOTION            1hr : 6mm MOTION 
Hb :   9 gms/dl(60 %) Ova:Nil Hb : 11 gms/dl(73 %) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):80 mgs%  Sugar(R):85  mgs%  
Urea :16  mgs%  Urea:18  mgs% RESPONSE:Good 
Cholesterol:190  mgs%  Cholesterol:200 mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :7 OP.NO :53500 NAME :Mrs.Rajammal AGE/SEX :40/F OCCUPATION :Farmer 
FROM :04.09.2008 TO :18.10.2008 NO.OF DAYS TREATED :45   
COMPLAINTS AND DURATION INVESTIGATION 
Dyspnoea on exertion & Giddiness  
since 6 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9800Cells/cumm Albumin:Nil TC:9300Cells/cumm Albumin:Nil 
DC:  P62   %  L32   %  E6   % Sugar:Nil DC:  P63   %  L33   %  E4   % Sugar:Nil
ESR:   ½ hr:4 mm Deposits:NAD ESR:   ½ hr: 2  mm Deposits:NAD 
1hr : 8 mm MOTION 1hr : 4 mm MOTION 
Hb : 10.2 gms/dl(68    %) Ova:Nil Hb : 12 gms/dl(80    %) Ova:Nil 
MCV:88 cu µ Cyst:Nil MCV:91 cu µ Cyst:Nil 
PCV:37% Occult blood:Nil PCV:39% Occult blood:Nil 
Sugar(R) :100 mgs%  Sugar(R):110 mgs%  
Urea:18  mgs%  Urea  :20 mgs% RESPONSE:Good 
Cholesterol:210  mgs%  Cholesterol:205 mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :8 OP.NO :53597 NAME :Mrs.Backiam AGE/SEX :45/F OCCUPATION :House wife 
FROM :05.09.2008 TO :20.10.2008 NO.OF DAYS TREATED :46   
COMPLAINTS AND DURATION INVESTIGATION 
Dyspnoea on exertion  since 6 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:8000Cells/cu mm Albumin:Nil TC:8300Cells/cumm Albumin:Nil 
DC:  P59   %  L36   %  E5   % Sugar:Nil DC  P60   %  L36   %  E4   % Sugar:Nil 
ESR:   ½ hr: 5  mm Deposits:NAD ESR :  ½ hr:2 mm Deposits:NAD 
1hr :10   mm MOTION 1hr : 6     mm MOTION 
Hb :9.6 gms/dl( 64 %) Ova:Nil Hb : 11.3 gms/dl(75%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):100 mgs%  Sugar(R)105 mgs%  
Urea :22 mgs%  Urea:25  mgs% RESPONSE:Good 
Cholesterol :200 mgs%  Cholesterol 210 mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :9 OP.NO :55683 NAME :Mrs.Thangam AGE/SEX :40/F OCCUPATION :House wife 
FROM :17.09.2008 TO :30.10.2008 NO.OF DAYS TREATED :44   
COMPLAINTS AND DURATION INVESTIGATION 
Loss of appetite & dyspnoea on 
exertion  since 8 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:7800 Cells/cumm Albumin:Nil TC:8000 Cells/cumm Albumin:Nil 
DC:  P60   %  L38   %  E2   % Sugar:Nil DC:  P60   %  L 36  %  E4   % Sugar:Nil
ESR :  ½ hr: 4 mm Deposits:Occ. Epithelial cells ESR:   ½ hr: 2    mm Deposits:NAD 
1hr : 7 mm MOTION 1hr : 4     mm MOTION 
Hb :  9.2 gms/dl( 61   %) Ova:Nil Hb : 10.2gms/dl( 68   %) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):120  mgs%  Sugar(R)110  mgs%  
Urea    :24   mgs%  Urea:25  mgs% RESPONSE:Fair 
Cholesterol :185 mgs%  Cholesterol 190 mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :10 OP.NO :55627 NAME :Mr.Velu AGE/SEX :65/M OCCUPATION :Carpenter 
FROM :17.09.2008 TO :30.10.2008 NO.OF DAYS TREATED :44   
COMPLAINTS AND DURATION INVESTIGATION 
Giddinesss & dyspnoea on exertion  
since 6 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:8100 Cells/cumm Albumin:Nil TC:8500Cells/cumm Albumin:Nil
DC:  P60   %  L 38  %  E2   % Sugar:Nil DC : P60   %  L36   %  E4   % Sugar:Nil 
ESR:   ½ hr: 4 mm Deposits:NAD ESR :  ½ hr: 2 mm Deposits:NAD 
1hr :6 mm MOTION 1hr :3 mm MOTION 
Hb : 9.2 gms/dl(62%) Ova:Nil Hb :11.2 gms/dl(75 %) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):110 mgs%  Sugar(R)    110mgs%  
Urea :20 mgs%  Urea     :25  mgs% RESPONSE:Good 
Cholesterol:215 mgs%  Cholesterol:210   mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :11 OP.NO :56062 NAME :Mrs.Manimegalai AGE/SEX :40/F OCCUPATION :Teacher 
FROM :18.0.2008 TO :31.10.2008 NO.OF DAYS TREATED :44   
COMPLAINTS AND DURATION INVESTIGATION 
Tiredness.loss of appetite & 
Dyspnoea on exertion  since 1 year 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9000 Cells/cumm Albumin:Nil TC:9100 Cells/cumm Albumin:Nil  
DC:  P50   %  L43   %  E7   % Sugar:Nil DC : P51   %  L43   %  E6   % Sugar:Nil
ESR:   ½ hr:5     mm Deposits:NAD ESR :  ½ hr:3  mm Deposits:NAD 
1hr : 11 mm MOTION 1hr :6mm MOTION 
Hb : 10.2  gms/dl(68%) Ova:Nil Hb :   11.6gms/dl(77%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):105 mgs%  Sugar(R):100 mgs%  
Urea :23 mgs%  Urea:24 mgs% RESPONSE:Good 
Cholesterol :180  mgs%  Cholesterol:181 mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :12 OP.NO :52058 NAME :Mrs.Shanthi AGE/SEX :43/F OCCUPATION :House wife 
FROM :20.09.2008 TO :06.10.2008 NO.OF DAYS TREATED :47   
COMPLAINTS AND DURATION INVESTIGATION 
Light headedness & giddiness since 
4 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC :9200Cells/cumm Albumin:Nil TC:9300 Cells/cumm Albumin:Nil 
DC:  P64   %  L30   %  E6   % Sugar:Nil DC : P65   %  L31   %  E 4  % Sugar:Nl 
ESR:   ½ hr:  6   mm Deposits:NAD ESR:   ½ hr: 4 mm Deposits:NAD 
1hr :13mm MOTION 1hr : 8  mm MOTION 
Hb : 9.2gms/dl(61%) Ova:Nil Hb : 10.2 gms/dl( 68%) Ova:Nil  
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):105 mgs%  Sugar(R)110mgs%  
Urea:25  mgs%  Urea:20  mgs% RESPONSE:Fair 
Cholesterol:190mgs%  Cholesterol:190mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :13 OP.NO :57391 NAME :Mrs.Seeniyammal AGE/SEX :47/F OCCUPATION :House wife 
FROM :26.09.2008 TO :07.11.2008 NO.OF DAYS TREATED :42   
COMPLAINTS AND DURATION INVESTIGATION 
Loss of appetite,palpitation & light 
headedness  since 6 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:8500Cells/cumm Albumin:Nil TC:8700 Cells/cumm Albumin:Nil 
DC:  P66   %  L30   %  E4   % Sugar:Nil DC : P67   %  L31   %  E3   % Sugar:Nil
ESR:   ½ hr: 5 mm Deposits:NAD ESR:   ½ hr: 3    mm Deposits:NAD 
1hr : 12 mm MOTION 1hr : 8     mm MOTION 
Hb : 8.7gms/dl(58%) Ova:Nil Hb : 10.3 gms/dl( 69%) Ova:Nil 
MCV:88cu µ Cyst:Nil MCV:91cu µ Cyst:Nil 
PCV:35% Occult blood:Nil PCV:39% Occult blood:Nil 
Sugar(R):100 mgs%  Sugar(R):105 mgs%  
Urea:23 mgs%  Urea:25 mgs%  
Cholesterol:195 mgs%  Cholesterol: 205 mgs%  RESPONSE:Good 
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :14 OP.NO :59386 NAME :Mrs.Thangam AGE/SEX :35/F OCCUPATION :Servant 
FROM :06.09.2008 TO :11.09.2008 NO.OF DAYS TREATED :45   
COMPLAINTS AND DURATION INVESTIGATION 
Dyspnoes on exertion,giddiness  
since 8 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9600 Cells/cumm Albumin:Nil TC:9700 Cells/cumm Albumin:Nil 
DC:  P 60  %  L36   %  E 4  % Sugar:Nil DC:  P62   %  L33   %  E5   % Sugar:Nil 
ESR :  ½ hr:8 mm Deposits:NAD ESR;   ½ hr: 4 mm Deposits:NAD 
1hr : 13mm MOTION 1hr : 9 mm MOTION 
Hb : 9.6 gms/dl(64%) Ova:Nil Hb : 10.9 gms/dl( 73 %) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV:Nil Occult blood:Nil 
Sugar(R):105 mgs%  Sugar(R):100 mgs%  
Urea:25 mgs%  Urea:23 mgs% RESPONSE:Good 
Cholesterol :210 mgs%  Cholesterol :215 mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :15 OP.NO:59905 Mr.Virumandi AGE/SEX :56/M OCCUPATION :Painter 
FROM :10.10.2008 TO :20.11.2008 NO.OF DAYS TREATED :41   
COMPLAINTS AND DURATION INVESTIGATION 
Palpitation,loss of appetite & 
giddiness since 1 year 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:7800 Cells/cumm Albumin:Nil TC:8000 Cells/cumm Albumin:Nil 
DC : P70   %  L25   %  E 5  % Sugar:Nil DC:  P72   %  L23   %  E5   % Sugar:Nil
ESR :  ½ hr:8 mm Deposits:NAD ESR:   ½ hr: 4 mm Deposits:NAD 
1hr :16 mm MOTION 1hr :7 mm MOTION 
Hb : 8.9 gms/dl( 60%) OVA Hb :  10.5gms/dl( 70 %) OVA 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):100 mgs%  Sugar(R):100 mgs%  
Urea:20mgs%  Urea:25 mgs% RESPONSE:Good 
Cholesterol:215 mgs%  Cholesterol:200mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :16 OP.NO :60293 NAME :Mrs.Visalakshmi AGE/SEX :32/F OCCUPATION :House wife 
FROM :13.10.2008 TO :20.11.2008 NO.OF DAYS TREATED :41   
COMPLAINTS AND DURATION INVESTIGATION 
Loss of appetite,palpitation & 
dyspnoea on exertion  since 6 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9600   Cells/cumm Albumin:Nil TC:9700 Cells/cumm Albumin:Nil 
DC:  P67   %  L30   %  E3   % Sugar:Nil DC:  P65   %  L38   %  E7   % Sugar:Nil 
ESR:   ½ hr: 8  mm Deposits:NAD ESR:   ½ hr:4 mm Deposits:NAD 
1hr : 14  mm MOTION 1hr :7  mm MOTION 
Hb :9.2  gms/dl( 61%) Ova:Nil Hb :     10.7gms/dl( 71%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):100 mgs%  Sugar(R):105 mgs%  
Urea:25 mgs%  Urea :30 mgs% RESPONSE:Good 
Cholesterol:213  mgs%  Cholesterol  :202mgs%   
 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :17 OP.NO :61430 NAME :Mrs.Ilavarasi AGE/SEX :28/F OCCUPATION :Teacher 
FROM :20.10.2008 TO :27.10.2008 NO.OF DAYS TREATED :39   
COMPLAINTS AND DURATION INVESTIGATION 
Tiredness & loss of appetite  since 7 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC :9500Cells/cumm Albumin:Nil TC:9300Cells/cumm Albumin:Nil 
DC:  P60   %  L35   %  E5   % Sugar:Nil DC:  P61   %  L36   %  E3   % Sugar:Nil
ESR:   ½ hr:7mm Deposits:NAD ESR:   ½ hr: 5 mm Deposits:NAD 
1hr : 15 mm MOTION 1hr : 7 mm MOTION 
Hb : 9.6 gms/dl( 64%) Ova:Nil Hb : 10.8 gms/dl(72 %) Ova:Nil  
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):111 mgs%  Sugar(R):110mgs%  
Urea:27  mgs%  Urea:25  mgs% RESPONSE:Good 
Cholesterol:175 mgs%  Cholesterol:180 mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :18 62037 NAME :Mrs.Seetha AGE/SEX :33/F OCCUPATION :House wife 
FROM :23.10.2008 TO :27.11.2008 NO.OF DAYS TREATED :36   
COMPLAINTS AND DURATION INVESTIGATION 
Dyspnoea on exertion,palpitation & 
tiredness  since 4 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9600 Cells/cumm Albumin:Nil TC:9700Cells/cumm Albumin:Nil 
DC:  P60   %  L34   %  E6   % Sugar:Nil DC:  P65   %  L33   %  E 2  % Sugar:Nil 
ESR:   ½ hr: 5 mm Deposits:NAD ESR :  ½ hr: 4 mm Deposits:NAD 
1hr :10 mm MOTION 1hr :8  mm MOTION 
Hb : 9 gms/dl(60%) Ova:Nil Hb : 10.6 gms/dl(71 %) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):100 mgs%  Sugar(R):105 mgs%  
Urea:30  mgs%  Urea:31  mgs% RESPONSE:Good 
Cholesterol:200mgs%  Cholesterol:205 mgs%   
 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :19 OP.NO :62048 NAME :Ms.Kaveri AGE/SEX :24/F OCCUPATION :Student 
FROM :29.10.2008 TO :05.12.2008 NO.OF DAYS TREATED :38   
COMPLAINTS AND DURATION INVESTIGATION 
Tiredness & loss of appetite  since 4 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9400Cells/cumm Albumin:Nil TC:9400 Cells/cumm Albumin:Nil 
DC:  P60   %  L35   %  E5   % Sugar:Nil DC:  P61   %  L36   %  E3  % Sugar:Nil
ESR:   ½ hr: 9mm Deposits:1-2 epithelial cells ESR:   ½ hr:5 mm Deposits:NAD 
1hr :18     mm MOTION 1hr : 9  mm MOTION 
Hb : 9.2      gms/dl(61%) Ova:Nil Hb :10.7 gms/dl(71%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):120   mgs%  Sugar(R) :110 mgs%  
Urea :27 mgs%  Urea       :28 mgs% RESPONSE:Good 
Cholesterol:205 mgs%  Cholesterol :200 mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :20 OP.NO :64048 NAME :Mrs.Fathima AGE/SEX :41/F OCCUPATION :House wife 
FROM :29.10.2008 TO :05.12.2008 NO.OF DAYS TREATED :38   
COMPLAINTS AND DURATION INVESTIGATION 
 
 
 
Tiredness,palpitation & dyspnoea 
on exertion   since 1 year 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9600Cells/cumm Albumin:Nil TC:9300Cells/cumm Albumin:Nil
DC:  P60   %  L34   %  E6   % Sugar:Nil DC:  P61   %  L35   %  E 4  % Sugar:Nil 
ESR:   ½ hr: 5  mm Deposits:NAD ESR   ½ hr:   3  mm Deposits:NAD 
1hr : 10  mm MOTION 1hr : 6     mm MOTION 
Hb :    9gms/dl ( 60%) Ova:Nil Hb :   10 gms/dl(67%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):85mgs%  Sugar(R):90mgs%  
Urea :25 mgs%  Urea:30  mgs% RESPONSE:Fair 
Cholesterol:190 mgs%  Cholesterol:195 mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :21 OP.NO :62451 NAME :Mrs.Krishnaveni AGE/SEX :29/F OCCUPATION :Farmer 
FROM :30.10.2008 TO:05.12.2008 NO.OF DAYS TREATED :37   
COMPLAINTS AND DURATION INVESTIGATION 
Loss of appetite & dyspnoea on 
exertion  since 7 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9800Cells/cumm Albumin:Nil TC:9900 Cells/cumm Albumin:Nil 
DC:  P58   %  L36   %  E6   % Sugar:Nil DC:  P60   %  L 35  %  E5   % Sugar:Nil
ESR:   ½ hr:8 mm Deposits:NAD ESR:   ½ hr:  4  mm Deposits:NAD 
1hr :10 mm MOTION 1hr : 7  mm MOTION 
Hb : 10 gms/dl( 68%) Ova:Nil Hb :  11.2 gms/dl(75    %) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):90mgs%  Sugar(R)  :95 mgs%  
Urea :26mgs%  Urea :25 mgs% RESPONSE:Good 
Cholesterol :190 mgs%  Cholesterol :190 mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :22 OP.NO :62492 NAME :Mr.Subramanian AGE/SEX :22/M OCCUPATION :Student 
FROM :30.10.2008 TO :05.12.2008 NO.OF DAYS TREATED :37   
COMPLAINTS AND DURATION INVESTIGATION 
Tiredness & palpitation  since 1 
year 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:10000 Cells/cumm Albumin:Nil TC :10500 Cells/cumm Albumin:Nil 
DC:  P60   %  L33   %  E5   % Sugar:Nil DC:  P60   %  L 30  %  E4   % Sugar:Nil 
ESR:   ½ hr:  5mm Deposits:NAD ESR :  ½ hr:  3  mm Deposits:NAD 
1hr : 7mm MOTION 1hr :   4  mm MOTION 
Hb : 9.8gms/dl(65%) Ova:Nil Hb :   11gms/dl( 73   %) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):95mgs%  Sugar(R):100  mgs%  
Urea       :25 mgs%  Urea :26 mgs% RESPONSE:Good 
Cholesterol:200 mgs%  Cholesterol:205 mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :23 OP.NO :62801 NAME :Mrs.Kumari AGE/SEX :31/F OCCUPATION :Housewife 
FROM :31.10.2008 06.12.2008  NO.OF DAYS TREATED :37   
COMPLAINTS AND DURATION INVESTIGATION 
Giddiness,dyspnoea on exertion 
since 6 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9200 Cells/cumm Albumin:Nil TC :9300Cells/cumm Albumin:Nil 
DC:  P60   %  L 34  %  E  6 % Sugar:Nil DC:  P61   %  L 36  %  E4   % Sugar:Nil
ESR:   ½ hr: 4  mm Deposits:NAD ESR:   ½ hr: 2 mm Deposits:NAD 
1hr : 8  mm MOTION 1hr :  4 mm MOTION 
Hb :  9.6gms/dl( 64%) Ova:Nil Hb :    10.8gms/dl( 72%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):81 mgs%  Sugar(R):90 mgs%  
Urea :20mgs%  Urea :21 mgs% RESPONSE:Good 
Cholesterol:180mgs%  Cholesterol :185mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :24 OP.NO :62873 NAME :Ms.Selvi AGE/SEX :15/F OCCUPATION :Student 
FROM :31.10.2008 TO :06.12.2009 NO.OF DAYS TREATED :37   
COMPLAINTS AND DURATION INVESTIGATION 
Lighr headedness & palpitation  
since 4 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9600Cells/cumm Albumin:Nil TC:9700Cells/cumm Albumin:Nil 
DC:  P60   %  L34   %  E 6  % Sugar:Nil DC : P65   %  L 33  %  E  2 % Sugar:Nil 
ESR :  ½ hr:   9  mm Deposits:Nil ESR:   ½ hr:   4  mm Deposits:Nil 
1hr : 15mm MOTION 1hr :  8 mm MOTION 
Hb : 9gms/dl( 60 %) Ova:Nil Hb :     10gms/dl( 67%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood: 
Sugar(R) :85 mgs%  Sugar(R) :90 mgs%  
Urea    :30 mgs%  Urea    :31 mgs% RESPONSE:Fair 
Cholesterol :170 mgs%  Cholesterol :180 mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :25 OP.NO :63560 NAME :Mr.Antony AGE/SEX:71/M OCCUPATION :Sweeper 
FROM :01.11.2008 TO :06.12.2008 NO.OF DAYS TREATED :36   
COMPLAINTS AND DURATION INVESTIGATION 
Tiredness & dyspnoea on exertion  
aince 7 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9800 Cells/cumm Albumin:Nil TC:9900 Cells/cumm Albumin:Nil 
DC:  P62   %  L32   %  E8   % Sugar:Nil DC:  P63   %  L33 %  E4 % Sugar:Nil
ESR:   ½ hr: 7 mm Deposits:NAD ESR:   ½ hr:  3   mm Deposits:NAD 
1hr :   14mm MOTION 1hr :  9    mm MOTION 
Hb :    10.2gms/dl( 68%) Ova:Nil Hb :     11.4   gms/dl(76%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R) :88 mgs%  Sugar(R):89mgs%  
Urea       :32 mgs%  Urea       :33 mgs% RESPONSE:Good 
Cholesterol:210mgs%  Cholesterol :215mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :26 OP.NO :63371 NAME :Mrs.Parvathy AGE/SEX :60/F OCCUPATION :Vendor 
FROM :01.11.2008 TO :06.12.2008 NO.OF DAYS TREATED :36   
COMPLAINTS AND DURATION INVESTIGATION 
Loss of appetite & giddiness  since 
1 year 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC :9000Cells/cumm Albumin:Nil TC:9100Cells/cumm Albumin:Nil 
DC:  P 52  %  L40   %  E 8  % Sugar:Nil DC:  P60   %  L35   %  E7   % Sugar:Nil 
ESR:   ½ hr: 8    mm Deposits:NAD ESR :  ½ hr:  3   mm Deposits:NAD 
1hr :  16  mm MOTION 1hr :   10   mm MOTION 
Hb : 9.3  gms/dl(62%) Ova:Nil Hb : 10.7 gms/dl( 71%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R) :100mgs%  Sugar(R) :105 mgs%  
Urea  :24 mgs%  Urea :25 mgs% RESPONSE:Good 
Cholesterol :150 mgs%  Cholesterol :160 mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :27 OP.NO :63669 NAME :Mrs.Faridha AGE/SEX :32/F OCCUPATION :House wife 
FROM :01.11.2008 TO :06.12.2008 NO.OF DAYS TREATED :36   
COMPLAINTS AND DURATION INVESTIGATION 
Giddiness,tiredness & dyspnoea on 
exertion  since 7 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:8500 Cells/cumm Albumin:Nil TC:8700 Cells/cumm Albumin:Nil 
DC:  P 68  %  L 27  %  E 5  % Sugar:Nil DC:  P 65  %  L 33  %  E2   % Sugar:Nil
ESR:   ½ hr:  8 mm Deposits:NAD ESR   ½ hr: 4    mm Deposits:NAD 
1hr : 16mm MOTION 1hr :  8    mm MOTION 
Hb :  9.3gms/dl(62%) Ova:Nil Hb :  10.6gms/dl(  71  %) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R)  :110mgs%  Sugar(R):105 mgs%  
Urea :21mgs%  Urea :20mgs% RESPONSE:Good 
Cholesterol :170mgs%  Cholesterol :180mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :28 OP.NO:64096 NAME :Mrs.Rajammal AGE/SEX :45/F OCCUPATION :Daily wages 
FROM :01.11.2008 TO :06.12.2008 NO.OF DAYS TREATED :36   
COMPLAINTS AND DURATION INVESTIGATION 
Loss of appetite,giddiness & 
dyspnoea on exertion  since 7 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:10000Cells/cumm Albumin:Nil TC :10100 Cells/cumm Albumin:Nil 
DC:  P61   %  L32   %  E 7  % Sugar:Nil DC : P 62  %  L33   %  E 5  % Sugar:Nil 
ESR :  ½ hr:   7  mm Deposits:NAD ESR :  ½ hr:3mm Deposits:NAD 
1hr :  16  mm MOTION 1hr :  11 mm MOTION 
Hb :   9.9gms/dl( 66%) Ova:Nil Hb :    11.1gms/dl( 74%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):90mgs%  Sugar(R):88 mgs%  
Urea :19 mgs%  Urea  :19  mgs% RESPONSE:Good 
Cholesterol :178 mgs%  Cholesterol :180 mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
OUT- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :29 OP.NO :64102 NAME :Mrs.Banu AGE/SEX :28/F OCCUPATION :House wife 
FROM :03.11.2008 TO :08.12.2008 NO.OF DAYS TREATED :36   
COMPLAINTS AND DURATION INVESTIGATION 
Tiredness.loss of appetite  since 7 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:7600 Cells/cumm Albumin:Nil TC:7700 Cells/cumm Albumin:Nil 
DC:  P48   %  L 48  %  E 4  % Sugar:Nil DC:  P 50  %  L 45  %  E 5  % Sugar:Nil
ESR :  ½ hr: 6 mm Deposits:NAS ESR :  ½ hr:  5 mm Deposits:NAD 
1hr : 12 mm MOTION 1hr :  9 mm MOTION 
Hb : 9 gms/dl( 60  %) Ova:Nil Hb :  10gms/dl(67%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R)  :113mgs%  Sugar(R):110 mgs%  
Urea :23 mgs%  Urea  :21mgs% RESPONSE:Fair 
Cholesterol:190 mgs%  Cholesterol :194mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :30 OP.NO :64102 NAME :Mrs.Velammal AGE/SEX :55/F OCCUPATION :Farmer 
FROM :03.11.2008 TO :08.12.2008 NO.OF DAYS TREATED :36   
COMPLAINTS AND DURATION INVESTIGATION 
Giddiness.loss of appetite & 
dyspnoea on exertion  since 6 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:7200 Cells/cumm Albumin:Nil TC :7300 Cells/cumm Albumin: 
DC:  P58   %  L 38  %  E4   % Sugar:Nil DC:  P 60  %  L36   %  E  4 % Sugar:Nil 
ESR:   ½ hr: 10 mm Deposits:NAD ESR :  ½ hr:  8  mm Deposits:NAD 
1hr :  20 mm MOTION 1hr :   16  mm MOTION 
Hb : 8.8 gms/dl(59%) Ova:Nil Hb : 9gms/dl( 60 %) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):110 mgs%  Sugar(R):111 mgs%  
Urea :25  mgs%  Urea :26 mgs% RESPONSE:Poor 
Cholesterol :200mgs%  Cholesterol :198 mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
IN- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :1 IP.NO :2186 NAME :Mrs.Annalakshmi AGE/SEX :43/F OCCUPATION :Servent 
FROM :01.09.2008 TO :30.09.2008 NO.OF DAYS TREATED :30   
COMPLAINTS AND DURATION INVESTIGATION 
Dyspnoea on exertion,giddiness & 
palpitation  since 6 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9000 Cells/cumm Albumin:Nil TC:9100 Cells/cumm Albumin:Nil 
DC:  P65   %  L30   %  E5   % Sugar:Nil DC:  P 60  %  L38   %  E2   % Sugar:Nil
ESR :  ½ hr: 6  mm Deposits:NAD ESR :  ½ hr: 4  mm Deposits:NAD 
1hr :  10 mm MOTION 1hr :  6mm MOTION 
Hb :  9.6gms/dl( 64%) Ova:Nil Hb :  10.8 gms/dl(72 %) Ova:Nil 
MCV:88 cu µ Cyst:Nil MCV:91 cu µ Cyst:Nil 
PCV:36% Occult blood:Nil PCV:39% Occult blood:Nil 
Sugar(R):104  mgs%  Sugar(R) :110 mgs%  
Urea :18 mgs%  Urea:20 mgs% RESPONSE:Good 
Cholesterol:190 mgs%  Cholesterol :180 mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :2 IP.NO :2838 NAME :Mrs.Chellammal AGE/SEX :43/F OCCUPATION :House wife 
FROM :10.10.2008 TO :14.11.2008 NO.OF DAYS TREATED :35   
COMPLAINTS AND DURATION INVESTIGATION 
Tiredness,loss of appetite  since 1 
year 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:7800 Cells/cumm Albumin:Nil TC:8000 Cells/cumm Albumin:Nil 
DC : P65   %  L32   %  E2   % Sugar:Nil DC:  P60 %  L38   %  E2% Sugar:Nil 
ESR:   ½ hr: 5mm Deposits:NAD ESR  : ½ hr: 3 mm Deposits:NAD 
1hr : 9 mm MOTION 1hr : 5 mm MOTION 
Hb : 9.2gms/dl( 61%) Ova:Nil Hb : 10.6 gms/dl( 71%) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:NIL 
PCV: Occult blood:Nil PCV: Occult blood:Nil 
Sugar(R):105mgs%  Sugar(R):110  mgs%  
Urea :20 mgs%  Urea :21mgs% RESPONSE:Good 
Cholesterol :200 mgs%  Cholesterol:205mgs%   
 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
IN- PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :3 IP.NO :2830 NAME :Mr.Sankaran AGE/SEX :60/M OCCUPATION :Servent 
FROM :10.10.08 TO :14.11.08 NO.OF DAYS TREATED :35   
COMPLAINTS AND DURATION INVESTIGATION 
Giddiness,tiredness & loss of 
appetite  since 6 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:7200 Cells/cumm Albumin:Nil TC:7400 Cells/cumm Albumin:Nil 
DC:  P60   %  L33   %  E7   % Sugar:Nil DC:  P65   %  L33   %  E 2  % Sugar:Nil
ESR:   ½ hr:6 mm Deposits:NAD ESR:   ½ hr: 4    mm Deposits:NAD 
1hr : 12 mm MOTION 1hr :   7   mm MOTION 
Hb : 9.6 gms/dl(64%) Ova:Nil Hb : 11.1gms/dl( 74%) Ova:Nil 
MCV:87 cu µ Cyst:Nil MCV:92 cu µ Cyst:Nil 
PCV:36% Occult blood:Nil PCV:40% Occult blood:Nil 
Sugar(R)  :95mgs%  Sugar(R):100mgs%  
Urea :15 mgs%  Urea :20mgs% RESPONSE:Good 
Cholesterol :205mgs%  Cholesterol :210 mgs%   
 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :4 IP.NO :2815 NAME :Mrs.Jeyalakshmi AGE/SEX :60/F OCCUPATION :Housewife 
FROM :07.10.2008 TO :15.11.2008 NO.OF DAYS TREATED :40   
COMPLAINTS AND DURATION INVESTIGATION 
Loss of appetite & dyspnoea on 
exertion  since 7 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC :8900Cells/cumm Albumin:Nil TC:9000 Cells/cumm Albumin:Nili 
DC:  P62   %  L32   %  E6   % Sugar:Nil DC:  P65   %  L33   %  E2   % Sugar:Nil 
ESR:   ½ hr: 5mm Deposits:NAD ESR:   ½ hr: 3 mm Deposits:NAD 
1hr :   10 mm MOTION 1hr : 6  mm MOTION 
Hb :  9.5 gms/dl( 63%) Ova:Nil Hb : 10.4 gms/dl( 69 %) Ova:Nil 
MCV: Cyst:Nil MCV: Cyst:Nil 
PCV: Occult blood: PCV: Occult blood:Nil 
Sugar(R):90  mgs%  Sugar(R):91 mgs%  
Urea:21 mgs%  Urea:22 mgs% RESPONSE:Fair 
Cholesterol:210  mgs%  Cholesterol;215 mgs%   
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
IN-PATIENTS 
DRUG : THIRILOGA CHENDOORAM, 250MG BD WITH HONEY DIAGONOSIS :  PAANDU 
S.NO :5 IP.NO :2820 NAME :Mrs.Chellammal AGE/SEX :47/F OCCUPATION :Vendor 
FROM :07.10.2008 TO :07.11.2008 NO.OF DAYS TREATED :32   
COMPLAINTS AND DURATION INVESTIGATION 
Giddiness,dyspnoea on exertion & 
palpitation  since 9 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:9100 Cells/cumm Albumin:Nil TC:9200 Cells/cumm Albumin:Nil 
DC:  P63   %  L30   %  E 7  % Sugar:Nil DC:  P65   %  L31   %  E4   % Sugar:Nil
ESR:   ½ hr: 6 mm Deposits:NAD ESR :  ½ hr:   3  mm Deposits:NAD 
1hr : 10 mm MOTION 1hr :   5   mm MOTION 
Hb :    9.8gms/dl( 65%) Ova:Nil Hb :    11gms/dl( 73%) Ova:Nil 
MCV:88 cu µ Cyst:Nil MCV:92 cu µ Cyst:Nil 
PCV:35% Occult blood:Nil PCV:39% Occult blood:Nil 
Sugar(R) :117 mgs%  Sugar(R) :107mgs%  
Urea       :26 mgs%  Urea :23  mgs% RESPONSE:Good 
Cholesterol :193 mgs%  Cholesterol:200 mgs%   
 
+ Mild  ++ Moderate  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms Poor Response – Insignificant relief of symptoms 
